Genome transcription/translation of segmented, negative-strand RNA viruses by Geerts-Dimitriadou, C.
 
 
 
 
 
 
 
 
Genome Transcription/Translation 
of 
Segmented, Negative-Strand RNA Viruses 
 
 
 
 
 
Christina Geerts-Dimitriadou 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis committee 
 
Thesis supervisor 
Prof. dr. J.M. Vlak 
Personal chair at the Laboratory of Virology 
Wageningen University 
 
Thesis co-supervisor 
Dr. ir. R.J.M. Kormelink 
Assistant Professor at the Laboratory of Virology 
Wageningen University 
 
Other members 
Prof. dr. A.H.J. Bisseling (Wageningen University) 
Prof. dr. R.M. Elliott (University of St. Andrews, United Kingdom) 
Prof. dr. R.A.M. Fouchier (Erasmus University Medical Center Rotterdam) 
Prof. dr. E.J. Snijder (Leiden University Medical Center) 
 
 
This research was conducted under the auspices of the Graduate School of Experimental 
Plant Sciences.   
 
 
 
 
 
 
 
 
Genome Transcription/Translation 
of 
Segmented, Negative-Strand RNA Viruses 
 
 
 
 
 
Christina Geerts-Dimitriadou 
 
 
 
 
 
Thesis 
submitted in fulfillment of the requirements for the degree of doctor 
at Wageningen University 
by the authority of the Rector Magnificus 
Prof. dr. M.J. Kropff, 
in the presence of the 
Thesis Committee appointed by the Academic Board 
to be defended in public 
on Tuesday 28th of June 2011 
at 11 a.m. in the Aula.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Christina Geerts-Dimitriadou 
 
Genome Transcription/Translation of Segmented, Negative-Strand RNA Viruses 
152 pages 
 
PhD Thesis, Wageningen University, Wageningen, The Netherlands (2011) 
with references, with summaries in English and Dutch 
ISBN 978-90-8585-931-4   
 
 
Step by Step 
Step by step… 
I climbed to the mountain… 
And now that I’m standing on the top… 
I noticed next to it another one… 
even higher… 
 
Christina Geerts-Dimitriadou 
 
 
 
 
 
 
 
To my lovely 
husband Roy and children Jannis and Eleni. 
 
 
To you my lovely one, 
who your little heart stopped beating too early. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Life is what is happening to you while you are making other plans.” 
“Ζωή είναι ό,τι σου συμβαίνει ενώ κάνεις άλλα σχέδια.” 
 
Translated from the original Dutch:  
“Het leven is wat je gebeurt terwijl je andere plannen maakt”. 
 
Acda en de Munnik, album “Naar huis”, song “Laat me slapen”. 
 
 
 
 
 
  
Abstract 
 
 
The requirements for alignment of capped RNA leader sequences along the viral 
genome during influenza transcription initiation (“cap-snatching”) have long been an 
enigma. Previous work on Tomato spotted wilt virus (TSWV) transcription initiation has 
revealed that this virus displays a preference for leaders with increasing base 
complementarity to the 3'-ultimate residues of the viral RNA template. Assuming that cap-
snatching is a highly conserved mechanism, it is tempting to speculate that the findings for 
TSWV apply to all segmented negative RNA viruses. The research in this thesis aimed to 
analyze whether similar cap donor requirements applied for Influenza A virus transcription 
initiation as compared to what has been found for TSWV. Indeed, in vitro studies 
demonstrated that influenza transcriptase prefers multiple base-pairing capped leaders. 
Additionally, the occurrence of “prime-and-realign” during influenza transcription initiation 
was observed, as well as internal priming at the 3'-penultimate viral residue. The in vitro 
findings were confirmed by similar studies performed during influenza infection of cell 
cultures. Whereas transcription initiation of TSWV has been relatively well studied, 
transcription termination has not. It is postulated that transcription termination/translation is 
triggered by the formation of a hairpin structure. In cell experiments support a role of the 
TSWV hairpin structure in translation. 
 
 
 
 
 
Subject headings: antiviral drug, capped RNA leader, hairpin structure, Influenza A virus, 
Tomato spotted wilt virus, transcription, translation. 
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Chapter 1 
 
 
General Introduction 
 
 
Segmented, single-stranded (ss) RNA viruses of negative (-) polarity are classified 
within the families Orthomyxoviridae, Bunyaviridae, Arenaviridae and a few floating 
genera (Fauquet et al., 2005). They contain well known members of medical as well as 
agronomical importance (Table 1-1). One of the best known examples is influenza 
orthomyxovirus that causes infections which are responsible annually for considerable 
morbidity and mortality in humans. Among the bunyaviruses Rift Valley fever virus 
(RVFV), Crimean Congo hemorhagic fever virus (CCHFV) and Tomato spotted wilt virus 
(TSWV) are viruses that receive considerable attention. Since the late 1990’s RVFV is 
emerging in East Africa and causes severe disease in cattle and sometimes humans. 
CCHFV is listed as a potential biological weapon. The virus is found in Eastern Europe, 
Central Asia, the Middle East, Southern Europe and Africa and in documented outbreaks of 
CCHFV mortality rates in hospitalized patients range from 10 up to 50%. The plant-
infecting bunyavirus TSWV belongs to the top ten of most devastating plant viruses 
worldwide due to its large host range that includes economically important agricultural and 
ornamental plants. Arenaviruses include the South American Hemorrhagic fever (HF) 
viruses and Lassa fever virus (LFV) which cause severe human disease and pose a threat as 
agents of bioterrorism. 
Although all these viruses differ from each other in many ways (e.g. pathogenicity, 
host range, mode of transmission), they do have several features in common. Some of these 
are highly conserved and play important roles during replication of the viral RNA (vRNA) 
genome. The genome of (-) RNA viruses is not infectious, in contrast to positive (+) RNA 
viruses, as it cannot be directly translated into viral proteins to support in ongoing 
transcription and replication. Instead, their vRNA requires the association with 
nucleoprotein and RNA-dependent RNA polymerase (RdRp), reconstituted into 
transcriptionally active, infectious ribonucleocapsids (RNPs), to initiate an infection cycle. 
In the next paragraphs a brief overview will be presented on the replication cycle of 
segmented, (-) ssRNA viruses, with emphasis on transcription (initiation and termination) 
and translation, followed by the scope of this thesis. 
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 TABLE 1-1.   
Segmented (-) ssRNA viruses. 
 
 
Replication and transcription of segmented (-) ssRNA viruses 
 
Once segmented (-) ssRNA viruses have entered the cell by receptor-mediated 
endocytosis, the viral envelope fuses with the endosome to release transcriptionally-active 
RNP complexes into the cytoplasm. The RNPs are composed of vRNA, viral nucleoprotein 
(N), and the viral RdRp and form the initiating complex for the synthesis of progeny vRNA 
(RNPs). The vRNA is first transcribed into mRNA (+ strand) to allow for the synthesis of 
larger amounts of viral proteins (N and RdRp) that are required for replication and 
subsequent encapsidation of progeny RNA into RNPs. Once viral proteins are synthesized, 
the vRNA will serve as template for the synthesis of full-length antigenomic (or viral-
complementary, vc) RNA, which subsequently serves as template for the synthesis of 
progeny vRNA. The latter becomes encapsidated by N and small amounts of RdRp to form 
transcriptionally-active RNPs. These then become enveloped, which usually involves 
budding through one of the cellular membranes. Viruses of the large family of arthropod-
born Bunyaviridae, whose members are primarily restricted to animals (Elliott, 1990), obtain 
their lipid envelop from intracellular membranes, i.e. the Golgi complex, which requires a 
final secretion from the cell after transport of the viruses within vesicles to the plasma 
membrane. For the plant-infecting bunyaviruses, in casu TSWV, particle assembly also 
takes place at the Golgi complex, but particles formed do not become secreted from plant 
cells. Instead they accumulate and are retained in large endoplasmic reticulum (ER)-derived 
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vesicles until uptake and further spread by its trips insect vector occurs. Members of the 
Orthomyxoviridae and Arenaviridae obtain their envelop by budding of RNPs from the 
plasma membrane from where virus particles are released and able to initiate infection of 
neighboring cells.  
Most of the segmented (-) ssRNA viruses replicate in the cytoplasm of infected 
host cells, with the exception of orthomyxoviruses which replicate in the nucleus (Table 1-
1). For the orthomyxoviruses, RNPs need to be transported from the cytoplasm into the 
nucleus where transcription and replication occur.  
The genomes of segmented (-) ssRNA viruses consist of two (Arenaviridae), three 
(Bunyaviridae) or six-to-eight RNA segments (Orthomyxoviridae). Each RNA segment 
constitutes a separate replication and transcription unit. The 5'- and 3'-terminal nucleotides 
of each segment are highly conserved (Table 1-2) and show partial inverted 
complementarity, leading to the formation of a panhandle structure that contains the base-
paired terminal ends. Due to the panhandle structure, RNPs reveal a pseudo-circular 
appearance in electron micrographs (Figure 1-1). The highly conserved 5' and 3' ends of 
genome vRNAs contain the promoter regions for replication and transcription.  
Reverse genetic studies using Bunyamwera virus (BUNV) replicons have revealed 
that the ability of the genomic RNA termini to base-pair is an important requirement of 
bunyavirus replication (Barr and Wertz, 2005). In addition, detailed analysis of the first 20 
nt of the 5' and 3' ends of the BUNV S segment showed that sequence complementarity and 
structure play a significant role in transcription as well (Kohl et al., 2004). Mutational 
analysis of the Uukuniemi virus (UUKV) putative promoter element surprisingly reveals 
major differences compared to studies carried out on the Influenza A virus (Flick et al., 
1996, id. 1999) and the RVFV (Prehaud et al., 1997) promoter regions. In UUKV, neither 
single point substitutions nor changing of panhandle base-pairs within the putative 
promoter element altered the resulting promoter activity (Flick et al., 2002). On the other 
hand, using a similar strategy the putative element of the influenza A promoter plays an 
important role during the viral polymerase interaction, either as a stabilizing double-
stranded promoter element (Flick et al., 1996; Fodor et al., 1994, id. 1995; Kim et al., 
1997) or as a regulatory element for viral mRNA transcription rates (Fodor et al., 1998).  
For influenza virus, several models exist for genome transcription based on the 
formation of specific folding structures within the 5' and 3' viral termini. The most 
simplified model describes formation of a panhandle structure due to base-pairing of the 5' 
and 3' ends (Hsu et al., 1987). A so called “Fork” model (Fodor et al., 1994, id. 1995), 
describes a single-stranded conformation for nucleotides 1-10 at the 5' end of the vRNA 
and nucleotides 1-9 at the 3' end, and a double-stranded element for nucleotides 11-13 and 
10-12 at the 5' and 3' end of the vRNA, respectively. The “Corkscrew” model (Flick et al., 
1996, id. 1999) suggests formation of short stem-loop structures within both termini upon 
binding to polymerase, and involves base-pairing of nucleotides at position 2 and 9, and 3 
and 8 of each genomic end and exposure of the intermediate positions 4-7 as a single-
  15 
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stranded tetra-loop RNA structure. One of the latest models describes a combination of the 
“Fork” and the “Corkscrew” models but only proposes a functional stem-loop structure at 
the 5' end and not at the 3' end of the vRNA (Pritlove et al., 1999).  
 
 
 TABLE 1-2.   
Sequence of the 3' UTRs of ten members of segmented (-) ssRNA viruses. 
Sequence of the 3' UTR with complementarity to the 5' UTR is in bold and italics. Abbreviation: UTR, 
untranslated region. Virus abbreviation: BUNV, Bunyamwera virus; DUGV, Dugbe virus; HTNV, Hantaan 
virus; LACV, La Crosse virus; LCMV, Lymphocytic choriomeningitis virus; RSV, Rice stripe virus; 
RVFV, Rift Valley fever virus; TSWV, Tomato spotted wilt virus. 
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Although replication of segmented (-) ssRNA viruses initiates from the 3' end of 
the genome vRNA and antigenome RNA to make full-length copies, genome transcription 
initiates only on the vRNA template with the exception of the arena-, phlebo- and 
tospoviruses. These viruses (additionally) contain one or more genome segments with an 
ambisense coding strategy and require bi-directional transcription of the v- and vcRNA 
strands for the expression of their genes. Whereas replication is initiated right at the 3' end 
of the vRNA template, transcription in contrast requires a short capped RNA primer for 
viral mRNA synthesis (Buchmeier et al., 2001; Lamb and Krug, 2001; Schmaljohn and 
Hooper, 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1-1. (A) Electron micrograph of TSWV RNPs. (B) Schematic presentation of the 
pseudo-circular RNPs of TSWV (upper diagram) and influenza virus (lower diagram).  
 
 
Transcription (initiation and termination) and translation strategies 
 
The RdRp of segmented (-) ssRNA viruses does not contain methyltransferase 
activity, and thus is not able to cap its own transcripts. To render translatable RNA 
transcripts, these viruses provide their mRNAs with a cap structures from host cellular 
mRNA molecules, by a process called “cap-snatching” (Bouloy et al., 1978). Viral 
transcripts thus can be distinguished from (anti)genomic RNA strands by the presence of a 
non-viral capped RNA leader sequences at their 5' ends. During cap-snatching, as being 
discovered and described first for influenza virus (Beaton and Krug, 1981; Bouloy et al., 
1978; Caton and Robertson, 1980; Dhar et al., 1980; Plotch et al., 1979, id. 1981), the 
A B 
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viral polymerase steals capped RNA leader sequences from nascent host cell RNA 
polymerase II transcripts in the nucleus (for influenza virus) or from mature transcripts in 
the cytoplasm (for arena- and bunyaviruses) by endonucleolytic cleavage and uses them as 
cap donors/primers to initiate genome transcription (Figure 1-2). 
The capped leaders vary in size from 1-7 nt in arenaviruses (Garcin and 
Kolakofsky, 1992; Meyer and Southern, 1993), 7-25 nt in hantaviruses (Garcin et al., 
1995), nairoviruses (Jin and Elliott, 1993b), orthobunyaviruses (Bishop et al., 1983; 
Bouloy et al., 1990; Dobie et al., 1997; Jin and Elliott, 1993a), phleboviruses (Collett, 
1986; Simons and Pettersson, 1991), tospoviruses (Duijsings et al., 2001; Kormelink et 
al., 1992b; van Knippenberg et al., 2005a) and 10-13 nt in influenza viruses (Lamb and 
Horvarth, 1991; Shaw and Lamb, 1984). 
 
 
 
 
 
 
 
 
 
 Figure 1-2. Schematic presentation of TSWV genome transcription 
initiation. Cleavage of a cellular mRNA and subsequent use of the capped 
RNA leader as primer for transcription initiation is shown. 
 
 
To explain data from transcription initiation and replication studies for Hantaan 
virus (Bunyaviridae), an additional “prime-and-realign” mechanism has been proposed 
(Garcin et al., 1995). During this phenomenon, transcription is primed by a capped RNA 
molecule with a G residue at its 3' end. Priming occurs internally, i.e. on the C residue at 
position +3 from the 3' end of the vRNA template (3'-AUC…). After extension for a few 
nucleotides the leader is released and progressive elongation takes place only after 
backward re-alignment by virtue of the viral 3'-terminal sequence repeats. Although this 
mechanism remains to be further elucidated, it also explains the presence of repetitive 
sequences within the 5' leader of viral mRNAs from several phleboviruses (Prehaud et al., 
1997; Simons and Pettersson, 1991), orthobunyaviruses (Bishop et al., 1983; Bouloy et 
al., 1990; Jin and Elliott, 1993a; Vialat and Bouloy, 1992) and tospoviruses (Duijsings et 
al., 1999, id. 2001; van Knippenberg et al., 2005a). 
Only limited information is available on transcription termination for many of the 
segmented (-) ssRNA viruses. Studies on influenza virus transcription termination have 
shown that RNA segments of this virus contain a U tract element near the 5' end of the 
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vRNA template that coincides with the end of transcription (Li and Palese, 1994; 
Robertson, 1979; Robertson et al., 1981) and appears functionally analogous to the U tract 
within non-segmented (-) RNA viruses (Poon et al., 1999). The poly(A) tail of influenza 
virus mRNAs is synthesized by reiterative copying of this U-tract sequence once the RNA 
polymerase bounces into the panhandle structure. In contrast, transcription termination for 
other segmented (-) RNA viruses, such as members of the Arena- and Bunyaviridae, is not 
at all clear (Buchmeier et al., 2001; Schmaljohn and Hooper, 2001). 
In the (-) sense coding segments of these viruses, sequence motifs have been found 
near or at the 3' end of mRNAs to be involved in transcription termination (Schmaljohn 
and Hooper, 2001). For the phleboviruses RVFV and Toscana virus (TOSV), mRNA 
transcribed from the M RNA segment was found to terminate after a C-rich region in the 
virus templates (Collett, 1986; Gro et al., 1997). For the ambisense coding segments, RNA 
secondary structures or G-rich like sequence motifs within the intergenic region (IR) appear 
to terminate the elongation by viral polymerase (Buchmeier et al., 2001; Schmaljohn and 
Hooper, 2001). For arenaviruses, transcription termination clearly involves secondary RNA 
structures as it was shown for Tacaribe virus (TV) (Iapalucci et al., 1991; Lopez and 
Franze-Fernandez, 2007). By using a reverse genetics system, for the first time direct 
experimental evidence was obtained which supported the idea that transcription termination 
in TV is related to a single, highly stable hairpin structure that is independent of sequence. 
This structural element comprises a terminal loop and a stem with variable numbers of 
uninterrupted base-pairs. Hairpin structures were also predicted at the IR of the ambisense 
S and M RNA segments of the plant-infecting tospoviruses, indicating that mRNA 
transcription termination of their ambisense RNA segments might also involve secondary 
RNA folding structures (mechanisms) similar to those described for arenaviruses (de Haan 
et al., 1990; van Knippenberg et al., 2005b). For the phleboviruses, transcription 
termination within the ambisense S RNA segment is less clear. Secondary structure 
prediction analysis suggests that the IR region of the S segment of Punta toro phlebovirus 
forms a stable hairpin structure while transcription termination of its mRNAs maps near the 
top of this structure (Emery and Bishop, 1987). Studies on the ambisense S RNA of 
Uukuniemi phlebovirus (UUKV) demonstrated that both RNA transcripts terminate beyond 
the IR, i.e. within a sequence that localizes in the 3' end of the other opposite open reading 
frame (ORF) (Simons and Pettersson, 1991). Within this IR region, a short A/U-rich 
hairpin folding structure is predicted, although this structure does not seem very stable. A 
similar overlap in the 3' ends of N and NSs (non-structural protein) mRNAs was observed 
for TOSV phlebovirus (Gro et al., 1992, id. 1997). However, no RNA folding structures 
were observed in the IR of the S RNA segment of RVFV, Sandfly fever Sicilian virus 
(SFSV), and TOSV phleboviruses. Instead, G-rich regions are present in the sequence 
where transcription termination occurs (Giorgi et al., 1991).  
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Systems for the manipulation of a segmented (-) RNA virus 
 
In order to study the cis-and trans-acting factors involved in replication and 
transcription of viral genomes from segmented (-) ssRNA viruses, several in vitro and 
reverse genetics systems have been established. The first system was developed by Luytjes 
et al. (1989) and allowed manipulation of Influenza A virus. The system was based on the 
transfection of in vitro reconstituted RNP complexes into helper influenza virus-infected 
cells. Although being the first of its kind, it had a few limitations and disadvantages. First, 
it required appropriate selection systems to distinguish the modified virus from the helper 
virus. Secondly, it did not allow identification of trans-acting signals required for 
transcription/replication of the viral genome. Thirdly, the system suffered from the 
limitation that engineering of all RNA segments was not possible. As an alternative, an 
influenza virus-free in vitro system was developed which was based on the use of 
recombinant Vaccinia virus-expressed PB1, PB2 and PA, and allowed exploration of the 
influenza virus polymerase complex. Studies using this approach demonstrated that the 
active polymerase requires sequences located at both the 5' and 3' ends of the viral genome 
(Hagen et al., 1994; Tiley et al., 1994). However, also within this system manipulation of 
all RNA segments was not possible. 
A system that provided this option became available with the development of 
reverse genetics systems based on minireplicons. These have meanwhile been developed 
for a majority of the segmented (-) RNA viruses [arenaviruses (Lee et al., 2000; Lopez et 
al., 1995) and bunyaviruses (Accardi et al., 2001; Blakqori et al., 2003; Dunn et al., 1995; 
Flick and Pettersson, 2001; Flick et al., 2003a and b; Prehaud et al., 1997)] in which, a 
virus-like RNA (minigenome) template containing a reporter gene (e.g. CAT) flanked with 
the 5' and 3' untranslated regions (UTR) of vRNA is driven from T7- or RNA polymerase I 
(Pol I)-driven plasmids. Replication and transcription of the RNA template was obtained 
during co-expression with the viral nucleoprotein and polymerase proteins from RNA 
polymerase II (Pol II)-driven plasmids or co-infection with helper virus (Figure 1-3). In 
case T7 RNA polymerase driven plasmids are used, the polymerase is provided by co-
infection with a T7-recombinant Vaccinia virus (vv-T7) (Accardi et al., 2001; Dunn et al., 
1995; Lopez et al., 1995) (Figure 1-4). The minireplicon system mimics replication and 
transcription of viral genomic RNA and is used as an excellent approach to identify and 
subsequently mutagenize promoter elements for initiation of both transcription and 
replication of vRNA segments, but also maps genome packaging signals. In this way, e.g. 
the panhandle structure of the UUKV phlebovirus S RNA segment was demonstrated to 
contain the promoter elements for transcription and replication, and that recognition by the 
viral RdRp involved both the 5' and 3' UTR (Flick et al., 2002).  
In contrast to the reconstitution of transcriptionally active RNPs from cloned 
copies of vRNA segments, the rescue of infectious virus particles entirely from cloned 
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cDNA has only been achieved for a few segmented (-) ssRNA viruses. The first one 
rescued entirely by reverse genetics was the BUNV (Bridgen and Elliott, 1996). Copies of 
the large (L), medium (M) and small (S) RNA segments were expressed from T7 RNA 
polymerase driven plasmids, flanked at their 3' end with a ribozyme to generate authentic 
viral termini. In the additional presence of N and RdRp encoding plasmids and T7 RNA 
polymerase-expressing Vaccinia virus, BUNV particles were obtained. Successful 
generation of recombinant Influenza A virus entirely from cDNAs was achieved with a 
system in which cDNA constructs for all (8) RNA segments were expressed from RNA 
Polymerase I driven plasmids in the additional presence of 4 RNA (Pol II) driven constructs 
coding for the N and polymerase (PA, PB1 and PB2) proteins (Fodor et al., 1999; 
Neumann et al., 1999). This system was a breakthrough in the field of orthomyxovirus 
research and allowed manipulation of all viral genomic segments simultaneously. In 
another case, the Thogoto orthomyxovirus (THOV) has been rescued by a combination of 
the T7- and Pol I-driven systems (Wagner et al., 2001). Most of the current knowledge on 
trans-acting elements required for viral transcription and replication has been obtained by 
studies involving the recovery of transcriptionally active RNPs from cloned cDNA. 
The limitation of the RNA Pol I system is that transcription exhibits species 
specificity. For this reason, species specific RNA Pol I promoters have to be used for each 
different cell type. On the other hand, the T7 RNA polymerase system is based on the 
vaccinia helper virus which has the potential disadvantage that due to the cytopathogenic 
effect of Vaccinia virus infection the cells can only be studied for a limited amount of time. 
For this reason, an improved T7 RNA polymerase system has been developed in which T7 
expressing cell lines are used that do not require the vaccinia helper virus anymore 
(Blakqori and Weber, 2005; Ikegami et al., 2006; Lowen et al., 2004; Sanchez and de la 
Torre, 2006; de Wit et al., 2007). A disadvantage of this system is that its success depends 
on stable cell lines with high levels of T7 polymerase expression.  
Despite some disadvantages and limitations with each of these systems, they 
altogether have enormously boosted the insight into the replication/transcription of 
segmented (-) ssRNA viruses. Besides this, influenza virus RNA packaging signals 
meanwhile have been identified and fine mapped (Liang et al., 2005, id. 2008), entire virus 
strains (e.g. 1918 Spanish Flu) have been reconstituted and their pathogenicity can now be 
studied as well as pathogenicity factors themselves. Furthermore, reassortants can readily 
be made for fundamental studies and/or to provide in new strains for vaccine production. 
Finally, the reverse genetics systems may contribute in the development of vectors for 
therapeutic gene delivery by generating virus-like particles. These particles lack one or 
more viral genes encoding structural proteins. As result, infectious progeny viruses cannot 
be generated.  
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 Figure 1-3. Systems for the generation of Influenza A virus from cloned cDNA. Cells are 
transfected with (A) a plasmid containing a cDNA that encodes one of the viral RNAs, flanked by 
RNA polymerase (Pol) I promoter and terminator sequences, or (B) plasmids that encode all eight 
vRNAs under the control of the RNA Pol I promoter and plasmids encoding the four required viral 
proteins (PB1, PB2, PA and NP) for vRNA replication and transcription under control of the RNA 
Pol II promoter. In the first case, influenza helper virus is required for vRNA replication and 
transcription. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1-4. Vaccinia virus-T7 (vv-T7) system. Virus rescue requires the transfection of a cell with 
plasmids encoding the genome segments along with the support plasmids encoding the viral proteins 
needed for replication and transcription, all under the control of a T7 promoter. RNA transcripts are 
produced by the bacteriophage T7 RNA polymerase which is provided by infection with a T7-
recombinant Vaccinia virus. The exact end of the RNA is specified by self-cleavage of the nascent 
RNA by the Hepatitis delta virus (Hep δ) antigenome ribozyme.   
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Scope of this Thesis 
 
Recently, extensive studies on transcription initiation of the plant-infecting 
bunyavirus TSWV have revealed that the virus displays a preference for multiple base-
pairing cap donors during transcription initiation (Duijsings et al., 1999, id. 2001; van 
Knippenberg et al., 2002, ead. 2005a). Considering that cap-snatching is a highly 
conserved mechanism, it is tempting to speculate that the findings for TSWV apply to all 
segmented (-) ssRNA viruses. However, for many of these viruses, no such information is 
available, and findings have been limited to the cloning of viral transcripts and elucidation 
of non-viral leader sequences. For Influenza A virus extensive research has been performed 
on transcription initiation (Beaton and Krug, 1981; Bouloy et al., 1978; Caton and 
Robertson, 1980; Dhar et al., 1980; Plotch et al., 1979, id. 1981), but one major question 
still has not been answered and has remained a matter of strong debate for a long time: do 
capped RNA leaders require a base complementarity to the vRNA template to prime 
transcription. For Influenza A virus conflicting reports exist on this issue. While some in 
vitro studies suggest that base-pairing between the capped leader and the viral genome may 
contribute to the alignment of the leader to the vRNA template (Plotch et al., 1981; Hagen 
et al., 1994; Chung et al., 1994), other studies support the idea, which is favored by most, 
that priming by capped RNA does not require base-pairing with the influenza vRNA 
template (Hagen et al., 1995; Krug et al., 1980).  
To address this issue, first an in vitro transcription system was established for 
influenza based on the use of transcriptionally active purified virus particles, and tested for 
its capacity to accept an exogenous Alfalfa mosaic virus (AlMV) RNA as a source for 
capped RNA leaders (Chapter 2). In Chapter 3, various mutant AlMV RNA3 (AlMV3) 
leaders, differing in i) base complementarity to the vRNA template, ii) residues 5' of 
potential base-pairing residues or iii) leader length, were tested as cap donors in the in vitro 
assay in pair-wise or multiple competition assays. Based on these findings, less-favored and 
well favored cap donor molecules were tested for their competitiveness during globin-
initiated influenza NS1 gene transcription in vitro. To substantiate these findings and 
confirm that the in vitro findings genuinely reflect the cap-snatching mechanism during a 
natural infection in vivo, similar studies were repeated in influenza virus infected cell 
cultures (Chapter 4).  
While transcription initiation of TSWV has been well studied, transcription 
termination from the ambisense S and M genomic RNA segments has not. In this case, 
transcription termination is most likely triggered by the formation of a folding structure 
during nascent transcription of the IR. The IR of TSWV contains stretches of highly A- and 
U-rich sequences which are predicted to fold into a stable hairpin structure. As a result, 
viral transcripts do not contain a common poly(A) tail, but a 3' predicted (AU-rich) hairpin 
structure. It is postulated that this hairpin likely acts as a functional equivalent to a poly(A) 
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tail and hence plays an important role in translation. To test this hypothesis, various N 
gene-based constructs (Figure 1-5) were made and tested in Baby Hamster Kidney (BHK-
21) cells for translation efficiency in a vv-T7 expression system (Chapter 5).  
In Chapter 6, the results of the experimental chapters are discussed in the light of 
reported findings on genome transcription initiation and termination of the animal-infecting 
bunyaviruses. The commonalities found between TSWV and Influenza A virus cap-
snatching are discussed and taken as a starting point for a proposed antiviral drug design 
against a large variety of different segmented (-) ssRNA viruses. 
 
 
 
 
 
 
 Figure 1-5. Tomato spotted wilt virus (TSWV). Schematic presentation of TSWV virus particle 
and its genomic organization. vRNA is viral sense RNA, vcRNA is viral complementary RNA. 
ORFs are indicated by boxes. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Education is a guide; knowledge is a key.” 
 
Buddha 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
  
Chapter 2 
26 
 
 
Purified Influenza A virus particles support genome 
transcription in vitro 
 
 
During influenza virus infection, the viral polymerase snatches cellular mRNAs to 
obtain capped RNA primers for transcription initiation. Here, an in vitro transcription 
system was established based on the use of purified influenza virus particles. De novo 
synthesis of viral RNA was shown only in the presence of Rabbit reticulocyte lysate (RRL) 
and rendered products that reflected viral genomic RNA segments in size. The requirement 
for RRL could not be replaced by the addition of RNA as source for capped RNA leaders, 
neither by elevating the rNTP concentration. The occurrence of de novo viral genome 
transcription was demonstrated by cloning and sequence analysis of viral transcripts 
containing non-viral leader sequences. The latter were snatched either from α- and β-globin 
mRNAs present within the RRL, or from Alfalfa mosaic virus RNAs that were added as 
source for capped RNA leaders.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A slightly modified version of this chapter has been published as: 
Geerts-Dimitriadou, C., Zwart, M.P., Goldbach, R., Kormelink, R., 2011. Virology 409, 17-26. 
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Introduction  
 
Influenza A virus is a representative of the Orthomyxoviridae, whose members are 
characterized by a segmented single-stranded (ss) RNA genome of negative (-) polarity. In 
contrast to positive (+) ssRNA viruses whose genomes are able to initiate infection in the 
absence of any other viral products, the genomes of (-) ssRNA viruses alone are non-
infectious. Initiation of virus transcription and replication requires the viral polymerase 
complexed with the viral RNA (vRNA) and nucleoprotein into transcriptionally active 
ribonucleoprotein (RNP) complexes. 
The viral polymerase of influenza virus consists of three subunits: PB1, PB2, and 
PA. It transcribes and replicates the viral genome which consists of eight RNA segments. 
Synthesis of viral mRNA from the (-) genomic vRNA is dependent on a capped RNA 
primer mechanism, known nowadays as “cap-snatching” (Beaton and Krug, 1981; Bouloy 
et al., 1978; Caton and Robertson, 1980; Dhar et al., 1980; Plotch et al., 1979, id. 1981). 
During this mechanism, the viral polymerase binds to the 5' cap structures of cellular 
mRNAs and cleaves the cellular mRNAs 10-13 nt downstream of the cap (Li et al., 2001). 
The resulting capped RNA leader is used by the viral polymerase to prime transcription. 
The 5' and 3' ends of the vRNA template have partial inverted complementarity and form a 
panhandle structure (Li and Palese, 1994; Robertson, 1979). During transcription 
termination the viral polymerase complex starts stuttering once it runs into the panhandle 
structure, leading to poly-adenylation template by a stretch of 5 to 7 U residues about 17 nt 
from the 5' end (Robertson et al., 1981). In contrast to transcription, replication of the 
genome does not require a primer. Instead, the viral polymerase initiates RNA synthesis on 
the 3' residue of the vRNA.  
Several studies have been carried out on the transcriptional activity of the 
polymerase and the requirements for elongation of capped RNA leaders on the vRNA 
template. The insight into these processes has advanced with the use of various in vitro 
(Hagen et al., 1994; Tiley et al., 1994) and reverse-genetics systems (Fodor et al., 1999; 
Neumann et al., 1999), in which many cis- and trans-acting elements involved in 
transcription/translation have been analyzed. Luytjes et al. (1989) established the first 
system for the manipulation of Influenza A virus. In vitro reconstituted RNPs were 
transfected into helper influenza virus-infected cells. RNP complexes were made by 
incubating synthetic RNA transcripts with purified nucleoprotein (NP) and the three viral 
polymerase proteins (PB1, PB2 and PA) from influenza virus. The helper virus was used as 
an intracellular source of viral NP and the polymerase proteins and of the other vRNAs. 
Alternative influenza virus-free in vitro systems have been described exploring the 
influenza virus polymerase complex expressed by recombinant vaccinia viruses (Hagen et 
al., 1994; Tiley et al., 1994).  
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Reverse genetics systems based on plasmid DNA for the reconstitution of 
Influenza A virus entirely from cDNAs (Fodor et al., 1999; Neumann et al., 1999), have 
made the vaccinia helper virus superfluous. Transfection of eight plasmids under the 
control of an RNA polymerase (Pol) I promoter for the production of vRNA and four 
expression plasmids encoding the three polymerase proteins and NP under the control of an 
RNA Pol II promoter resulted in the rescue of infectious virus. Hoffmann et al. (2000) 
introduced a modification of the RNA Pol I system, the Pol I/II system, in which virus can 
be generated from only eight instead of 12 plasmids. In this system, the eight genome 
segments encoding (-) sense vRNA is cloned between the RNA Pol I promoter and 
terminator transcription unit. This transcription unit is further inserted in the (+) orientation 
between an RNA Pol II promoter and a transcription termination signal. Transfection of 
these eight plasmids results in the production of mRNA and (-) sense vRNA generated from 
the same DNA template. In order to reduce the number of plasmids to be transfected and 
thus enabling the use of cell lines with low transfectability, an improved Pol I system was 
also developed (Neumann et al., 2005). In this system, plasmids containing up to eight 
RNA Pol I transcription cassettes were generated.  
All these systems have the disadvantage of using a species specific RNA Pol I 
transcription which limits their use to cells of primate or avian origin. To circumvent this 
problem, another reverse-genetics system was developed for the rescue of recombinant 
influenza virus using T7 RNA polymerase (de Wit et al., 2007). Expression of T7 RNA 
polymerase was provided from a contransfected plasmid DNA, a strategy that is applicable 
in all mammalian cell lines irrespective of their host origin. One potential disadvantage, 
however, is the strict dependency on cell lines which constitutively express high levels of 
T7 RNA Polymerase. 
So far, the many diverse in vitro and in vivo reconstitution systems used to study 
transcription/translation of influenza virus have led to some conflicting results, e.g. the 
requirement of only one terminal end for endonuclease activity in one system (Li et al., 
2001), versus both termini in another system (Cianci et al., 1995; Hagen et al., 1994).  
More recent studies on the plant-infecting bunyavirus Tomato spotted wilt virus 
(TSWV) have shown that extensive base-pairing between capped RNA leaders and vRNA 
template promote cap donor usage (Duijsings et al., 2001; van Knippenberg et al., 2005a). 
On this point only limited data is available for influenza virus, but also here several studies 
present conflicting results (Hagen et al., 1994; Krug et al., 1980; Rao et al., 2003). Since 
cap-snatching seems a highly conserved mechanism of transcription initiation for 
segmented (-) ssRNA viruses, it is not unlikely that the observations earlier made for 
TSWV apply for influenza virus as well. In order to test this hypothesis and in specific 
analyze cap donor requirements during influenza virus cap-snatching in further detail, a 
virus transcription system was required.  
The present study describes the establishment of an in vitro system that employs 
purified Influenza A virus particles to support the synthesis of viral mRNA. The use of α- 
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and β-globin mRNAs present in the RRL, and exogenously added wild type (WT) Alfalfa 
mosaic virus RNA3 (AlMV3) as source for capped RNA leaders opens the possibility to 
exploit the system to study influenza transcription initiation in further detail. 
 
 
 
 
Results 
 
Influenza A transcription in the presence of RRL 
 
To enable an investigation on cap donor requirements during influenza 
transcription initiation, an in vitro transcription assay was established (Figure 2-1; 
Materials and methods) in which purified Influenza A virus particles support transcription. 
It was decided to choose purified mature virus particles for this since these contain the 
minimal elements to initiate, like in a natural infection cycle, the first transcription steps 
that are required for ongoing transcription/replication.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2-1. Schematic representation of the methodology. In vitro influenza 
transcription assay of de novo synthesized viral transcripts. As cap donors 
endogenous globin mRNA or exogenously added AlMV3 transcripts are used.  
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In vitro reaction products from assays performed in the presence of 
radionucleotides were resolved by RNA electrophoresis. The results showed that purified 
virus particles supported the de novo synthesis of RNA molecules, but only in the presence 
of RRL (Figure 2-2, lanes 1 and 2). Earlier, this was also observed for several other (-) 
ssRNA viruses (Bellocq et al., 1987; Nguyen et al., 1997; van Knippenberg et al., 2002; 
Vialat and Bouloy, 1992) in which the requirement of RRL was explained to provide not 
only in a source of capped RNAs but also factors needed to support in ongoing transcription 
and prevent premature transcription termination.  
When AlMV3 RNAs were used as primers for in vitro influenza transcription in 
the absence of RRL, similar to earlier studies on several other (-) ssRNA viruses (Bouloy et 
al., 1980; Li et al., 2001; Plotch et al., 1979, id. 1981; Robertson et al., 1980; van 
Knippenberg et al., 2002), no transcriptional activity was observed (Figure 2-2, lane 4). 
The additional increase of rNTP concentrations in the absence of RRL did not recover 
influenza transcriptional activity either (data not shown).  
When in addition to RRL, AlMV3 RNA was provided to the in vitro transcription 
no further increase in transcriptional activity was observed in comparison to the activity 
observed in the presence of RRL only (Figure 2-2, lanes 1 and 3). This was most likely 
due to the fact that sufficient globin mRNA molecules were present in the RRL to supply in 
a source of capped RNA for cleavage of 9-13 nt capped RNA leaders. This was 
strengthened by the observation that the same RRL was previously shown to provide 
sufficient amounts of globin RNA for cleavage of ~16 nt sized capped globin RNA leaders 
to initiate in vitro genome transcription of TSWV (van Knippenberg et al., 2002), in which 
additional AlMV RNA also did not further increase the yields of TSWV transcription. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2-2. Analysis of in vitro 
synthesized influenza mRNA. In vitro 
transcription reactions using [α-32P]CTP 
radiolabelled nucleotides in the 
presence/absence of RRL were resolved 
in a 1% agarose gel and subsequently 
blotted to Hybond-N membrane. Lanes 
1-4: Active virus. Lanes 5-6: heat-
inactivated virus. In the absence of RRL, 
addition of AlMV3 leaders did not 
recover transcription. RNA size markers 
are indicated at the left.  
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RT-PCR analysis of influenza transcripts 
 
To verify that (some of) the de novo synthesized RNA molecules were products of 
genuine transcriptional rather than replicational activity, NS1 RNA molecules from the in 
vitro reaction were reverse transcriptase (RT) PCR cloned and analyzed for the presence of 
non-viral leader sequences. In view of the expected short (9-13 nt) added leaders, a strategy 
using the template-switch capacity of SuperscriptTM II RT was applied to amplify de novo 
synthesized transcripts (Figure 2-3A; Materials and methods). In brief, first-strand cDNA 
was primed using an internal oligonucleotide for the Influenza NS1 (or NP) gene in the 
additional presence of a template-switch oligonucleotide (TS-oligo) (Figure 2-3A). Once 
Superscript II RT reached the 5' end of a mRNA (and not of a genomic RNA strand), its 
terminal transferase activity attached several C-residues onto the newly synthesized cDNA 
strand. Subsequently, the TS-oligo, containing a terminal stretch of G residues, paired with 
the extended first strand cDNA tail and served as an extended template for RT to switch to. 
As a result, the template switch approach resulted in a DNA copy of the entire 5' leader 
sequence of viral mRNA transcripts flanked by the TS-oligo sequence. Final PCR 
amplification of the first-strand cDNA involved a nested NS1 (or NP) primer, and a primer 
matching the TS-oligo sequence in combination with i) the first 11 nt of the α-globin 
mRNA leader sequence, ii) the first 6 nt identical in both α- and β-globin mRNA leader 
sequence, or iii) the first 8 nt of the AlMV3 leader sequence. 
Cloning and sequencing of the products obtained (Figure 2-3B, lane 1) revealed 
the presence of α- or β-globin RNA leader sequences at the 5' ends of NS1 transcripts, 
snatched from globin mRNAs present in the RRL (Table 2-1), thus confirming the 
occurrence of in vitro transcription. Control reactions using heat-inactivated virus never 
yielded any PCR product (Figure 2-3B, lane 2). Surprisingly, 16 out of the 19 clones 
analyzed contained α-globin leader sequences in viral transcripts and only 3 (out of 19) β-
globin leader (Table 2-1). A closer look at those sequences indicated that cleavage of α-
globin leaders possibly took place after A14 or A14G15 in order to allow base-pairing with 
the UC residues at positions +1 and/or +2 from the 3' end of the vRNA template (3'-
UCG…). On the other hand, cleavage of β-globin leaders might have occurred after A14 to 
assist in base-pairing to the ultimate U residue of the influenza template.  
The idea of base-pairing is further strengthened by the observation that 5 out of 
these 19 clones, lacked the first viral A residue, which likely could be due to cleavage after 
G9 or G10 within the α-globin leader and after G13 within the β-globin leader and subsequent 
internal priming on the 3'-penultimate C residue of the viral template (Table 2-1). 
Additionally, 3 of these leaders showed a repetitive sequence (GCAGC) that probably may 
have resulted from prime-and-realign. 
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 Figure 2-3. RT-PCR of de novo synthesized viral transcripts. (A) Schematic procedure of 
RT-PCR amplification of influenza viral transcripts harboring non-viral leader sequences, using 
the template-switch methodology. (B) RT-PCR analysis of in vitro synthesized influenza mRNA 
in the presence of RRL, and active virus (lane 1) or heat-inactivated virus (lane 2). Reverse 
transcription was performed using internal primer specific for the Influenza NS1 gene, followed 
by PCR using internal primer for the same gene in combination with a primer specific for the 5' 
first 6 nt of α- or β-globin mRNA. M: molecular marker. 
 
 
 
 TABLE 2-1.   
Distribution and nucleotide sequence of α- and β-globin leaders snatched from globin 
messengers to prime virus NS1 mRNA transcription in vitro. 
Capped leader Retrieved mRNA 5' sequence # clones 
α-globina 5'-ACACUUCUGGUCCAGCAAAA 
5'-ACACUUCUGGCAGCAAAA 
5'-ACACUUCUGCAGCAAAA 
13 
1 
2 
β-globinb 5'-ACACUUGCUUUUGAGCAAAA 
5'-ACACUUGCUUUUGCAAAA 
1 
2 
Viral sequence is underlined, while residues that possibly could originate from the globin leader and with 
complementarity to the vRNA template (3'-UCG…) are in bold and italics. 
 
a α-globin RNA sequence: 5'-ACACUUCUGGUCCAGUCCGA....3' 
b β-globin RNA sequence: 5'-ACACUUGCUUUUGACACAAC....3' 
14 9 
13 
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Exogenous AlMV3 capped RNA leaders are used as cap donors for in vitro 
transcription 
 
To test whether the established in vitro transcription system would accept an 
exogenous (manipulable) source of capped RNA, WT AlMV3 was provided to the in vitro 
transcription assay (Table 2-2). De novo synthesized viral transcripts were RT-PCR cloned 
using an internal NS1 primer combined with a TS-oligo primer containing only the first 4 
AlMV3 nucleotides, and subsequently sequence analyzed for the presence of AlMV3 RNA 
leader sequences.  
 
 
 TABLE 2-2.   
WT AlMV3 leader used in assay. 
Capped leader 5' end sequence of capped leader 
WT 5'-GUAUUAAUACCAUUUUCAAAAUAUUCC 
Residue potentially base-pairing to the viral template (3'-UCG…) is underlined. 
 
 
Products of expected size (Figure 2-4, lane 1) were obtained and showed to 
consist of the NS1 transcript preceded with the first 11 nt from the AlMV3 5'-terminal 
RNA leader sequences (Table 2-3). It is of importance to mention that the WT AlMV3 
contains a potential single base complementarity to the vRNA template (nucleotide A12). 
Further analysis of the leader sequence within the NS1 clones showed the presence of 
repetitive sequences in 1 clone. The RT-PCR control, without any addition of AlMV3 
leaders, did not show any product (Figure 2-4, lane 2).  
 
 
 
 
 
 
 
 
 
 
 
 
12 
 Figure 2-4. RT-PCR of in vitro synthesized 
influenza transcripts. RT-PCR analysis of in 
vitro synthesized influenza mRNA in the presence 
of RRL, and presence (lane 1) or absence (lane 2) 
of WT AlMV3 leader. Reverse transcription was 
performed using internal primer specific for the 
Influenza NS1 gene, followed by PCR using 
internal primer for the same gene in combination 
with a TS-oligo primer specific for the AlMV3 
leader. M: molecular marker. 
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The results altogether suggested that the influenza virus transcription system 
developed was able to accept an exogenous source of synthetic capped RNA leaders which 
make the system manipulable and a powerful tool to further study the cap donor 
requirements in further detail. Using synthetic, mutant AlMV3 RNA transcripts, cap donor 
requirements, and in specific the importance of base-pairing as a selective criterion for cap 
donor usage, can now be addressed. 
 
 
 TABLE 2-3.   
Usage of WT leader snatched to prime NS1 mRNA transcription in vitro. 
Capped leader offered Retrieved mRNA 5' sequence # clones 
WT 
(500 ng) 
5'-GUAUUAAUACCAGCAAAA 
5'-GUAUUAAUACCAGCAGCAAAA 
6 
1 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered 
and with complementarity to the vRNA template (3'-UCG…) are in bold and italics.  
 
 
 
 
 
Discussion  
 
During in vitro influenza virus transcription in the presence of RRL, globin 
messengers were used to prime transcription as expected, as the RRL (although 
micrococcal nuclease treated) was earlier already shown to contain sufficient amounts of 
fragmented endogenous cap donors (van Knippenberg et al., 2002). Although the 
requirement of RRL for in vitro transcription still remains unknown, it was also observed 
for several other (-) ssRNA viruses (Bellocq et al., 1987; Nguyen et al., 1997; van 
Knippenberg et al., 2002; Vialat and Bouloy, 1992). Initially the requirement during in 
vitro transcription studies of bunyaviruses suggested a translational dependence, but no 
actual viral protein products were required. Further analyses using translation inhibitors as 
well as in vitro assays using a nucleotide analogue led to the hypothesis that the RRL was 
required to provide not only in a source of capped (globin) RNAs but also factors needed to 
support in ongoing transcription and prevent premature transcription termination (Bellocq 
et al., 1987; Vialat and Bouloy, 1992; van Knippenberg et al., 2004). The observations 
made here, in which the exchange of RRL for AlMV3 RNA did not recover Influenza A 
virus transcriptional activity in vitro, at least implies that the RRL is not solely required to 
provide in a source of cap donor.  
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Previous studies have reported that the globin molecules are good primers for 
influenza virus transcription initiation (Bouloy et al., 1978; Plotch et al., 1979, id. 1981; 
Robertson et al., 1980), and some have even suggested β-globin leaders are more effective 
primers than α-globin (Bouloy et al., 1978; Plotch et al., 1979). Considering that β-globin 
messengers appear to be more abundant in RRL than α-globin messengers (Bouloy et al., 
1978), the higher presence of α-globin leader sequences in viral transcripts within a 
population of randomly cloned α- and β-globin initiated influenza transcripts (Table 2-1) 
was surprising and suggests a preference for the α-globin leader. A further look at both 
leader sequences revealed a base complementarity of the α-globin, by the A14G15 
dinucleotide, to the 3'-ultimate residues of the influenza vRNA template compared to the β-
globin leader that only contained a single complementary nucleotide (A14) (Figure 2-5A). 
The preferential use of α-globin leaders versus β-globin leaders could thus be explained by 
its higher base complementarity to the vRNA template. This would be in agreement with 
earlier observations made for TSWV, and for which base-pairing has been shown a 
selective criterion for cap donor usage (Duijsings et al., 2001; van Knippenberg et al., 
2005a).  
Interestingly, the α-globin mRNA also contains G residues at positions 9 and 10, 
which could base-pair with the penultimate C residue of the influenza vRNA template 
(Figure 2-5B). De novo transcripts resulting from this internal priming lack the first viral A 
residue. Cloning of NS1 transcripts in which the A residue indeed showed to be absent thus 
strengthened the idea that base-pairing plays an important role during influenza 
transcription initiation. Similar internal priming was observed with the β-globin leaders as 
well (Figure 2-5B). This phenomenon was earlier observed for TSWV mRNAs synthesized 
in vitro (van Knippenberg et al., 2005a), where the first one or even the first two viral 
nucleotides were sometimes missing as a result of internal base-pairing of the capped leader 
and priming of transcription at the second or even third residue of the viral template. Why 
internal priming occurs during cap-snatching is still unknown, but in many influenza in vivo 
studies, cloned copies of mRNAs were noticed that had primed on the 3' penultimate C 
residue of the vRNA template instead on the ultimate U residue (Beaton and Krug, 1981; 
Caton and Robertson, 1980; Dhar et al., 1980; Lai et al., 1981; Lamb and Lai, 1980; 
Lamb and Lai, 1981; Markoff and Lai, 1982; Vreede et al., 2008). 
The presence of repetitive sequences (GCAGC) in 4 out of 26 cloned viral 
transcripts (Tables 2-1 and 2-3) indicates that “prime-and-realign”, as first described for 
Hantaan virus and later for transcription initiation of other members of the Bunyaviridae 
and Arenaviridae (Bishop et al., 1983; Bouloy et al., 1990; Duijsings et al., 1999, id. 
2001; Garcin et al., 1995; Jin and Elliott, 1993b; Simons and Pettersson, 1991; van 
Knippenberg et al., 2005a), also occurs with influenza virus. During prime-and-realign WT 
AlMV3 leaders offered are likely cleaved by the viral polymerase/endonuclease 
downstream A12, and after alignment, by virtue of the base-pairing A residue, on the vRNA 
template become elongated for two nucleotides (GC). Before further elongation proceeds,  
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 Figure 2-5. Base-pairing between α- or β-globin leader and the vRNA template. (A) 
Schematic representation of single or double base-pairing interactions. (B) The occurrence of 
internal priming. Influenza sequence is underlined, while residues that possibly could originate 
from the globin leader and with complementarity to the vRNA template are in bold and italics. 
The potential base-pairing between the 3'-terminal A residue of the capped RNA leader and the 
3'-terminal U residue of the vRNA template is shown with dotted lines. 
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the chain realigns backwards on the vRNA template (Figure 2-6). Although prime-and-
realign has never been observed during influenza transcription, it recently has been reported 
during replication (Vreede et al., 2008) where realignment was observed of a de novo 
synthesized pppApG dinucleotide, templated by nucleotides 4 and 5 from the 3' end of the 
complementary RNA template, to residues 1 and 2 to allow elongation to full-length vRNA. 
Prime-and-realign of capped RNA leader sequences during influenza transcription 
strengthens the occurrence of base-pairing between capped RNA leaders and the vRNA 
template. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2-6. Occurrence of prime-and-realign during initiation of influenza mRNA 
synthesis. Influenza sequence is underlined, while residues that possibly could originate from the 
globin leader and with complementarity to the vRNA template are in bold and italics. The 
potential base-pairing between the 3'-terminal A residue of the capped RNA leader and the 3'-
terminal U residue of the vRNA template is shown with dotted lines. 
 
 
Earlier in vivo studies on the cap-snatching mechanism of the plant-infecting 
bunyavirus TSWV have demonstrated a requirement for base complementarity of AlMV-
derived capped RNA leaders to the ultimate or penultimate 3' residue of the TSWV vRNA 
template (Duijsings et al., 2001). Similar results have been obtained using an in vitro 
transcription system based on purified TSWV particles supplemented with rabbit RRL (van 
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Knippenberg et al., 2002), suggesting that the in vitro system faithfully reflected 
transcription initiation in vivo. Using the same in vitro assay, several AlMV-derived 
(mutant) cap donors were offered in pair-wise competitions, and showed that TSWV 
prefers capped leaders with a specific leader length and increasing base complementarity to 
the 3'-terminal residues of the vRNA template, even when offered at relative low amounts 
compared to others with less base complementarity (van Knippenberg et al., 2005a).  
The preference of Influenza A virus for α-globin leaders over the β-globin (Table 
2-1) could also be explained due to increased base complementarity of the capped RNA 
leader to the vRNA template, as earlier observed for TSWV. To investigate whether 
Influenza A virus prefers cap donors with increased base complementarity to the vRNA 
template, the use of synthetic mutant AlMV3 RNA transcripts can be exploited. To this 
end, mutant AlMV3 transcripts differing in their complementarity to the 3' end of the 
vRNA template will be made and pair-wise tested in the in vitro influenza virus 
transcription assay and their use will be quantified. 
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Materials and methods 
 
Virus 
Influenza virus strain A/Puerto Rico/8/34 (H1/N1) was propagated and purified 
from embryonated chicken eggs. In brief, allantoic fluid was collected and cleared by low 
speed centrifugation for 10 min at 1000xg and filtrated through a 0.45 µm-pore-size filter. 
The filtrate was layered onto 0.5 ml 60% (wt/vol) sucrose (in PBS) - 2.0 ml 20% (wt/vol) 
sucrose (in PBS) step gradients and centrifuged at 150,000xg for 2 h at 4 °C, using a SW41 
rotor (Beckmann). Virus particles were recovered from the interface, adjusted to 20% 
(wt/vol) sucrose (in PBS), and loaded onto the top of a 12 ml 20% to 60% (wt/vol) 
continuous sucrose gradient (in PBS). After centrifugation at 150,000xg for 16 h at 4 °C in 
a SW41 rotor (Beckmann), the virus fraction was collected. Purified virus (10-15 μg/μl) 
was stocked in small aliquots at -80 oC prior to use in transcription assays. 
 
Construction of WT AlMV3 
WT was generated from plasmid pXO32NcoP3, which contains a full-length 
cDNA clone of AlMV3 (Neeleman et al., 1993). WT was PCR amplified by using primer 
AlMV3-Rv (complementary to nucleotides 339-313 of the AlMV3 sequence) and primer 
WT. Primer sequences are listed in Table 2-4. 
Amplified PCR fragments were separated by electrophoresis in a 1% agarose gel 
and purified using the GFX PCR purification kit (Roche). Purified products were restriction 
enzyme digested with BamHI/EcoRI and ligated into pUC19 using T4 DNA ligase 
(Promega). The nucleotide sequence of individual clones was verified by the 
dideoxynucleotide chain termination method (Sanger et al., 1977) using standard M13 
sequencing primers and ultra-high throughput (ABI Prism 3700) DNA sequencer 
(GreenomicsTM, Wageningen University and Research Centre, The Netherlands). 
 
Synthesis of cap-0 RNA leaders 
In vitro synthesis of capped RNA leaders was performed by using the Ambion T7 
mMESSAGE mMACHINE kit according to the manufacturer’s instruction. Transcription 
was performed in the presence of cap-analog m7G5'ppp5'G. The cap analog:GTP ratio of this 
solution is 4:1 and results in an 80% yield of capped transcripts. 
Prior to transcription each DNA template was linearized with EcoRI. T7 promoter 
sequences were introduced upstream of the AlMV3 leader by PCR amplification in order to 
allow in vitro synthesis of capped leaders.  
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 TABLE 2-4.   
Primer sequences for WT AlMV3 construct and RT-PCR. 
Name Primer sequence (5'→3') 
WT 
 
AlMV3-Rv 
CCCGGATCCTAATACGACTCACTATAGTATTAATACCATTTT 
CAAAATATTCC 
CCCGAATTCGAAGAGTACGAATTACGCG 
TS-oligo 
α-globin 
α-/β-globin 
AlMV3-leader1 
NS1UP1 
NS1UP2 
NPUP1 
NPUP2 
CCCGGATCCGGGGG 
CCCGGATCCGGGGGACACTTCTGGT 
CCCGGATCCGGGGGACACTT 
CCCGGATCCGGGGGGTATTAATA 
CCCGAATTCGAGTCTCCAGCCGGTC 
CCCGAATTCCGCCTGGTCCATTCTG 
CCCGAATTCGAGTCAGACCAGCCGTTGC 
CCCGAATTCGCTTGGCGCCAGATTCGCC  
Residues which could potentially base-pair to the viral template are underlined; bold residues are T7 promoter 
sequence. 
 
 
In vitro influenza transcription and AlMV3 leader competition assays 
In vitro influenza transcription assays were performed using approximately 10 µg 
of purified influenza virus particles in a final volume of 25 µl (Figure 2A). Assays were 
done according to van Knippenberg et al. (2002). These assays contained 4 mM Mg 
acetate, 1 mM of each NTP, 0.1% NP-40, 0.8 U/µl RNasin, 2.5 µl translation mix (amino 
acid mixture of 1:1:1 -cys; -lys; -met), and were supplemented by the AP-Biotech RRL 
system (GE Healthcare) according to the manufacturer’s procedures. For visualization of 
the RNA products, 1 mM of [α-32P]CTP (800 Ci/mmol) was added instead of CTP. The 
amount of AlMV3 leaders added to the reactions is indicated in the text and tables. After 
incubation for 2 h at 37 oC, the reaction mixture was extracted with phenol-chloroform and 
the RNA ethanol precipitated. Radiolabeled RNA products were resolved by 
electrophoresis in a 1% denaturing agarose gel and subsequently transferred onto Hybond-
N membrane using the TurboBlotter System (Schleicher and Schuell). Radiolabeled RNA 
synthesized was visualized by exposure of the membrane to autoradiographic film. 
 
Analyses of AlMV3-influenza mRNA sequences 
RT-PCR amplification of de novo synthesized Influenza NP or NS1 mRNAs 
containing capped 5' sequences derived from AlMV3 was achieved by a strategy during 
which a known sequence was efficiently incorporated at the end of the cDNA during first 
strand synthesis, without adaptor ligation (Figure 2-3A) (Schmidt and Mueller, 1999; 
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Schramm et al., 2000). First-stand cDNA was synthesized by using the template-switch 
primer TS-oligo in combination with primer NPUP1 or NS1UP1. PCR amplification was 
performed using primer α-globin, α-/β-globin or AlMV3-leader1, and a nested primer 
NPUP2 or NS1UP2. Primer sequences are listed in Table 2-4. 
PCR products of expected size were purified from a 1% agarose gel using the GFX 
PCR purification kit (Roche) and cloned into pGEM-T Easy (Promega) according to the 
manufacturer’s procedures, prior to sequence analysis by the dideoxynucleotide chain 
termination method (Sanger et al., 1977) using standard T7 sequencing primer and ABI 
Prism 3700 sequencer (GreenomicsTM). 
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Base-pairing promotes leader selection to prime in vitro 
influenza genome transcription  
 
 
The requirements for alignment of capped leader sequences along the viral genome 
during influenza transcription initiation (cap-snatching) have long been an enigma. In this 
study, competition experiments using an in vitro transcription assay revealed that influenza 
virus transcriptase prefers leader sequences with base complementarity to the 3'-ultimate 
residues of the viral template, 10 or 11 nt from the 5' cap. Internal priming at the 3'-
penultimate residue, as well as prime-and-realign was observed. The nucleotide identity 
immediately 5' of the base-pairing residues also affected cap donor usage. Application to 
the in vitro system of RNA molecules with increased base complementarity to the viral 
RNA template showed stronger reduction of globin RNA leader initiated influenza 
transcription compared to those with a single base-pairing possibility. Altogether the results 
indicated an optimal cap donor consensus sequence of 7mG-(N)7-8-(A/U/G)-(A/U)-AGC-3'. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A slightly modified version of this chapter has been published as: 
Geerts-Dimitriadou, C., Zwart, M.P., Goldbach, R., Kormelink, R., 2011. Virology 409, 17-26. 
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Introduction  
 
“Cap-snatching” is the transcription initiation mechanism found among segmented, 
negative (-) ssRNA viruses as first described for influenza A (Beaton and Krug, 1981; 
Bouloy et al., 1978; Caton and Robertson, 1980; Dhar et al., 1980; Plotch et al., 1979, id. 
1981). During this process, the viral transcriptase cleaves m7G-capped RNA leader 
sequences from host mRNAs to prime transcription of the viral genome segments (Figure 
3-1). The development of in vitro systems (Bouloy et al., 1978; Hagen et al., 1994; Plotch 
et al., 1979) and reverse genetics approaches (Fodor et al., 1999; Neumann et al., 1999; 
Pleschka et al., 1996) has advanced the insight into cis- and trans-acting factors involved 
in cap-snatching.  
 
 
 
 
 
 
 
 Figure 3-1  Schematic presentation of influenza virus genome 
transcription initiation. Cleavage of a cellular mRNA and subsequent use of 
the capped RNA leader in priming genome transcription is shown. 
 
 
The influenza heterotrimeric polymerase complex consists of subunits, PB1, PB2 
and PA. Whereas PB2 recognizes and binds to the 5' cap structure of cellular mRNAs 
(Braam et al., 1983; Li et al., 2001), PB1 has been thought to contain the active site of the 
polymerase and to cleave bound capped RNAs at a site 10-13 nt downstream of the cap (Li 
et al., 2001). The role of PA in viral transcription and replication has long been unknown 
but recently the crystal structure of the N-terminal domain of PA (PAN: residues 1-159) has 
been determined (Yuan et al., 2009).This structure and the presence of a bound magnesium 
ion by a motif similar to the (P)DXN(D/E)XK motif characteristic of many endonucleases 
strongly suggests that PAn holds the endonuclease activity rather than PB1 (Yuan et al., 
2009). Biochemical and structural studies have shown that the amino-terminal 209 residues 
of the PA contain the endonuclease activity (Dias et al., 2009). Although several reports 
suggested that specific base-pairing between multiple residues of the 5'- and 3'-terminal end 
of the viral RNA (vRNA) template is required for activation of the endonuclease (Cianci et 
al., 1995; Hagen et al., 1994), others have suggested that the presence of the 5'-terminal 
end of the vRNA template is sufficient for cap-dependent endonuclease activity (Li et al., 
2001). 
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For Influenza A virus, a preference for purine at the 3' end of the donor leader has 
been proposed (Beaton and Krug, 1981; Plotch et al., 1981), while only leaders harboring 
a 3'-terminal CA dinucleotide would effectively be used as primers (Beaton and Krug, 
1981; Rao et al., 2003; Shaw and Lamb, 1984). For Bunyamwera and Dugbe virus (family 
Bunyaviridae), a strong preference for cleavage after a U or C residue, respectively, has 
been postulated (Jin and Elliott, 1993a and b). In all these cases, however, conclusions 
were drawn from a limited number of viral mRNAs produced in vivo and on basis of the 
leader sequences only, while the origin of the selected leader and further downstream 
sequences remained unknown. Hence, it cannot be ruled out that these leaders had been 
cleaved 1-2 nt downstream of the assumed 3' end and prior to which base-pairing of 
residues downstream of the snatched leader sequence assists in the alignment of leader on 
the vRNA template to render a stabilized transcription initiation complex. Indeed some in 
vitro studies on Influenza A virus support the idea of base-pairing during leader alignment 
on the viral template (Chung et al., 1994; Hagen et al., 1994, id. 1995; Plotch et al., 1981; 
Chapter 2). Work by Chung et al. (1994) already showed the possibility of RNA leaders to 
directly become elongated on the vRNA template, without the need for additional cleavage. 
While the involvement of base complementarity of these leaders to the vRNA template was 
not investigated, these leaders did contain one up to three residues at their 3' terminus with 
complementarity to the vRNA template to immediately allow elongation without further 
cleavage. In another study, Hagen et al. (1995) concluded that the endonuclease cleavage 
site within an mRNA is completely controlled by the mRNA and does not depend upon 
interactions with the vRNA template, though the site of initiation is influenced by template-
primer interactions. However, a more detailed look at the altered cleavage sites within 
mutated mRNA leader sequences shows that the altered cleavage sites vary with the 
possibility to allow initiation/elongation after base-pairing of the leader 3' residues with the 
vRNA template. In addition to their earlier observed requirement of a vRNA template 
(harboring the 5' and 3' termini) to activate endonuclease cleavage and transcription (Hagen 
et al., 1994), these data support the idea that base-pairing between nucleotide residues of 
the snatched leader sequence, and residues further downstream, to the vRNA 3' terminus 
may play an important role during the alignment and subsequent endonuclease cleavage. 
This is furthermore supported by the observation of α-globin mRNA leader sequences, 
containing a higher base complementarity around the endonuclease cleavage site to the 
viral RNA template, being preferentially used during Influenza A virus transcription 
initiation in comparison to β-globin leader sequences, which only contained a single base-
pairing residue around the endonuclease cleavage site (Chapter 2). 
On the other hand, some studies report cleavage without the presence of the 3' 
terminal sequence of the vRNA template and the absence of any base complementarity of 
RNA leaders to the 3' end of the vRNA template (Krug et al., 1980; Rao et al., 2003). 
However, in one of the latest cap-snatching models presented (Rao et al., 2003), the 
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possibility of base-pairing between the 3' terminal A residue with the terminal U of the 3' 
end of the vRNA template was not excluded. 
A “prime-and-realign” mechanism has been proposed for Hantaan virus to account 
for the vRNA polymerase to initiate (anti)genome/mRNA synthesis with GTP (Garcin et 
al., 1995), but a prime-and-realign could also explain the presence of repetitive sequences 
observed within the leader sequence of viral transcripts from other viruses that apply cap-
snatching (Bishop et al., 1983; Bouloy et al., 1990; Duijsings et al., 2001; Garcin et al., 
1995; Jin and Elliott, 1993b; Simons and Pettersson, 1991; van Knippenberg et al., 
2005a), and indicate the involvement of base-pairing between leader and template.  
Here we set out to analyze Influenza A virus cap donor requirements, and more 
specifically the possible role of base-pairing between donor and template, during 
transcription initiation. To this end, various Alfalfa mosaic virus RNA3 (AlMV3)-derived 
mutants were tested as cap donors in pair-wise or multiple competitions using the in vitro 
influenza A transcription system as described in Chapter 2. The results show that base 
complementarity to the viral genome template promotes the use of capped leaders and that 
residues 5' of the base-pairing residues are of importance.  
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Results 
 
Base complementarity enhances cap donor preference 
 
Since exogenous AlMV3 RNA was shown to be accepted as cap donor in our in 
vitro influenza virus transcription assay (Chapter 2), the assay was next exploited to 
analyze whether base complementarity would enhance cap donor selection. To this end, 
four variant AlMV3 constructs (Table 3-1) differing in their complementarity to the 3' end 
of the vRNA template, were made and tested in pair-wise competition. Since AlMV3 
capped RNA leaders were shown to become cleaved at residue A12 (Chapter 2), this 
residue and nucleotides further downstream, were targeted for mutagenesis to investigate 
their involvement in the alignment on the vRNA template. The first AlMV3 construct, i.e. 
wild type (WT), showed a single base complementarity to the vRNA template (nucleotide 
A12), the second one (denoted Mut-2) was made to contain 2 base-pairing residues (A12G13), 
the third (Mut-3) 3 residues (A12G13C14) while the fourth construct (Mut-N14) reflected a 
genuine influenza A transcript, i.e. a NP mRNA provided with the first 11 nt of the AlMV3 
leader (Chapter 2), and harboring 14 nt complementary to the NS1 vRNA template. To 
discriminate between the WT and the three mutant sequences, a marker nucleotide was 
introduced by changing residue C10 into A, G or T respectively (Table 3-1).  
 
 
 TABLE 3-1.   
Wild type (WT) and mutant AlMV3 leaders used in assays. 
Capped leader 5' end sequence of capped leader 
WT  
Mut-2  
Mut-3  
Mut-N14  
5'-GUAUUAAUACCAUUUUCAAAAUAUUCC 
5'-GUAUUAAUAACAGUUUCAAAAUAUUCC 
5'-GUAUUAAUAGCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUAUCAGCAAAAGCAGGGUAG 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
 
Synthetic, capped RNA transcripts of the constructs were provided to the in vitro 
transcription assay and de novo synthesized viral transcripts were RT-PCR cloned using an 
internal NS1 primer combined with a TS-oligo primer containing only the first 4 AlMV3 
nucleotides as described in Chapter 2. Clones obtained were sequence analyzed for the 
presence of the marker nucleotide within the AlMV3 RNA leader sequence. 
12 
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When WT and Mut-2 were added to the system, all cloned AlMV3-NS1 transcript 
sequences contained marker nucleotide A (Table 3-2), indicative for the presence of the 
Mut-2 RNA leader sequence. Even when Mut-2 was offered in a ratio 10 times less than 
WT (Table 3-2), all NS1 transcript clones, except of one which had a leader of unknown 
origin, contained the Mut-2 leader sequence (Table 3-2), indicating a strong preference for 
AlMV3 Mut-2. Next, Mut-N14 was tested along with WT. When offered in 1:1 ratio (50 or 
500 ng each), 35 out of 39 cloned NS1 transcript sequences contained the marker 
nucleotide of Mut-N14 (Table 3-2). When WT and Mut-N14 were offered in a 10:1 ratio, 
still 21 out of 25 contained the Mut-N14 leader (Table 3-2). The origin of the leader 
sequence from 4 additional clones could not be identified due to the absence of the marker 
nucleotide (Table 3-2).  
 
 
 TABLE 3-2.   
Distribution and nucleotide sequence of WT and mutant AlMV3 leaders snatched during pair-wise 
competition to prime virus NS1 mRNA transcription in vitro. 
Capped leaders 
offered 
Retrieved mRNA 5' sequence # clones Origin leader 
WT + Mut-2  
(1:1; 500 ng each) 
5'-GUAUUAAUAACAGCAAAA 
5'-GUAUUAAUAACAGCAGCAAAA 
5'-GUAUUAAUAAGCAAAA 
31 
1 
2 
Mut-2 
Mut-2 
Mut-2 
WT + Mut-2  
(10:1; 500 vs. 50 ng) 
5'-GUAUUAAUAACAGCAAAA 
5'-GUAUUAAUAACGCAAAA 
5'-GUAUUAAUAAGCAAAA 
5'-GUAUUAAUAGCAAAA 
9 
1 
1 
1 
Mut-2 
Mut-2 
Mut-2 
? 
WT + Mut-N14  
(1:1; 50 ng each) 
5'-GUAUUAAUAUCAGCAAAA 
5'-GUAUUAAUAUUAGCAAAA 
5'-GUAUUAAUAUCAGCAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
15 
5 
3 
3 
Mut-N14 
Mut-N14 
Mut-N14 
WT 
WT + Mut-N14  
(1:1; 500 ng each) 
5'-GUAUUAAUAUCAGCAAAA 
5'-GUAUUAAUAUUAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
11 
1 
1 
Mut-N14 
Mut-N14 
WT 
WT + Mut-N14  
(10:1; 500 vs. 50 ng) 
5'-GUAUUAAUAUCAGCAAAA 
5'-GUAUUAAUAUCAGCAGCAAAA 
5'-GUAUUAAUAUGCAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
5'-GUAUUAAUACGCAGCAAAA 
5'-GUAUUAAUAGCAGCAAAA 
17 
3 
1 
2 
2 
4 
Mut-N14 
Mut-N14 
Mut-N14 
WT 
WT 
? 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded.    
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The data obtained indicate that in vitro influenza prefers leader sequences with 
increasing complementarity to the 3' end of the vRNA template. This was further 
strengthened by the performance of an additional competition assay in which Mut-2 and 
Mut-3, only differing in the complementarity to the vRNA template by one residue, was 
tested in a pair-wise manner (Table 3-3). When provided in equimolar amounts, the Mut-3 
leader was preferred, being used twice as often as the Mut-2 leader (Table 3-3). 
Surprisingly, when Mut-3 and Mut-N14 were offered to the in vitro transcription assay in 
various ratios, no clear preference for the Mut-N14 leader was observed (Table 3-3).  
Further analysis of the leader sequence within all NS1 clones showed the presence 
of repetitive sequences in 9 clones, likely as a result of prime-and-realign of capped leader 
sequences as previously observed with WT AlMV3 (Chapter 2), indicating again the 
occurrence of base-pairing during the transcription process.  
 
 
 TABLE 3-3.   
Distribution and nucleotide sequence of mutant AlMV3 leaders snatched during pair-wise 
competition to prime virus NS1 mRNA transcription in vitro. 
Capped leaders  
offered 
Retrieved mRNA 5' sequence # clones Origin leader 
Mut-2 + Mut-3 
(1:1; 500 ng each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-GUAUUAAUAGCAGCAGCAAAA 
5'-GUAUUAAUAACAGCAAAA 
5'-GUAUUAAUAAGCAAAA 
19 
1 
8 
1 
Mut-3 
Mut-3 
Mut-2 
Mut-2 
Mut-3 + Mut-N14 
(1:1; 500 ng each) 
5'-GUAUUAAUAUCAGCAAAA 
5'-GUAUUAAUAGCAGCAAAA 
12 
9 
Mut-N14 
Mut-3 
Mut-3 + Mut-N14 
(1:1; 500 vs. 50 ng) 
5'-GUAUUAAUAUCAGCAAAA 
5'-GUAUUAAUAGCAGCAAAA 
2 
7 
Mut-N14 
Mut-3 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded. 
 
 
Initiation of Influenza A virus mRNA synthesis, irrespective of a cap-0 or cap-1 
structure 
 
Previously, the influence of different cap structures on influenza transcription 
initiation in vitro was demonstrated suggesting a preference for cap-1 structures (Bouloy et 
al., 1980). However, these studies also showed that AlMV RNA leaders were relatively 
effective primers for the polymerase reaction as well. The high priming activity of AlMV 
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RNA appeared not to be due to the presence of cap-1 termini as, in agreement with other 
reports (Pinck, 1975), only mono-methylated cap-0 termini were detected.  
To rule out the possibility that the presence of cap-0 structures at the 5' end of 
AlMV3 RNA affected the use of capped RNA leaders during cap donor competition assays, 
two pair-wise competition assays were performed with Mut-2 and Mut-3. In the first assay 
both leader mutants were provided with cap-0 structures and in the second assay with cap-1 
structures. After pair-wise competition the results showed that, irrespective of the presence 
of a cap-0 or cap-1 structure, Mut-3 was clearly preferred (Table 3-4) and being used twice 
as often as Mut-2 as earlier observed (Table 3-3). Altogether, these results justified the 
further use of AlMV3 molecules to analyze leader sequence requirements for influenza 
virus transcription initiation. 
 
 
 TABLE 3-4.   
Distribution and nucleotide sequence of leaders having a cap-0 or cap-1 structure snatched during 
pair-wise competition to prime virus NS1 mRNA transcription.  
Capped leaders 
offered 
Retrieved mRNA 5' sequence # clones Origin leader 
Cap-0 structures 
Mut-2 + Mut-3 
(1:1; 500 ng each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-GUAUUAAUAGCGCAAAA 
5'-GUAUUAAUAACAGCAAAA 
12 
1 
7 
Mut-3 
Mut-3 
Mut-2 
Cap-1 structures 
Mut-2 + Mut-3 
(1:1; 500 ng each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-GUAUUAAUAACAGCAAAA 
12 
6 
Mut-3 
Mut-2 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded. 
 
 
Influence of the 3'-terminal nucleotide of the leader 
 
To analyze whether the nucleotide within the sequence, upstream of the base-
pairing residues affects leader preference, another set of AlMV3 leader constructs was 
made that harbored a C (WT), A, G or U at position 11 and a single base-pairing residue 
A12 (Table 3-5). Capped transcripts of all four AlMV3 constructs were offered in 
equimolar amounts to the in vitro assay. Surprisingly, 18 out of the 32 clones analyzed 
contained a G at position 11 (Table 3-6), indicating a preference for the G11A12 sequence. 
However, 17 out of these 18 clones, lacked the first viral A residue, likely due to cleavage 
after G11 and internal priming on the 3'-penultimate C residue of the viral template.  
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 TABLE 3-5.   
Mutant AlMV3 leaders used in multiple competition assay. 
Capped leader 5' end sequence of capped leader 
C11A12 (WT) 
G11A12 
A11A12 
U11A12 
5'-GUAUUAAUACCAUUUUCAAAAUAUUCC 
5'-GUAUUAAUACGAUUUUCAAAAUAUUCC 
5'-GUAUUAAUACAAUUUUCAAAAUAUUCC 
5'-GUAUUAAUACUAUUUUCAAAAUAUUCC 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
 
 TABLE 3-6.   
Usage of leaders with a mutation at position -1 relative to the single base-pairing A12 residue snatched 
to prime NS1 mRNA transcription in vitro. 
Capped leaders  
offered 
Retrieved mRNA 5' sequence # clones Origin leader 
(C/G/A/U)11A12 
(1:1:1:1; 500 ng each) 
 
5'-GUAUUAAUACGAGCAAAA 
5'-GUAUUAAUACGCAAAA 
5'-GUAUUAAUACGCAGCAAAA 
5'-GUAUUAAUACAAGCAAAA 
5'-GUAUUAAUACAGCAAAA 
5'-GUAUUAAUACUAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
1 
9 
8 
1 
7 
4 
2 
G11A12 
G11A12 
G11A12 
A11A12 
A11A12 
U11A12 
C11A12 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded. 
 
 
Furthermore, 8 of these leaders showed a repetitive sequence that probably resulted 
from prime-and-realign. From the remaining 14 (out of 32) clones, 8 clones contained A11, 
4 U11 and 2 C11. A closer look at the snatched leaders from mutant A11A12 showed that 7 out 
of the 8 clones resulted from cleavage downstream A11 rather than A12, giving rise to a CA 
3' terminus. Only in 2 (out of 32) clones the leader originated from mutant C11A12, after 
cleavage downstream of A12. Hence, although all 4 single base-pairing AlMV3 leaders 
were used as cap donor, there was a clear preference for leaders harboring a 3' CGA, 
primarily leading to internal priming, while a 3' CCA sequence was least preferred. 
Although explanations as an alternative to the base-pairing hypothesis cannot be excluded, 
e.g. cleavage after C10 and subsequent initiation on the 3'-penultimate residue in case of the 
9 clones assigned to G11A12, such strategy does not explain the presence of a (non-
templated) U residue in 4 clones of U12A12.  
12 
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To determine which nucleotides at positions 10 (2 nt upstream the base-pairing 
residues) and 11 would promote leader selection without provoking internal priming, a next 
set of AlMV3 mutant leaders was made, all harboring 3 base-pairing residues (AGC) at 
their 3' end and variable residues at positions 10 or 11 (Tables 3-7 and 3-8). The resulting 
constructs were referred to as C10C11A12GC, A10C11A12GC, G10C11A12GC and 
U10C11A12GC, and C11A12GC, A11A12GC, G11A12GC and U11A12GC respectively. 
 
 
 TABLE 3-7.   
Mutant AlMV3 leaders used in multiple competition assay. 
Capped leader 5' end sequence of capped leader 
C10C11A12GC  
G10C11A12GC 
A10C11A12GC 
U10C11A12GC 
5'-GUAUUAAUACCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUAGCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUAACAGCUUCAAAAUAUUCC 
5'-GUAUUAAUAUCAGCUUCAAAAUAUUCC 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
 
 TABLE 3-8.   
Mutant AlMV3 leaders used in multiple competition assay. 
Capped leader 5' end sequence of capped leader 
C11A12GC 
G11A12GC 
A11A12GC 
U11A12GC 
5'-GUAUUAAUACCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUACGAGCUUCAAAAUAUUCC 
5'-GUAUUAAUACAAGCUUCAAAAUAUUCC 
5'-GUAUUAAUACUAGCUUCAAAAUAUUCC 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
 
When all 4 leaders differing in position 11 were offered in an equimolar mix, 19 
out of 40 NS1 mRNA clones contained A11 and 15 U11 (Table 3-9). Of the remaining 
clones, 5 contained G11 and only 1 C11. Furthermore, in case the leader originated from the 
G11-containing cap donor, internal priming was only observed in 1 out of 5 clones. When 
G11 was offered individually to the system, 5 out of 22 retrieved NS1 clones showed the 
absence of the first viral A residue, indicative for internal priming (Table 3-9). The lower 
frequency of internal priming with G11A12GC in comparison to G11A12 was likely due to the 
extra base-pairing residues present in G11A12GC that apparently forced proper alignment 
along the 3'-terminal residues of the vRNA template.  
12 
12 
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When all cap donor molecules harboring an altered nucleotide at position 10 were 
simultaneously offered, no clear preference was found, but C appeared to be inefficient 
(Table 3-10). 
 
 
 TABLE 3-9.   
Usage of leaders with a mutation at position -1 relative to the triple base-pairing A12GC residues 
snatched to prime NS1 mRNA transcription in vitro. 
Capped leader(s) 
offered 
Retrieved mRNA 5' sequence # clones Origin leader 
(C/G/A/U)11A12GC 
(1:1:1:1; 500 ng each) 
 
5'-GUAUUAAUACGAGCAAAA 
5'-GUAUUAAUACGCAAAA 
5'-GUAUUAAUACAAGCAAAA 
5'-GUAUUAAUACAGCAAAA 
5'-GUAUUAAUACUAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
4 
1 
18 
1 
15 
1 
G11A12GC 
G11A12GC 
A11A12GC 
A11A12GC 
U11A12GC 
C11A12GC 
G11A12GC 
(500 ng) 
5'-GUAUUAAUACGAGCAAAA 
5'-GUAUUAAUACGAGCAGCAAAA 
5'-GUAUUAAUACGCAAAA 
5'-GUAUUAAUACGCAGCAAAA 
16 
1 
1 
4 
 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded. 
 
 
 TABLE 3-10.   
Usage of leaders with a mutation at position -2 relative to the triple base-pairing A12GC residues 
snatched to prime NS1 mRNA transcription in vitro. 
Capped leaders  
offered 
Retrieved mRNA 5' sequence # clones Origin leader 
(C/G/A/U)10C11A12GC 
(1:1:1:1; 500 ng each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-GUAUUAAUAGCAGCAGCAAAA 
5'-GUAUUAAUAACAGCAAAA 
5'-GUAUUAAUAUCAGCAAAA 
5'-GUAUUAAUAUCAGCAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
10 
1 
7 
11 
1 
1 
G10C11A12GC 
G10C11A12GC 
A10C11A12GC 
U10C11A12GC 
U10C11A12GC 
C10C11A12GC 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded. 
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Pair-wise competition between a single and a triple base-pairing leader with 
reciprocal 5' upstream sequences 
 
Based on the results above, single base-pairing AlMV3 leaders harboring a 3' AA 
were relatively favored but not those harboring a 3' CA. To analyze whether this difference 
was also found in pair-wise competitions among leaders with triple base-pairing 
possibilities, thereby underscoring the importance of the nucleotide identity at position 11, 
two additional competition experiments were performed. In the first one, leaders referred to 
as A11A12 and C11A12GC (Table 3-11) were tested and in the second one their reciprocal 
variants, C11A12 (identical to WT) and A11A12GC (Table 3-11).  
In the first case, 14 out of 18 clones analyzed contained a leader from mutant 
C11A12GC and 4 from A11A12 (Table 3-12). In the second case, 18 of the 19 clones 
contained the A11A12GC sequence and only one C11A12 (Table 3-12). These results indicate 
that while nucleotide sequences within the leader are of some importance, extending base 
complementary to the viral template is the predominant selective criterion. 
 
 TABLE 3-11.   
WT and mutant AlMV3 leaders used in pair-wise competition assays. 
Capped leader 5' end sequence of capped leader 
C11A12 (WT) 
A11A12 
C11A12GC 
A11A12GC 
5'-GUAUUAAUACCAUUUUCAAAAUAUUCC 
5'-GUAUUAAUACAAUUUUCAAAAUAUUCC 
5'-GUAUUAAUACCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUACAAGCUUCAAAAUAUUCC 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
 TABLE 3-12.   
In vitro competition of a less preferred (CA) versus more preferred (AAGC) leader and their 
reciprocal leader variants during priming of NS1 mRNA transcription. 
Capped leaders  
offered 
Retrieved mRNA 5' sequence # clones Origin leader 
A11A12 + C11A12GC 
(1:1; 500 ng each) 
5'-GUAUUAAUACCAGCAAAA 
5'-GUAUUAAUACCAGCAGCAAAA 
5'-GUAUUAAUACAAGCAAAA 
5'-GUAUUAAUACAGCAAAA 
13 
1 
2 
2 
C11A12GC 
C11A12GC 
A11A12 
A11A12 
C11A12 + A11A12GC 
(1:1; 500 ng each) 
5'-GUAUUAAUACAAGCAAAA 
5'-GUAUUAAUACAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
11 
7 
1 
A11A12GC 
A11A12GC 
C11A12 
12 
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Footnote belongs to Table 3-12 (page 55). Influenza sequence is underlined, while residues that 
possibly could originate from the RNA leader offered and with complementarity to the vRNA template (3'-
UCG…) are in bold and italics; the marker nucleotide of each mutant is shaded.  
 
 
Leader length requirements for priming influenza transcription 
 
Several publications indicate that the influenza transcriptase generally cleaves at a 
position 9-15 nt downstream of the cap (Bouloy et al., 1978; Plotch et al., 1979; Robertson 
et al., 1980). To define the optimal leader length of a cap donor, AlMV3 leaders with base-
pairing residues at various positions relative to the 5' cap were made and tested. All 
constructs contained a CAGC sequence embedded within an oligo U stretch, to guarantee 
proper alignment of the leader along the vRNA template (Table 3-13). The initial choice 
for the CAGC context was made based on the earlier reported and apparent preference of 
influenza virus for RNA leaders with a 3'-terminal CA (Rao et al., 2003).  
Leader transcripts were simultaneously offered in equimolar amounts. RT-PCR 
cloning and sequence analysis of de novo synthesized viral transcripts revealed that 9 out of 
17 transcripts contained capped leaders originating from C9A10GC, and 5 from C10A11GC 
(Table 3-14), suggesting an optimal leader length of 10-11 nt. Several clones revealed the 
presence of repetitive sequences, again indicative for prime-and-realign. 
 
 
 TABLE 3-13.   
Mutant AlMV3 leaders used in multiple competition assay. 
Capped leader 5' end sequence of capped leader 
C7A8GC 
C8A9GC 
C9A10GC 
C10A11GC 
C11A12GC 
C12A13GC 
C13A14GC 
C14A15GC 
C15A16GC 
C16A17GC 
C17A18GC 
5'-GUAUUUCAGCUUUUUUUUUUUUCAAAAUAU 
5'-GUAUUUUCAGCUUUUUUUUUUUCAAAAUAU 
5'-GUAUUUUUCAGCUUUUUUUUUUCAAAAUAU 
5'-GUAUUUUUUCAGCUUUUUUUUUCAAAAUAU 
5'-GUAUUUUUUUCAGCUUUUUUUUCAAAAUAU 
5'-GUAUUUUUUUUCAGCUUUUUUUCAAAAUAU 
5'-GUAUUUUUUUUUCAGCUUUUUUCAAAAUAU 
5'-GUAUUUUUUUUUUCAGCUUUUUCAAAAUAU 
5'-GUAUUUUUUUUUUUCAGCUUUUCAAAAUAU 
5'-GUAUUUUUUUUUUUUCAGCUUUCAAAAUAU 
5'-GUAUUUUUUUUUUUUUCAGCUUCAAAAUAU 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
8 
18 
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 TABLE 3-14.   
Usage of RNA leaders varying in length from 7 to 17 nt relative to the position of base 
complementarity (AGC) during priming of NP mRNA transcription. 
Capped leader offered Retrieved mRNA 5' sequence # clones 
C8A9GC 5'-GUAUUUUCAGCAGCAAAA 1 
C9A10GC 5'-GUAUUUUUCAGCAAAA 1 
 5'-GUAUUUUUCAGCAGCAAAA 8 
C10A11GC 5'-GUAUUUUUUCAGCAAAA 2 
 5'-GUAUUUUUUCAGCAGCAAAA 3 
C11A12GC 5'-GUAUUUUUUUCAGCAAAA 1 
C12A13GC 5'-GUAUUUUUUUUCAGCAAAA 1 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader 
offered and with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the 
marker nucleotide of each mutant is shaded. 
 
 
Reduced α-globin leader use in the presence of singly or triply base-pairing cap 
donors 
 
To analyze the potential competitor effect of singly and triply base-pairing leaders 
on α-globin leader primed transcription, 3 leader constructs (C11A12, C11A12GC and 
A11A12GC) (Table 3-11), were individually offered in various concentrations to the 
transcription assay. These leaders differed in their base complementarity to the vRNA 
template and/or one residue at position 11 just upstream the putative base-pairing residue(s) 
of the leader sequence. Since the RRL lysate used (AP-Biotech) had been treated with 
micrococcal nuclease by the manufacturer the exact amounts of residual globin mRNA 
molecules as source for capped RNA leaders was unknown. As a consequence, the 
reduction in globin leader initiated viral transcription by various mutant AlMV3 leader 
RNAs would only provide a relative indicator on the competitor effect of AlMV3 leaders. 
The relative reduction in α-globin leader NS1 transcription initiation was analyzed by RT-
PCR and revealed that increasing amounts of C11A12 reduced globin leader initiated NS1 
transcription to a lesser extent than C11A12GC and A11A12GC did (data not shown), in other 
words increasing complementarity of the AlMV3 leader sequence to the vRNA template 
increased its use and strength as competitor.  
To further quantify this effect, the AlMV3-NS1/α-globin-NS1 ratio was 
determined by means of a two step quantitative real-time PCR (Materials and methods). 
A significant, almost 3-fold increase of the AlMV3-NS1/α-globin-NS1 ratio was observed 
when leader A11A12GC was used compared to C11A12 (WT) (Figure 3-2A; pair-wise t-test 
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on log transformed data, T2 = −7.197, P = 0.019). When all leaders were compared, samples 
containing A11A12GC (with a triple base complementarity and optimal A residue at position 
11) gave the highest AlMV3/α-globin-NS1 ratio, followed by C11A12GC (with a triple base 
complementarity and a less optimal C residue at position 11) and then by C11A12 (with a 
single base complementarity and less optimal C residue at position 11) (Figure 3-2B). 
There was a significant effect of the leader used on the AlMV3/α-globin ratio (ANOVA on 
log transformed data, F2,8 = 63.483, P < 0.001), and all three pair-wise comparisons 
between the three leaders gave a significant outcome with a suitable post hoc test (Tukey 
HSD, P < 0.010 for all three comparisons). When only influenza infected material was 
used as negative control, no viral NS1 transcripts containing cellular capped leaders were 
PCR amplified with AlMV3 and NS1 primers (Figure 3-2B).  
 
 
 
 Figure 3-2. Quantification of AlMV3 and α-globin leader initiated NS1 transcription by two-
step real-time PCR analysis. In vitro synthesized mRNA in the presence of RRL and addition of 
AlMV3 leader, was reverse transcribed using an internal primer for Influenza NS1 gene. Quantitative 
real-time PCR amplification was performed using a nested primer for the NS1 gene and a primer for 
the AlMV3 or α-globin mRNA. The geometric mean and standard error of the AlMV3/α-globin-NS1 
ratio are given in both panels. (A) Active virus and increasing concentrations of C11A12 (WT) or 
A11A12GC were used (concentrations are indicated in the X-axis). (B) Active virus and 0.5 μg of 
C11A12, C11A12GC or A11A12GC were used. In the case of control, no AlMV3 leader was offered.   
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Discussion  
 
Although models for influenza are postulated as a paradigm for cap-snatching by 
all segmented, (-) ssRNA viruses (Rao et al., 2003), the matter of base-pairing between 
capped RNA leader and viral template has remained unresolved. Here, it is shown that in 
vitro influenza transcriptase selects donors with increasing base complementarity to the 3'-
ultimate residues of the vRNA template (Tables 3-1 to 3-4, 3-11, and 3-12). Competition 
experiments in which 2, 4 or even up to 11 capped leaders were offered indicated that this 
preference is influenced, and even overruled when the base-pairing residues were 
positioned in a less optimal distance to the 5' cap, or when the residues immediately 5' of 
the base-pairing residues changed. Leaders in which the first base-pairing residue (A) was 
positioned 10 or 11 nt downstream the cap were most favored (Tables 3-13 and 3-14). 
When alignment of the leader at the 3'-ultimate U residue of the vRNA template occurred 
(e.g. forced by offering triple base-pairing leaders), there was a preference for an A or U 
residue 5' of the A12 base-pairing residue (Tables 3-8 and 3-9).  
The presented data indicate that priming by virtue of base-pairing is a preferred 
determinant for the selection of RNA leaders during transcription initiation (Tables 3-1 to 
3-12). During this process, base-pairing most likely occurs before cleavage takes place, 
otherwise the preference for extensive base complementarity cannot be explained. In light 
of these observations, de novo synthesized viral transcripts perfectly match the criteria for 
preferential use as cap donors. However, selective protection of viral transcripts by the viral 
polymerase has previously been demonstrated (Shih and Krug, 1996) and likely prevents a 
down regulation of viral transcription due to re-snatching events of viral transcript leaders. 
The occurrence of base-pairing prior to endonuclease cleavage is also supported by the 
observation that elongation of short oligoribonucleotides can take place after the first, 
second or third base-pairing residue of the leader, but not after a fourth. This implies that 
endonuclease cleavage can take place after the first base-pairing residues but not beyond 
the third (Honda et al., 1986). In case of the latter, an additional cleavage would be 
required to further trim the RNA leader sequence to render a primer that can be elongated 
(Chung et al., 1994). The absence of a clear viral preference for cap donors with either 
triple (Mut-3) or multiple (Mut-N14) nucleotide complementarity to the vRNA template 
would then suggest that residues further downstream of the initial base-pairing ones do not 
play a major role anymore in the alignment along the viral template. 
In only 5 out of 397 cloned viral transcripts the marker nucleotide, to discriminate 
between leader sequences, was lacking. The reason for the absence of the marker nucleotide 
is not clear, but might be due to sequencing error, or due to a transcription initiation event 
that did not involve alignment of a capped RNA leader along the vRNA template by virtue 
of base-pairing. In case of the latter, the very low number of viral transcripts without a 
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marker nucleotide would strongly support the importance of a base-pairing requirement of 
capped RNA leaders during cap-snatching. 
A total of 44 out of 397 cloned viral transcripts contained repetitive sequences 
(GCAGC), indicating the phenomenon of prime-and-realign. This phenomenon is likely 
intrinsic to the mechanistic model of cap-snatching in which primer alignment involves 
base-pairing. The reason why some leaders appear to give rise to higher rates of prime-and-
realign than others remains unknown. Kawaguchi and Nagata (2007) postulated that during 
replication of the influenza complementary RNA strand, the vRNA polymerase converts 
from an initiating form that holds the RNA weakly to an elongation form that holds the 
RNA tightly. In light of these results, we speculate that a similar phenomenon may occur 
during transcription initiation. During such process, an apparent realignment occurs that in 
reality represents a new initiation event involving an earlier aborted (weakly bound) 
primer-initiation complex and resulting in the presence of a repetitive sequence.  
The need for base complementarity between cellular leaders and the viral template 
during influenza cap-snatching has been the source of a long debate due to apparently 
conflicting data from many earlier studies. Several in vitro studies (Chung et al., 1994; 
Hagen et al., 1994; Plotch et al., 1981) showed that base-pair interactions can contribute 
for alignment of the leader to the influenza vRNA template, which is further supported by 
the ability of di- (ApG) and tri-nucleotides to prime transcription in vitro (Honda et al., 
1986). On the other hand, capped ribopolymers lacking a sequence (AG or AGC) 
complementary to the 3' terminus of the vRNA (3'-UCGU) were still accepted as primers 
for transcription, which led to the suggestion that base-pair interactions are not required 
(Hagen et al., 1995; Krug et al., 1980). Furthermore, in contrast to an earlier study (Rao et 
al., 2003), the results presented here suggest that influenza does not effectively use CA-
terminating sequences as primers for in vitro transcription.  
The stronger in vitro reduction of α-globin RNA leader initiated transcription by 
triply base-pairing cap donors compared to singly base-pairing variants (Figure 3-2) 
demonstrates the competitiveness of such molecules during transcription initiation. 
Whether priming by virtue of base-pairing also is a preferred determinant in vivo, remains 
to be analyzed. 
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Materials and methods 
 
Construction of plasmids 
WT was constructed as described previously (Chapter 2). AlMV3 mutants were 
generated as well from plasmid pXO32NcoP3 (Neeleman et al., 1993). Mut-2 and Mut-3 
were PCR amplified by using primer AlMV3-Rv (Table 2-4) and primers Mut2 or Mut3 
respectively. Mut-N14, an AlMV3-influenza NP mutant which could base-pair over a stretch 
of 14 nt to the 3' end of the viral NS1 template, was amplified with primers MutN14 and 
NPUP2.  
AlMV3 constructs that contained a point mutation at position 11 of the AlMV3 
sequence were made by first amplifying pXO32NcoP3 using primers AlMV3-Rv and B11A 
(B = G, A or T). A second amplification was performed with primer T7prom1-AlMV3 for 
extension of the AlMV3 leader with the T7 promoter sequence. Point mutants of AlMV3 at 
nucleotide 11 are referred to as G11A12, A11A12 and U11A12 (in which nucleotide at position 
11 was changed from C residue into a G, A or T respectively). 
Similarly, AlMV3 mutants that contained a mutation at either position 10 or 11 of 
the AlMV3 sequence, and additionally the 3 base-pairing residues (AGC) were made by 
first amplification of the same plasmid with primers AlMV3-Rv and D10CAGC (D = C, G, 
A or T) or E11AGC (E = C, G, A or T) respectively. Second amplification was performed 
with primer T7prom2-AlMV3 or T7prom1-AlMV3 for AlMV3 constructs with mutation at 
position 10 or 11 respectively. Point mutants of AlMV3 at 10 or 11 nt with the additional 3 
base-pairing residues were referred to as G10C11A12GC (in which nucleotide 10 was 
changed from C into an G, and nucleotides at positions 13 and 14 into a G and C 
respectively), A10C11A12GC and U10C11A12GC or G11A12GC, A11A12GC and U11A12GC 
respectively. C10C11A12GC and C11A12GC were made by changing the nucleotide U at 
positions 13 and 14 into a G and C respectively. 
Amplified PCR fragments were separated by electrophoresis in a 1% agarose gel 
and purified using the GFX PCR purification kit (Roche). Purified products were restriction 
enzyme digested with BamHI/EcoRI and ligated into pUC19 using T4 DNA ligase 
(Promega). The nucleotide sequence of individual clones was verified by the 
dideoxynucleotide chain termination method (Sanger et al., 1977) using standard M13 
sequencing primers and ultra-high throughput (ABI Prism 3700) DNA sequencer 
(GreenomicsTM). 
Constructs for the leader length requirements experiment were made by first 
amplifying pXO32NcoP3 with primer AlMV3-Rv and primers C7A8, C8A9, C9A10, C10A11, 
C11A12, C12A13, C13A14, C14A15, C15A16, C16A17, or C17A18. Primer T7prom3-AlMV3 was 
used in the second PCR amplification. For these constructs, capped transcripts were made 
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directly from the purified PCR fragments without additional cloning. Primer sequences are 
listed in Table 3-15. 
 
Synthesis of cap-0 and cap-1 RNA leaders 
Cap-0 AlMV3 leaders were obtained by run-off transcription with Ambion T7 
mMESSAGE mMACHINE kit as described in Chapter 2. 
For the cap-0 versus cap-1 experiments, T7 RNA polymerase transcripts were 
made in the absence of cap-analog. These uncapped RNA leaders were subsequently 
provided cap-0 or cap-1 structures by using the ScriptCapTM m7G Capping System 
(EPICENTRE Biotechnologies) in the absence or presence of the ScriptCapTM 2'-O-
Methyltransferase according to the manufacturer’s instruction.  
 
In vitro influenza transcription and AlMV3 leader competition assays 
In vitro influenza transcription assays were performed as described in Chapter 2. 
 
Analyses of AlMV3-influenza mRNA sequences 
RT-PCR and cloning analysis of RNA products was performed as described in 
Chapter 2. In the case of the leader length requirements experiment, primer AlMV3-
leader2 (Table 3-15) was used instead of primer AlMV3-leader1 during the PCR 
amplification.  
 
 
Two-step quantitative real-time PCR analysis 
De novo synthesized NS1 transcripts were reverse transcribed into cDNA as 
described earlier. Afterwards, the first-strand cDNA was applied in a SYBR Green 1-based 
quantitative real-time PCR according to Zwart et al. (2008), with minor modifications: an 
annealing temperature of 50 °C was used and template concentrations were determined 
using the standard curve method (RotorGene 6.0 software, Corbett Research). Template 
cDNA was diluted 500-fold. A PCR reaction was performed with the AlMV3-leader1 and 
NS1UP2 primers to determine the AlMV3-NS1 cDNA concentration in the sample. A 
separate PCR reaction was performed with the α-globin and NS1UP2 primers to determine 
the α-globin-NS1 cDNA concentration. The AlMV3-NS1/α-globin-NS1 ratio was 
determined for each pair of replicates, and three replicates were performed in total. The 
geometric mean and standard error of mean of the AlMV3-NS1/α-globin-NS1 ratio were 
then calculated. All further statistical analysis was performed in SPSS 15.0 (SPSS Inc., 
Chicago, IL). Primer sequences are listed in Table 2-4. 
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 TABLE 3-15.   
Primer sequences for mutant AlMV3 construct. 
Name Primer sequence (5'→3') 
Mut2 
Mut3 
MutN14 
CCCGGATCCTAATACGACTCACTATAGTATTAATAACAGTTTCAAAATATTCC 
CCCGGATCCTAATACGACTCACTATAGTATTAATAGCAGCTTCAAAATATTCC 
CCCGGATCCTAATACGACTCACTATAGTATTAATATCAGCAAAAGCAG 
B11A 
D10CAGC 
E11AGC 
CACTATAGTATTAATACBATTTTCAAAATATTCC 
CACTATAGTATTAATADCAGCTTCAAAATATTCC 
CACTATAGTATTAATACEAGCTTCAAAATATTCC 
C7A8 
C8A9 
C9A10 
C10A11 
C11A12 
C12A13 
C13A14 
C14A15 
C15A16 
C16A17 
C17A18 
CGACTCACTATAGTATTTCAGCTTTTTTTTTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTCAGCTTTTTTTTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTCAGCTTTTTTTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTTCAGCTTTTTTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTTTCAGCTTTTTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTTTTCAGCTTTTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTTTTTCAGCTTTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTTTTTTCAGCTTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTTTTTTTCAGCTTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTTTTTTTTCAGCTTTCAAAATATTCCAAT 
CGACTCACTATAGTATTTTTTTTTTTTTCAGCTTCAAAATATTCCAAT 
T7prom1-AlMV3 
T7prom2-AlMV3 
T7prom3-AlMV3 
CCCGGATCCTAATACGACTCACTATAGTATTAATAC 
CCCGGATCCTAATACGACTCACTATAGTATTT 
CCCGGATCCTAATACGACTCACTATAGTATTT 
AlMV3-leader2 CCCGGATCCGGGGGGTATT 
Residues which could potentially base-pair to the viral template are underlined; bold residues are T7 promoter 
sequence. 
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“Don’t escape when you have a problem because there always is a way to solve it.” 
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Preferential use of RNA leader sequences during influenza 
A transcription initiation in vivo 
 
 
In vitro transcription initiation studies revealed a preference of Influenza A virus 
for capped RNA leader sequences with base complementarity to the viral RNA template. 
Here, these results were verified during an influenza infection in MDCK cells. Alfalfa 
mosaic virus RNA3 leader sequences mutated in their base complementarity to the viral 
template, or the nucleotides 5' of potential base-pairing residues, were tested for their use 
either singly or in competition. These analyses revealed that influenza transcriptase is able 
to use leaders from an exogenous mRNA source with a preference for leaders harboring 
base complementarity to the 3'-ultimate residues of the viral template, as previously 
observed during in vitro studies. Internal priming at the 3'-penultimate residue, as well as 
“prime-and-realign” was observed. The finding that multiple base-pairing promotes cap 
donor selection in vivo, and the earlier observed competitiveness of such molecules in vitro, 
offers new possibilities for antiviral drug design. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A slightly modified version of this chapter has been published as: 
Geerts-Dimitriadou, C., Goldbach, R., Kormelink, R., 2011. Virology 409, 27-32. 
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Introduction  
 
The Influenza A virus genome is composed of eight negative-sense RNA segments 
(Palese and Schulman., 1976; Scholtissek et al., 1976), which can encode up to 11 viral 
proteins (Palese and Shaw, 2006). Upon infection, viral ribonucleoproteins are transported 
to the nucleus where viral genome transcription and replication take place. Influenza 
transcription initiation involves m7G-capped RNA leader sequences which are cleaved from 
host cellular mRNAs (Bouloy et al., 1978; Krug et al., 1979; Plotch et al., 1979). Binding 
and cleavage of such leaders are catalyzed by the viral polymerase complex, consisting of 
PB1, PB2 and PA, of which PA has recently been suggested to hold the endonuclease 
activity rather than PB1 (Braam et al., 1983; Dias et al., 2009; Li et al., 2001; Shi et al., 
1995; Yuan et al., 2009). This transcription initiation mechanism, known as “cap-
snatching”, is shared among all other families of segmented, negative (-) ssRNA viruses 
(Duijsings et al., 2001; Garcin et al., 1995; Huiet et al., 1993; Jin and Elliott, 1993a and 
b; Kormelink et al., 1992b).  
While the bunyaviruses and arenaviruses replicate in the cytoplasm and use the 
available pool of mature mRNAs as source for capped RNA leaders, influenza virus 
replicates in the nucleus and requires ongoing RNA polymerase II (Pol II) transcription, as 
demonstrated by the sensitivity to the RNA Pol II inhibitor α-amanitin (Lamb and 
Choppin, 1977; Mark et al., 1979). In the nucleus, the influenza virus RNA polymerase 
complex interacts with the large subunit of Pol II via its C-terminal domain (CTD), leading 
to a colocalization of the virus with RNA Pol II transcription sites. It is suggested that these 
sites may correspond to the earlier described “nuclear cages” or the nuclear matrix function 
where influenza virus RNA synthesis takes place (Engelhardt et al., 2005). 
Being confined to RNA Pol II transcription sites, the virus has direct access to 
locally higher concentrations of cellular capped pre-mRNAs as source to initiate genome 
transcription. Endonuclease cleavage of these simultaneously leads to premature RNA Pol 
II transcription termination (Chan et al., 2006; Engelhardt et al., 2005). Coupling of viral 
transcription to RNA Pol II transcription additionally seems logic due to the fact that two of 
the viral mRNAs are processed by the cellular splicing machinery associated with RNA Pol 
II transcription. 
With few exceptions, endonuclease cleavage by the influenza transcriptase 
complex generally takes place around 10-13 nt from the 5' cap structure (Shi et al., 1995), 
which appears to represent an optimal size of RNA leader sequence as shown by recent in 
vitro transcription assays in which 11 differently sized leaders were offered in a 
competition experiment and tested for their use (Chapter 3). For several segmented (-) 
ssRNA viruses, sequence analyses of viral mRNAs have shown a nucleotide preference at 
the 3' end of the non-viral leader, assumed to reflect a sequence preference for 
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endonuclease cleavage (Jin and Elliott, 1993a and b). For Influenza A virus a preference 
for purine residues has been proposed and suggested sufficient for influenza transcription 
initiation in vitro (Beaton and Krug, 1981; Krug et al., 1980; Plotch et al., 1981; Rao et 
al., 2003). Others have discussed the possibility of base-pair interactions during the 
alignment of capped leaders to the influenza viral RNA (vRNA) template but experimental 
data in support of this have been conflicting and inconclusive (Chung et al., 1994; Hagen 
et al., 1994; Plotch et al., 1981).  
Recently, we have demonstrated that priming by virtue of base-pairing is a 
preferred determinant for the selection of leaders during influenza transcription initiation in 
vitro and those nucleotides 5' of the base-pairing residues are of importance. Furthermore, 
leaders harboring a 3'-terminal CA dinucleotide, and suggested to be the only effectively 
used primers (Rao et al., 2003), appeared to be relatively inefficient cap donors (Chapter 
3). Whether base-pairing also promotes the selection of capped leaders in vivo, however, 
remains to be questioned. 
Here, results are being described from influenza virus transcription initiation 
experiments in Madin-Darby canine kidney (MDCK) cells which show that, in support of 
our earlier in vitro studies, alignment of capped RNA leader sequences by virtue of base-
pairing enhances their use during influenza A transcription initiation.  
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Results 
 
Influenza A prefers leaders with extended base complementarity to the vRNA 
template during genome transcription in vivo 
 
Previously, we have shown that base complementary to the vRNA template is a 
preferred determinant for the selection of capped RNA leaders during transcription 
initiation in vitro (Chapter 3).  
To verify if influenza virus in vivo would exhibit a similar preference for leaders 
with increased base complementarity to the vRNA template, MDCK cells were infected 
with Influenza A virus and co-transfected with wild type (WT) or Alfalfa mosaic virus 
RNA3 (AlMV3)-derived mutants, that differed in complementarity to the 3' end of the 
vRNA template (Table 4-1), and tested for their use as cap donor in pair-wise competition 
as earlier described (Chapter 3). 
 
 
 TABLE 4-1.   
Wild type (WT) and mutant AlMV3 leaders used in pair-wise assays. 
Capped leader 5' end sequence of capped leader 
WT  
Mut-2  
Mut-3  
Mut-N14  
5'-GUAUUAAUACCAUUUUCAAAAUAUUCC 
5'-GUAUUAAUAACAGUUUCAAAAUAUUCC 
5'-GUAUUAAUAGCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUAUCAGCAAAAGCAGGGUAG 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
 
Reverse-transcription PCR-cloning of de novo synthesized influenza transcripts 
from infected cells co-transfected with capped RNA from WT and Mut-2 (Figure 4-1, lane 
1), resulted in the presence of the Mut-2 leader sequence in all cloned AlMV3-NS1 
transcript sequences (Table 4-2). The WT was also offered in a 1:1 competition with Mut-
3, and almost all clones (18 out of 20) had a leader derived from Mut-3 and only 2 (out of 
20) a leader from the single base-pairing WT (Table 4-2). When WT was offered as cap 
donor in pair-wise competition with Mut-N14 in 1:1 ratio (0.3 μg or 3 μg each), all clones 
from newly synthesized NS1 transcripts contained the marker nucleotide of Mut-N14 (Table 
4-2). Similarly, when WT and Mut-N14 were offered in a 10:1 ratio (3 μg versus 0.3 μg 
respectively), still all clones contained the Mut-N14 leader (Table 4-2).  
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When Mut-2 and Mut-3 were pair-wise tested in cell, no clear preference for one of 
the two leaders showed up initially [Table 4-2, Mut-2 and Mut-3 (a)], but during a 
repeated analyses Mut-3 leader was used twice as often as Mut-2 [Table 4-2, Mut-2 and 
Mut-3 (b)]. Furthermore, a closer look at the snatched leaders from Mut-2 showed two 
potential cleavage sites, i.e. one clone resulted from cleavage downstream A10 and the rest 
of the clones from cleavage downstream of A12 in both cases [Table 4-2, Mut-2 and Mut-
3 (a and b)].  
Finally, an experiment was performed in which MDCK cells were infected with 
Influenza A virus and co-transfected with three (mutant) capped leaders, i.e. WT, Mut-2 and 
Mut-3, in a 1:1:1 ratio. Reverse-transcription PCR-cloning and sequence analysis of de 
novo synthesized influenza transcripts showed that 18 out of 25 clones analyzed contained a 
leader from Mut-3, while 6 clones contained a leader from Mut-2 and only 1 the WT leader 
(Table 4-2). Altogether these results strongly suggested that, like in vitro (Chapter 3), 
influenza virus in vivo prefers leaders with extended base complementarity to the vRNA 
template. 
During all experiments, control reactions with influenza infected only MDCK cells 
did not show any RT-PCR product (Figure 4-1, lane 2). 
 
 
 
 
 
 
 
 
 
 Figure 4-1  Analysis of in cell 
synthesized influenza mRNA. RT-PCR 
analysis of influenza transcripts from 
virus-infected MDCK cells transfected 
(lane 1) or not (lane 2) with WT and Mut-
2 capped leaders. Reverse transcription 
was performed using internal primer 
specific for the Influenza NS1 gene, 
followed by PCR using internal primer 
for the same gene in combination with a 
primer specific for the AlMV3 mRNA. 
M: molecular marker. 
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 TABLE 4-2.   
Distribution and nucleotide sequence of WT and mutant AlMV3 leaders snatched during virus NS1 
mRNA transcription in vivo. 
Capped leaders 
offered 
Retrieved mRNA 5' sequence # clones Origin leader 
WT + Mut-2  
(1:1; 3 μg each) 
5'-GUAUUAAUAACAGCAAAA 15 Mut-2 
WT + Mut-3  
(1:1; 3 μg each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-
GUAUUAAUAGCAGCAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
17 
1 
2 
Mut-3 
Mut-3 
WT 
WT + Mut-N14  
(1:1; 0.3 μg each) 
5'-GUAUUAAUAUCAGCAAAA 12 Mut-N14 
WT + Mut-N14  
(1:1; 3 μg each) 
5'-GUAUUAAUAUCAGCAAAA 
5'-GUAUUAAUAUGCAGCAAAA 
5'-GUAUUAAUAUGCAAAA 
23 
1 
1 
Mut-N14 
Mut-N14 
Mut-N14 
WT + Mut-N14  
(10:1; 3 μg resp 0.3 μg) 
5'-GUAUUAAUAUCAGCAAAA 6 Mut-N14 
Mut-2 + Mut-3 (a) 
(1:1; 3 μg each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-GUAUUAAUAACAGCAAAA 
5'-GUAUUAAUAAGCAAAA 
14 
13 
1 
Mut-3 
Mut-2 
Mut-2 
Mut-2 + Mut-3 (b) 
(1:1; 3 μg each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-GUAUUAAUAACAGCAAAA 
5'-GUAUUAAUAAGCAAAA 
19 
10 
1 
Mut-3 
Mut-2 
Mut-2 
WT + Mut-2 + Mut-3 
(1:1:1; 3 μg each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-GUAUUAAUAACAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
18 
6 
1 
Mut-3 
Mut-2 
WT 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded. 
 
 
Nucleotide/-s close to the 3' terminus of the leader do not play an essential role during 
cap-snatching in vivo 
 
Previous studies suggested that only leaders harboring a 3'-terminal CA 
dinucleotide are effectively used as primers during transcription initiation (Rao et al., 
2003). However, in these studies capped leaders were singly used and subsequently 
comparatively analyzed while these differed in length and sequence context relative to the 
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first A base-pairing residue. To analyze whether nucleotides within the leader sequence 
positioned upstream of the first base-pairing residue to the vRNA template indeed would 
affect the efficiency of cap donor usage, a transcription assay was performed in which the 
use of competing leaders during influenza transcription initiation was quantified. To this 
end, transcripts of four mutant AlMV3 constructs, harboring three base-pairing residues 
(AGC) and a variable nucleotide at position 11, were simultaneously offered to influenza 
virus infected MDCK cells and analyzed for their use. The AlMV3 mutants were referred to 
as C11A12GC, G11A12GC, A11A12GC and U11A12GC (Table 4-3) in which the nucleotide 
residue at position 11 also served as marker nucleotide to discriminate between leaders 
derived from these mutants.  
 
 
 TABLE 4-3.   
Mutant AlMV3 leaders used in multiple competition assay. 
Capped leader 5' end sequence of capped leader 
C11A12GC 
G11A12GC 
A11A12GC 
U11A12GC 
5'-GUAUUAAUACCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUACGAGCUUCAAAAUAUUCC 
5'-GUAUUAAUACAAGCUUCAAAAUAUUCC 
5'-GUAUUAAUACUAGCUUCAAAAUAUUCC 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the 
marker nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
 
When transcripts of all four AlMV3 constructs were offered in equimolar amounts 
to influenza virus infected cells, cloned NS1 gene transcripts harboring the AlMV3 leader 
sequence revealed a G residue at position 11 in 12 out of 33 clones, an A residue in 9 
clones, a U residue in 8 clones and a C residue in 4 clones (Table 4-4). A detailed look at 
the nucleotide sequence of clones with the leader sequence of G11A12GC revealed that the 
first viral A residue was lacking in 9 out of these 12 clones, likely due to endonuclease 
cleavage immediately after the G residue and subsequent internal priming on the 3'-
penultimate C residue of the vRNA template. The presence of a repetitive sequence in one 
of these clones furthermore indicated the occurrence of a prime-and-realignment event. 
In case the leader sequence originated from the construct with an A at position 11, 
1 out of 9 clones lacked an A residue at position 12 (Table 4-4), likely due to endonuclease 
cleavage downstream A11 and subsequent alignment on the vRNA template by a single 
base-pairing interaction with the ultimate 3' U residue of the vRNA template.  
 
 
 
12 
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 TABLE 4-4.   
Usage of leaders with a mutation at position -1 relative to the triple base-pairing A12GC residues 
snatched to prime NS1 mRNA transcription in vivo. 
Capped leaders offered Retrieved mRNA 5' sequence # clones Origin leader 
(C/G/A/U)11A12GC 
(1:1:1:1; 3 μg each) 
 
5'-GUAUUAAUACGAGCAAAA 
5'-GUAUUAAUACGCAAAA 
5'-GUAUUAAUACGCAGCAAAA 
5'-GUAUUAAUACAAGCAAAA 
5'-GUAUUAAUACAGCAAAA 
5'-GUAUUAAUACUAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
3 
8 
1 
8 
1 
8 
4 
G11A12GC 
G11A12GC 
G11A12GC 
A11A12GC 
A11A12GC 
U11A12GC 
C11A12GC 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded. 
 
 
We next determined whether AlMV3 leaders with three base-pairing residues and a 
variable residue at position 10, and referred to as C10C11A12GC, G10C11A12GC, 
A10C11A12GC and U10C11A12GC (Table 4-5), were affected in their relative usage during 
influenza transcription initiation in vivo. When transcripts of all four constructs were 
offered in a multiple competition, 6 out of 11 NS1 mRNA clones contained G10, 4 
contained A10 and only 1 contained U10 (Table 4-6). No clones were retrieved with C10. In 1 
out of the 4 clones containing the leader from A10C11A12GC the absence of C11 within the 
leader sequence implied the occurrence of an endonuclease cleavage immediately 
downstream A10. 
Although the results altogether did not reveal a strong preference for a specific 
nucleotide residue at position 10 or 11, capped RNA leaders harboring a C residue at these 
positions always were most poorly used. 
 
 
 TABLE 4-5.   
Mutant AlMV3 leaders used in multiple competition assay. 
Capped leader 5' end sequence of capped leader 
C10C11A12GC  
G10C11A12GC 
A10C11A12GC 
U10C11A12GC 
5'-GUAUUAAUACCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUAGCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUAACAGCUUCAAAAUAUUCC 
5'-GUAUUAAUAUCAGCUUCAAAAUAUUCC 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
12 
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 TABLE 4-6.   
Usage of leaders with a mutation at position -2 relative to the triple base-pairing A12GC residues 
snatched to prime NS1 mRNA transcription in vivo. 
Capped leaders offered Retrieved mRNA 5' sequence # clones Origin leader 
(C/G/A/U)10C11A12GC 
(1:1:1:1; 3 μg each) 
5'-GUAUUAAUAGCAGCAAAA 
5'-GUAUUAAUAACAGCAAAA 
5'-GUAUUAAUAAGCAAAA 
5'-GUAUUAAUAUCAGCAAAA 
6 
3 
1 
1 
G10C11A12GC 
A10C11A12GC 
A10C11A12GC 
U10C11A12GC 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded. 
 
 
Pair-wise competition between a singly and a triply base-pairing leader with 
reciprocal 5' upstream sequences 
 
All results so far support the idea that base-pairing residues within a leader 
sequence are of importance during influenza transcription initiation in vivo and nucleotides 
upstream these residues at positions -1 and -2 ( i.e. in our constructs at position 10 or 11) 
are of lesser importance, although a C at these positions was not favored. To further 
substantiate these findings a singly base-pairing leader (A11A12) was offered to influenza 
virus infected MDCK cells in pair-wise competition with a triply base-pairing leader 
(C11A12GC) (Table 4-7), and in a second one their reciprocal variants, C11A12 (identical to 
WT) and A11A12GC (Table 4-7). 
 
 
 TABLE 4-7.   
WT and mutant AlMV3 leaders used in pair-wise competition assays. 
Capped leader 5' end sequence of capped leader 
C11A12 (WT) 
A11A12 
C11A12GC 
A11A12GC 
5'-GUAUUAAUACCAUUUUCAAAAUAUUCC 
5'-GUAUUAAUACAAUUUUCAAAAUAUUCC 
5'-GUAUUAAUACCAGCUUCAAAAUAUUCC 
5'-GUAUUAAUACAAGCUUCAAAAUAUUCC 
Residues potentially base-pairing to the viral template (3'-UCG…) are underlined; the marker 
nucleotide used to discriminate between the different AlMV3 leaders is shaded. 
 
 
12 
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In the first experiment, 10 out of 14 NS1 transcript clones analyzed contained a 
leader from mutant C11A12GC and 4 from A11A12 (Table 4-8). In the second experiment 
with their reciprocal leader variants, 13 of the 16 clones contained the A11A12GC sequence 
and 3 the C11A12 (Table 4-8). In both experiments the triple base-pairing leaders were 
favorably used versus the single ones, and only in case of C at position 11 seemed 
somewhat reduced in its usage. The outcome of these experiments clearly indicate that 
base-pairing between the leader and the viral template enhances the use of leader sequences 
during influenza transcription initiation in vivo whereas residues at positions -1 and -2 to a 
lesser extent. 
 
 
 TABLE 4-8.   
In vivo competition of a less preferred (CA) versus more preferred (AAGC) leader and their 
reciprocal leader variants during priming of NS1 mRNA transcription. 
Capped leaders offered Retrieved mRNA 5' sequence # clones Origin leader 
A11A12 + C11A12GC 
(1:1; 3 μg each) 
5'-GUAUUAAUACCAGCAAAA 
5'-GUAUUAAUACAAGCAAAA 
5'-GUAUUAAUACAGCAAAA 
10 
1 
3 
C11A12GC 
A11A12 
A11A12 
C11A12 + A11A12GC 
(1:1; 3 μg each) 
5'-GUAUUAAUACAAGCAAAA 
5'-GUAUUAAUACAGCAAAA 
5'-GUAUUAAUACAGCAGCAAAA 
5'-
GUAUUAAUACAAGCAAAGCAAAA 
5'-GUAUUAAUACCAGCAAAA 
7 
4 
1 
1 
3 
A11A12GC 
A11A12GC 
A11A12GC 
A11A12GC 
C11A12 
Influenza sequence is underlined, while residues that possibly could originate from the RNA leader offered and 
with complementarity to the vRNA template (3'-UCG…) are in bold and italics; the marker nucleotide of each 
mutant is shaded.  
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Discussion  
 
Influenza viral mRNA synthesis is initiated by cap-snatching; a mechanism in 
which the endonuclease cleaves capped RNAs to ensure the required primers for viral 
mRNA synthesis (Beaton and Krug, 1981; Bouloy et al., 1978; Caton and Robertson, 
1980; Dhar et al., 1980; Plotch et al., 1979, id. 1981). Recently, we observed that 
influenza virus in vitro exhibits a strong preference for capped RNA leaders harboring 3'-
terminal residues with complementarity to the vRNA template (Chapter 3). Here we 
demonstrate that also during an infection in MDCK cells the influenza viral polymerase 
complex favors capped RNA leaders that match this criterion. Priming is not restricted to 
the ultimate viral template residue but can also take place internally, i.e. on the penultimate 
viral (C) residue, leading to absence of the first viral A residue in transcript sequences. A 
pair-wise competition of singly and triply base-pairing leaders with reciprocal 5' upstream 
sequences showed that the presence of less favorable residues in the leader sequence is 
overruled by the presence of downstream base-pairing residues, and again strengthens the 
importance of base complementarity (Table 4-8). Since not only for Influenza A virus but 
also for a completely different virus, the plant-infecting Tomato spotted wilt virus (TSWV) 
(Duijsings et al., 1999, id. 2001; van Knippenberg et al., 2002, ead. 2005a), the presence 
of base complementarity within the snatched leader sequence appears a preferred 
determinant for the selection of capped RNA leaders, it is likely that this applies to all other 
families of segmented (-) ssRNA viruses. For influenza virus, base complementarity is 
optimally positioned around 10-11 nt from the cap structure of the leader (Chapter 3) 
whereas for TSWV, likely due to a difference in the conformational folding of the viral 
transcription complex, is more optimal when positioned around 16 nt from the cap structure 
(Duijsings et al., 2001). The preference of influenza virus for leaders with base 
complementarity at positions 10-11 probably also explains why mutant G11A12GC (Table 
4-4) more often leads to (internal) priming by G11, as observed by the absence of the first 
viral A residue, instead of alignment and priming by the (less optimally positioned) A12GC. 
Whereas the in vitro pair-wise competition between Mut-2 and Mut-3 (Chapter 3), 
as well as the in vivo multiple competition between WT, Mut-2 and Mut-3 (this Chapter) 
clearly showed a two- to three-fold increased use of Mut-3 over Mut-2, it is interesting to 
note that in one out of two in vivo pair-wise competition experiments between Mut-2 and 
Mut-3 no clear preference for one of the two capped RNA leaders was observed (Table 4-
2). This could be caused by other factors that may influence the selection of leaders during 
transcription initiation. In light of this, it is interesting to mention that experimental 
evidence supports the formation of specific folding structures within the 5' and 3' viral 
termini as a requirement for genome transcription, which could as well affect the 
thermodynamics of primer alignment on the vRNA template. The most simplified model 
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describes formation of a panhandle structure due to base-pairing of the 5' and 3' ends (Hsu 
et al., 1987), but others have described a so-called “Fork” model (Fodor et al., 1994, id. 
1995), a “Corkscrew” model (Flick et al., 1996, id. 1999) or a combination of both 
(Pritlove et al., 1999). While the requirement of both 5'- and 3'-terminal ends for cap-
dependent endonuclease cleavage by the viral polymerase complex still is a matter of 
debate (Cianci et al., 1995; Hagen et al., 1994; Lee et al., 2003), and one might discuss 
which of the predicted stem-loop folding structures genuinely exists in vivo, the proposed 
involvement of a secondary structure on the 3' end of the vRNA template could affect the 
competitiveness of Mut-3 during a pair-wise testing with Mut-2 (Table 4-2). This could, 
likewise, explain the absence of a beneficial effect of extended base complementarity of 
Mut-N14 during a pair-wise competition in vitro with Mut-3 (Chapter 3). 
When revisiting the published 5' non-viral leader sequence data from previous in 
vivo Influenza A virus studies (Table 4-9) in view of our proposed model, 9 out of 15 
transcripts may have resulted from priming of capped RNA leaders on the 3'-ultimate U 
residue by means of single (or even multiple) base complementarity. The remaining 6 
clones showed the absence of the first viral A residue (Beaton and Krug, 1981; Caton and 
Robertson, 1980; Dhar et al., 1980; Lai et al., 1981; Vreede et al., 2008), likely due to 
internal priming of a G-terminated leader on the 3'-penultimate C residue of the vRNA 
template. For Influenza B virus, on the other hand, 10 out 19 transcripts may have resulted 
from priming of leaders on the vRNA template and 9 out 19 from internal priming (Table 
4-10) (Briedis et al., 1982; Briedis and Lamb, 1982; Briedis and Tobin, 1984; Shaw et al., 
1982; Shaw and Lamb, 1984). Furthermore, the 5' non-viral leader sequence data from in 
vivo Influenza A virus studies (Table 4-9) do not indicate a preference for capped RNA 
leaders with a 3' CA-terminus, in support of our in vitro and in vivo findings (Chapter 3 
and this Chapter), whereas those from Influenza B virus show a C residue upstream the 
base-pairing (A or G) residue in 14 out of 19 clones analyzed (Table 4-10). This indicates a 
preference of Influenza B virus for such leaders, and could be confirmed using capped RNA 
leader competition assays similarly as being described in this paper. 
Influenza virus steals capped RNA leaders from nascent RNA in the nucleus. 
There, the virus is confined to RNA Pol II transcription sites through binding of its RNA 
polymerase complex to the large subunit of Pol II via its CTD, which allows the virus direct 
access to higher concentrations of cellular capped pre-mRNAs as source to initiate genome 
transcription. The benefit for the virus is obvious but brings up the question whether the 
viral polymerase, while being attached to the RNA Pol II CTD, is limited to nascent RNA 
as substrate for capped leaders. Our data shows that the influenza virus during 
transcription/replication in the nucleus is able to accept leaders from an exogenous source. 
Whether this involves the RNA Pol II bound viral polymerase complex, or the viral 
polymerase at sites distinct from this (nuclear cages or the nuclear matrix function) 
(Engelhardt et al., 2005), remains unclear.  
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 TABLE 4-9.  
Host-derived sequences at the 5' ends of influenza A mRNA reported in earlier publications on 
sequencing of cloned cDNAs. 
Retrieved Influenza A virus mRNA 5' sequence vRNA References 
5'-AAGUAGAGCAAAA 
5'-ACCGGAGGGAGCAAAGCAAAA 
5'-AUCCUUUUGCAAGCAAAA 
5'-AUCUUUUGCAAGCAAAA 
5'-ACCAGCAGAAGCAAAA 
5'-AAGGCUUGUAGCAAAA 
5'-AGUGUUCGCAGCAAAA 
5'-AUUUACAGCUCAGCAAAA 
5'-AACAAACUUCAGCAAAA 
5'-CGGAAGGCCUCGGCAAAA 
5'-AGUGUCUCCGCGGCAAAA 
5'-CUGGUUGCGGGCAAAA 
5'-CAACAAGAUGGCAAAA 
5'-GUUCAUCAUCCCUGCAAAA 
5'-GAAGCGCUUCCGCAAAA 
NS 
HA 
NS 
NS 
NA 
NA 
HA 
NA 
M 
NS 
NA 
NS 
NA 
M 
NA 
Dhar et al., 1980 
Dhar et al., 1980 
Lamb and Lai, 1980 
Dhar et al., 1980 
Vreede et al., 2008 
Markoff and Lai, 1982 
Dhar et al., 1980 
Vreede et al., 2008 
Lamb and Lai, 1981 
Beaton and Krug, 1981 
Lai et al., 1981 
Dhar et al., 1980 
Vreede et al., 2008 
Caton and Robertson, 1980 
Vreede et al., 2008 
Influenza sequence is underlined, while the first residue base-pairing to the viral template and with possible origin 
from the RNA leader is in bold and italics; the non-viral 3'-terminal nucleotide at position -1 relative to the 
potential first base-pairing residue which might influence the use of the leader during cap-snatching process is 
shaded. The proteins encoded by the cloned segments are also indicated.  
 
 
During the past years, a number of reports have appeared in which RNA molecules 
were shown to down-regulate influenza vRNA replication/transcription in vitro. Small 
RNA molecules (47 nt) containing the conserved termini of influenza inhibited most of the 
CAT expression from a NS-CAT RNA molecule in their recombinant 
replication/transcription system (Luo et al., 1997). In another study, a pool of capped 
oligonucleotides (4-9 nt in length) was designed, too short to prime transcription, but long 
enough to bind (sequester) the viral polymerase and these were shown to be potent 
inhibitors of cap-dependent transcription (Chung et al., 1994). Uncapped RNA molecules 
lacking sequence complementarity to the 3' end of the influenza vRNA template, and with 
diminished secondary structure, have also been shown to be potent inhibitors of the 
transcription primed by ApG or globin mRNAs (Krug et al., 1980). Although in all cases 
described an inhibitory effect of specific RNAs on replication/transcription has been 
observed, there are no reports on possible antiviral effects of these molecules during 
influenza infection in vivo. Whether such oligos would work in vivo remains to be 
analyzed, especially when considering that they would have to compete for the polymerase 
with naturally and possibly more favorable abundant cap donors. 
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 TABLE 4-10.   
Host-derived sequences at the 5' ends of influenza B mRNA reported in earlier publications on 
sequencing of cloned cDNAs. 
Retrieved Influenza B virus mRNA 5' sequence vRNA References 
5'-AAUAGCAGAGCAGAA 
5'-AGAGGAUUGCUUGCAGCAGAA 
5'-CUUGCCUUGCAGCAGAA 
5'-CAGAUGUAUGCAGCAGAA 
5'-CUCUUGUGUGCAGCAGAA 
5'-ACCUCCCUCGGCAGCAGAA 
5'-UCAUUCUGGCAGCAGAA 
5'-AGACACACGCAGCAGAA 
5'-CAGCCGCCGCAGCAGAA 
5'-CAGUUCGGCGCAGCAGAA 
5'-AAGCGGCUGGUCGGCAGAA 
5'-CUAGGGCGGCAGAA 
5'-AGCAGCUCCUGCAGAA 
5'-CUUGCUUUUGCAGAA 
5'-CAGAGGACGCAGAA 
5'-AGUCUCUCUCGCGCAGAA 
5'-CCACCACCGCGCAGAA 
5'-AGACGGCGCGCGCAGAA 
5'-AAAACCCCCCACCGCAGAA 
NA 
M 
M 
M 
NA 
M 
NS 
NA 
M 
NS 
NP 
M 
M 
NA 
NS 
NS 
M 
M 
M 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Shaw et al., 1982 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Briedis and Tobin, 1984 
Shaw and Lamb, 1984 
Briedis et al., 1982 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Briedis and Lamb, 1982 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Shaw and Lamb, 1984 
Influenza sequence is underlined, while the first residue base-pairing to the viral template and with possible origin 
from the RNA leader is in bold and italics; the non-viral 3'-terminal nucleotide at position -1 relative to the 
potential first base-pairing residue which might influence the use of the leader during cap-snatching process is 
shaded. The proteins encoded by the cloned segments are also indicated.  
 
 
 
 
 
The recently observed stronger in vitro reduction of α-globin RNA leader initiated 
transcription by triply base-pairing cap donors compared to singly base-pairing variants 
(Chapter 3), and the confirmation that also in vivo influenza virus strongly prefers cap 
donor molecules with extended base complementarity to the vRNA template, not only 
demonstrates the competitiveness of such molecules during transcription initiation but also 
holds a promise, once made dysfunctional, in their use as antiviral RNA compounds.  
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Materials and methods 
 
Virus and Construction of plasmids 
Influenza A virus and AlMV3 plasmids used have been described previously 
(Chapter 2 and 3). 
 
Synthesis of capped RNA leaders 
In vitro synthesis of capped RNA leaders was performed by using the Ambion T7 
mMESSAGE mMACHINE kit according to the manufacturer’s instruction.  
 
Cell culture 
MDCK cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; 
Gibco® Invitrogen, Breda, The Netherlands) supplemented with 10% FBS, 100 U·ml−1 
penicillin, and 10 µg·ml−1 streptomycin. The cells were cultured in a 5% CO2 atmosphere at 
37 oC. 
 
Influenza transcription in vivo 
Cells were grown in DMEM (without FBS and antibiotics) at 60% to 70% 
confluence in a 6-well plate at 37 °C and infected with Influenza A virus at a multiplicity of 
infection (m.o.i.) of 3-10. After 2 h the medium was removed, cells were washed and 
subsequently transfected with the indicated amounts of wild type (WT) or (mutant) AlMV3 
RNA leaders using Lipofectamine reagent (Invitrogen, Breda, The Netherlands) according 
the manufacturer's instructions. After 4 h the transfection, medium was removed and 
substituted for supplemented DMEM. Cells were harvested after 17 h and total RNA was 
extracted with Trizol® (Invitrogen, Breda, The Netherlands), phenol-chloroform and 
subsequently ethanol precipitated. AlMV3 leader initiated influenza mRNA transcripts 
were RT-PCR amplified and sequence analyzed as previously described (Chapter 2). 
Healthy and virus infected only MDCK cells were used as controls.  
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“The good lad always knows of an alternate path.” 
 
Greek proverb  
 
 
 
 
 
  
  
 
Chapter 5 
Chapter 5 
 84 
 
 
Analysis of the Tomato spotted wilt virus S RNA-encoded 
hairpin structure in translation 
 
 
Transcripts of Tomato spotted wilt virus (TSWV) generally possess a 5' cap 
structure followed by an untranslated region (UTR) and at its 3' end a UTR containing a 
sequence that is predicted to fold into a stable hairpin structure. Due to the lack of a 
poly(A) tail, the predicted hairpin structure is postulated to act as an functional equivalence. 
In the present study, the role of the predicted hairpin structure in translation was 
investigated by expression analysis of various Renilla luciferase sensor constructs 
containing modified 3' and/or 5' UTR sequences of the TSWV nucleocapsid (N) gene. The 
results showed good luciferase expression levels in the presence of the 3' UTR including 
the predicted hairpin structure, and a loss of expression when the hairpin sequence was 
removed. Constructs containing the entire 3' UTR, but lacking the 5' UTR still rendered 
good expression levels, but when in addition the entire 3' UTR was exchanged for that of 
the non-structural (NSs) gene transcript, containing the complementary hairpin folding 
sequence, the loss of luciferase expression could only be recovered by providing the 5' 
UTR sequence of the NSs transcript. Luciferase activity remained unaltered when the 
hairpin structure sequence was swapped for the analogous one from Tomato yellow ring 
virus, another distinct tospovirus. The addition of viral N and NSs proteins further 
increased luciferase expression levels from hairpin structure containing constructs. The 
results suggest a role for the predicted hairpin structure in translation in concert with the 
viral N and NSs proteins.  
 
 
 
 
 
 
 
 
 
 
A slightly modified version of this chapter has been submitted for publication. 
Geerts-Dimitriadou, C., Lu, Y.Y., Geertsema, C., Goldbach, R., Kormelink, R.  
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Introduction  
 
The Bunyaviridae are a large and diverse family of primarily animal-infecting 
viruses that are characterized by spherical enveloped virus particles of 80-120 nm in 
diameter and having a segmented negative (-) strand tripartite RNA genome. Based on 
molecular, serological and biological (host) features, members of this family are divided 
into five genera, i.e. Orthobunyavirus, Hantavirus, Nairovirus, Phlebovirus, and 
Tospovirus (Table 1-1; Chapter 1) of which the latter contain the plant-infecting members. 
Most bunyaviruses are arthropod-borne and include causal agents for several important so-
called “emerging infections” in human, livestock and plant pathogens, such as La Crosse 
and Rift Valley fever virus which cause encephalitis in human and epizootics in livestock 
respectively (Elliott, 1997).  
Tomato spotted wilt virus (TSWV) is the representative of the plant-infecting 
tospoviruses and ranks among the top ten of economically most important plant viruses 
worldwide (Mumford et al., 1996). The TSWV genome comprises three single-stranded 
RNA segments (Figure 1-5; Chapter 1), and distinguishes from the other Bunyaviridae 
members as two out of its three genomic segments contain an ambisense gene arrangement. 
Only the large (L) segment is of entire negative polarity and encodes an RNA-dependent 
RNA polymerase (RdRp; L protein). The medium (M) segment codes in ambisense 
arrangement for a precursor of the envelope glycoproteins (Gn and Gc) and for the cell-to-
cell movement protein (NSm). The small (S) segment contains, like the M RNA, two non-
overlapping open reading frames (ORFs) on opposite strands, coding for the nucleocapsid 
(N) and non-structural (NSs) protein respectively. The NSs has been shown to be involved 
in suppression of gene silencing (Bucher et al., 2003; Takeda et al., 2002). All three 
segments are encapsidated by the N protein and together with small amounts of the RdRP 
form transcriptionally active ribonucleoproteins (RNPs), the templates for RNA synthesis 
(replication and transcription) by the L protein (Figure 5-1) (Goldbach and Peters, 1996).  
Within each genomic RNA segment, the first 8 nucleotides of both termini are 
complementary and conserved. Depending on the segment, terminal complementarity 
extends for up to 65 nucleotides (de Haan et al., 1989, id. 1990; Kormelink et al., 1992a). 
These complementary regions are thought to base-pair intramolecularly to form stable 
panhandle structures in vivo, as evidenced by the observed circular conformation of viral 
RNPs in electron micrographs (de Haan et al., 1989; Kellmann et al., 2001; Kitajima et 
al., 1992; Martin, 1964). The remainder internal regions of the untranslated regions 
(UTRs) are unique to each segment.  
The two non-overlapping genes of each ambisense RNA segment are located on 
opposite strands and separated by a large intergenic region (IR). The IR contains stretches 
of highly A- and U-rich sequences which are predicted to fold into a stable hairpin 
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structure. Genes encoded by the ambisense RNA segments become expressed by the 
synthesis of subgenomic messenger RNA (mRNA) molecules, a process that is being 
initiated by cap-snatching from host cellular mRNAs (Kormelink et al., 1992b; van 
Poelwijk et al., 1996). Whereas the requirements for cap-snatching have been studied in 
quite some details for TSWV (Duijsings et al., 1999, id. 2001; van Knippenberg et al., 
2002, ead. 2005a) and shown to similarly apply for influenza (Chapters 2, 3 and 4), not 
much is known yet on TSWV transcription termination and translation initiation. All 
bunyavirus transcripts lack a common poly(A) tail, and sequences that signal transcription 
termination have not been identified yet. Transcription termination for the ambisense 
encoded genes is thought to involve formation of the hairpin structure in the same manner 
as prokaryotic transcription termination occurs (Iapalucci et al., 1991). This is being 
supported by the observation that 3′ end mapping of viral mRNAs revealed the presence of 
the entire hairpin structure encoding sequence (van Knippenberg et al., 2005b).  
Eukaryotic mRNAs possess a 5' cap structure and a 3' poly(A) tail that are involved 
in bridging the 3' and 5' ends of the mRNA (Gallie, 1998, id. 2002). This circularization 
supports efficient translation of mRNA, presumably by facilitating recycling of the 
ribosomal subunits from the 3' end back to the 5' end. While bunyavirus mRNAs lack a 
poly(A) tail, it is not unlikely that such role is assigned to a structural sequence that 
functionally acts as an equivalent. For the TSWV ambisense encoded genes, the 3' hairpin 
structure could thus have an additional role as functional analog of a poly(A) tail, and 
support efficient translation. 
To test this hypothesis here, various N gene-based constructs were made and tested 
in Baby Hamster Kidney (BHK-21) cells for translation efficiency in a Vaccinia virus-T7 
(vv-T7) expression system. These constructs differed in their 3' termini, i.e. with mutations 
in the sequence of the predicted hairpin structure. For quantification purposes, the viral N 
gene was swapped for the Renilla (REN) luciferase gene. Results from this analysis are 
shown and suggest a role of the TSWV hairpin structure in translation, during which the 5' 
UTR may act in concert with the hairpin structure. 
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Results 
 
TSWV S segment 3' UTR is required for translation 
 
To analyze the involvement of the predicted hairpin structure within the IR region 
of the ambisense TSWV S RNA segment in translation of the S RNA-encoded N and NSs 
transcripts, translation studies were performed on variants of a model template that 
reflected authentic viral mRNAs (Figure 5-1). To this end, a copy of an N mRNA molecule 
was made, preceded with an Alfalfa mosaic virus RNA 3 (AlMV3) leader sequence and at 
its 3' end flanked with the predicted hairpin structure sequence (Materials and methods). 
This construct was fused at its 3' end with a ribozyme sequence, to create 3' ends that would 
most closely mimic authentic viral transcripts. The entire construct was cloned in a T7 
promoter-terminator cassette. For (sensitive) quantification purposes, the viral N gene was 
next swapped by the REN luciferase gene (Figure 5-2A). This construct, marked pREN-
HA/U-rich, was used for the construction of variants in which the predicted hairpin structure 
sequence was (partially) deleted, mutated, or exchanged for another tospovirus hairpin 
sequence and subsequently analyzed for translation efficiency using the vv-T7 system. The 
first set of variants from pREN-HA/U-rich differed at the 3' termini, i.e. either lacked the entire 
predicted hairpin structure sequence (construct pREN-NoH, Figure 5-2B), or instead 
contained a poly(A) tail coding sequence of 40 nucleotides (pREN-polyA, Figure 5-2B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5-1. Structural features within the S RNA segment.  
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BHK-21 cells were first infected with vv-T7 and then co-transfected with the 
aforementioned mutant REN luciferase constructs and a firefly (FF) luciferase plasmid 
(pIRES-FF) as internal control. While the REN luciferase gene, flanked with the 5' and 3' 
UTR of the N gene and including the sequence for the hairpin structure, showed good 
expression levels, no luciferase expression was observed when the hairpin structure 
sequence was deleted from this REN construct (Figure 5-2B). When the REN sensor 
construct from which the hairpin was deleted, was being provided a 3' poly(A) tail-
encoding sequence (pREN-polyA), high levels of luciferase activity were recovered again 
(Figure 5-2B). To exclude that differences in luciferase expression were not due to 
differences or even absence of transcription, transcriptional expression of all mutant REN 
constructs was verified by semi-quantitative RT-PCR and revealed similar levels (data not 
shown). Altogether, the results indicate the requirement/importance of the TSWV hairpin 
sequence for translation. 
 
 
 
 Figure 5-2. Analysis of the hairpin structure sequence in translation. Schematic presentation of 
TSWV-N (REN) and derived templates with modifications at the 3' UTR (A and B). (C) Luciferase 
activity monitored from REN constructs transfected to BHK-21 cells. Cells were infected with vv-T7 
and subsequently co-transfected with 100 ng of the indicated REN constructs and 0.5 ng of the FF 
luciferase expression plasmid (pIRES-FF) as internal control. The relative luciferase expression 
(REN/FF) was measured after 23 h post transfection. Error bars indicate standard deviations from the 
means of three replicate experiments.   
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Requirement of 5' and 3' UTR interaction for translational enhancement 
 
In order to determine whether the observed translation of pREN-HA/U-rich required 
the presence of a hairpin structure at the 3' end of the mRNA or just the IR sequence, a 
reporter construct was produced (pREN-HA/U*-rich) that contained the reverse 
complementary copy of the IR sequence encoding the hairpin structure (Figure 5-3). While 
this construct now contained a different sequence at its 3' end, i.e. the sequence normally 
involved in transcription termination of the ambisense S RNA encoded NSs gene, it still 
was able to fold into a similar hairpin structure (Zuker, 2003) (Figure 5-3, A and B). The 
construct was transfected to Vaccinia virus infected BHK-21 cells and its translational 
activity was measured. As a control, transcriptional expression of all mutant REN sensor 
constructs was verified by semi-quantitative RT-PCR and revealed similar transcription 
levels (data not shown). Although both hairpin constructs, pREN-HA/U-rich and pREN-HA/U*-
rich, are highly AU-rich and share structural homology to each other (Figure 5-3A), a 
reduction in luciferase activity was observed with the reverse complementary pREN-HA/U*-
rich construct (Figure 5-3C).  
To enhance the recruitment of ribosomes during translation of eukaryotic mRNAs, 
the 5' and 3' UTR sequences may also directly interact and lead to the formation of a 
pseudo-circularized mRNA molecule. The reduction in luciferase activity of pREN-HA/U*-
rich could thus be due to the presence of heterologous 5' and 3' UTR sequences, i.e. the 5' 
UTR originating from the TSWV N gene and the 3' hairpin encoding IR from the TSWV 
NSs gene, and their inability to interact. To analyze whether the 3' hairpin sequence acts in 
concert with the 5' UTR, the latter sequence was either removed from the REN sensor 
hairpin constructs or replaced by the 5' NSs UTR (Figure 5-4).  
Luciferase expression analysis revealed no change in the activity of the N-based 
hairpin construct lacking the 5' UTR or having the 5' NSs UTR. However, the previous loss 
of reporter activity observed with the NSs-based hairpin construct harboring the 5' N UTR 
(pREN-HA/U*-rich), and recovery after the addition of the 5' NSs UTR (Figure 5-4) indicated 
that the presence of both 5' and 3' UTR sequences of the NSs gene was required to enhance 
translation. The observation that the N gene hairpin structure encoding 3' UTR sequence 
could be replaced by its reverse complement, able to fold into a similar structure, pointed 
towards the requirement for the hairpin structure rather than a specific nucleotide sequence. 
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 Figure 5-3. Requirement of the 3' UTR of TSWV mRNAs in translation. (A) Sequence 
alignment of the TSWV N gene 3' UTR (pREN-HA/U-rich) and its reverse complement (pREN-HA/U*-
rich). (B) Mfold predictions of the highly AU-rich sequence in the viral sense RNA (vRNA) flanking 
the 3' end of the NSs ORF (pREN-HA/U*-rich, panel A), and the analogous sequence in the viral 
complementary RNA (vcRNA) flanking the 3' end of the N ORF (pREN-HA/U-rich, panel A). (C) 
Luciferase activity measured from BHK-21 cells infected with vv-T7 and subsequently co-transfected 
with 100 ng of expression REN constructs (pREN-HA/U-rich, pREN-HA/U*-rich, or pREN-polyA) and 0.5 
ng of pIRES-FF as internal control. The relative luciferase expression (REN/FF) was measured after 
23 h post transfection. Error bars show the standard deviations from the means of three replicate 
experiments. 
 
  
TSWV transcription termination/translation initiation 
91 
 
 
 
 Figure 5-4. Requirement of the 5' UTR sequence in translation. BHK-21 cells were infected with 
Vaccinia virus, and subsequently co-transfected with 100 ng of the indicated REN constructs and 0.5 
ng of pIRES-FF as internal control. The relative luciferase expression (REN/FF) was measured after 
23 h post transfection. Error bars show the standard deviations from the means of three replicate 
experiments. 
 
 
Rescue of TSWV translation by an IR-encoding hairpin structure sequence from a 
distinct tospovirus  
 
To further substantiate the finding that the hairpin structure, rather than a sequence 
specific element within the IR, is involved in translation of the TSWV S RNA-encoded N 
and NSs genes, the hairpin structure sequence within the TSWV N-gene 3' UTR was 
exchanged for the one from a completely distinct tospovirus, i.e. Tomato yellow ring virus 
(TYRV). Whereas the TYRV S RNA encoded hairpin structure sequence from the N gene 
is also AU-rich, it is a bit larger in size than the one from TSWV (Figure 5-5, A and B). 
When the TSWV hairpin structure sequence from pREN-HA/U-rich was replaced by the one 
from TYRV (construct pREN-TYRV H), no difference in luciferase activity was observed 
in BHK21 cells between the two hairpin constructs (Figure 5-5C).  
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 Figure 5-5. Comparison of the predicted hairpin structure sequence from TSWV (N gene 
transcript) with the analogous one from TYRV. (A) Alignment of the TSWV and TYRV N-based 
hairpin structure sequence. (B) Predicted hairpin structure at the 3' end of the N gene of TSWV 
respectively TYRV. (C) BHK-21 cells were infected with Vaccinia virus and transfected with 100 ng 
of either pREN-HA/U-rich, pREN-TYRV H, or pREN-polyA. In addition to the REN construct, 0.5 ng 
of pIRES-FF was added as internal control. After 23h, the cells were lysed and assayed for relative 
luciferase activity. Error bars show the standard deviations from the means of three replicate 
experiments. 
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The A-rich stretch of the predicted hairpin structure suffices for translation  
 
A close look at the IR showed that the first half of the predicted hairpin structure 
sequence contained stretches rich in A residues followed by a second half rich in U residues 
(Figure 5-6). Due to this sequence arrangement, it could not be excluded that only the first 
half of the predicted hairpin sequence mimicked a natural poly(A)-tail. To analyze this 
possibility, two mutants of pREN-HA/U-rich were made, referred to as pREN-halfHA-rich and 
pREN-halfHU-rich, from which the U- respectively A-rich part was lacking (Figure 5-7). 
Furthermore, mutant pREN-halfHA*-rich was made, containing the A-rich sequences from 
the reverse complementary strand of the hairpin, i.e. the A-rich sequence part of the 
predicted hairpin structure of the NSs gene transcript.  
Analyses of these constructs on luciferase expression interestingly revealed a two 
fold increase of luciferase activity with mutants pREN-halfHA-rich and pREN-halfHA*-rich 
compared to the plasmid containing the entire hairpin structure sequence (Figure 5-7), 
while no activity was measured with mutant pREN-halfHU-rich (Figure 5-7). Transcriptional 
expression of all REN sensor constructs was verified and observed to be similar based on 
semi-quantitative RT-PCR (data not shown). These findings supported the possibility that 
the A-rich sequence within the hairpin structure sequence could assist in translation by 
mimicking a poly(A) tail. 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5-6. Localization of the A- and U-rich part within 
the predicted hairpin structure sequence. 
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 Figure 5-7. Analysis of the A- and U-rich part of the predicted hairpin structure sequence in 
translation. BHK-21 cells were infected with vv-T7 and co-transfected with 100 ng of pREN 
sensor constructs (pREN-HA/U-rich, pREN-halfHA-rich, pREN-halfHA*-rich, pREN-halfHU-rich, or pREN-
polyA) and 0.5 ng of pIRES-FF as internal control. Relative luciferase expression was measured 
after 23 h post transfection. Error bars show the standard deviations from the means of three 
replicate experiments. 
 
 
Requirement of viral (N and NSs) proteins in translation of hairpin structure 
sequence containing sensor constructs 
 
While previous experiments indicated an important role of the TSWV hairpin 
structure sequence in translation, although do not rule out a poly(A)-tail mimicking effect 
either, the requirement of the viral N and NSs proteins in translation was tested. To this 
end, the hairpin luciferase constructs pREN-HA/U-rich, pREN-halfHA-rich, and pREN-polyA 
were expressed in BHK21 cells in the absence or presence of expression constructs pTUG-
NSs and/or pTUG-N. As a negative control, a MBP (Maltose binding protein) expression 
construct was included. As another negative control from which no protein would become 
expressed, pUC19 vector DNA was used as MOCK. Whereas no change in luciferase 
activity was observed when the N or NSs gene constructs were added individually (450 ng 
each), a clear increase was observed in the presence of both proteins (450 ng expression 
constructs each) (Figure 5-8A). When the N and NSs gene constructs were added in a 
higher concentration (700 ng each), translation was even more strongly enhanced (Figure 
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5-8B). In all samples MBP, N, and NSs protein could be detected at 23 hours of post 
transfection (Figure 5-8C).  
 
 Figure 5-8. Influence of N and NSs on translation. BHK-21 cells were infected with Vaccinia 
virus and co-transfected with 100 ng of expression vectors encoding REN luciferase, FF luciferase 
and MBP, N, NSs, combination of N and NSs, or pUC19 at the amount of 450 ng (A) and 700 ng (B). 
Luciferase expression was measured 23 h post transfection. The relative luciferase expression is 
shown, corrected for the internal FF control (REN/FF). (C) Cells were analyzed for expression of 
MBP, N, or NSs by Western blotting and using antisera specific for MBP, N or NSs respectively. 
Abbreviation: MBP, Maltose binding protein; N, nucleoprotein; NSs, non-structural protein; H, 
hairpin; ½H, half hairpin; pA, polyA.   
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Discussion  
 
The mRNAs from the majority of segmented (-) ssRNA viruses are not 
polyadenylated as common eukaryotic mRNAs, but instead feature translation enhancing 3' 
UTRs. In general, the mechanism that allows these viral mRNAs to be efficiently translated 
in infected cells is poorly understood. In this study, we provide evidence that the 3' hairpin 
structure sequence of TSWV S RNA-encoded mRNAs constitutes a translation enhancer 
that mediates efficient translation in the absence of a common poly(A) tail. Substitutions 
and deletions at the 3' end, as shown in Figures 5-2 to 5-7, strongly suggest that the hairpin 
structure sequence is required for translation. Deletion of the hairpin sequence resulted in 
diminished translation rates (Figure 5-2), while its substitution for another slightly different 
hairpin encoding sequence, i.e. from its reverse complement or from another distinct 
tospovirus, still supported translation. The lower levels of translation in case of a REN 
sensor construct with a hairpin encoding sequence from the reverse complement and its 
recovery by complementation with the corresponding homologous 5' UTR implies a 
concerted action, i.e. interaction, of the 5' and 3' UTR (Figure 5-4). Due to the possibility 
to exchange the hairpin structure sequence among different tospoviruses indicates that these 
viruses share a common protein expression strategy where the hairpin structure rather than 
particular sequences might be the key feature in translation.  
While the TSWV S RNA specific mRNAs are shown to contain the entire hairpin 
structure sequence at their 3' end (van Knippenberg et al., 2005b), stable secondary hairpin 
structures are predicted at the IR of both highly AU-rich ambisense S and M RNA 
segments (Figures 5-3B and 5-9). It is not unlikely that these structures are also involved 
in mRNA transcription termination similar to what has been described for other ambisense 
RNA viruses. For Tacaribe arenavirus, it was shown that transcription termination is 
related to a small stable GC-rich hairpin structure and independent of a specific nucleotide 
sequence (Iapalucci et al., 1991; Lopez and Franze-Fernandez, 2007). A termination 
mechanism based on formation of a hairpin structure is also suggested for Lymphocytic 
choriomeningitis arenavirus (LCMV) (Meyer and Southern, 1993). Transcription 
termination of LCMV mRNAs has been suggested to be reminiscent of rho-independent 
transcription in prokaryotes, in which termination also occurs at several positions 3' of a 
GC-rich hairpin structure (Platt, 1986; Reynolds et al., 1992; Reynolds and Chamberlin, 
1992). For the Uukuniemi phlebovirus transcription termination of the S RNA specific 
mRNAs was reported to similarly occur 3' of an AU-rich intergenic hairpin structure 
(Simons and Pettersson, 1991). On the other hand, the 3' ends of the mRNAs of Punta toro 
phlebovirus seemed to map near to the top of a 200 base-pair predicted AU-rich hairpin 
structure (Emery and Bishop, 1987).  
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 Figure 5-9. RNA folding predictions of TSWV M segment. Mfold predictions 
of the highly AU-rich IR in the vRNA flanking the 3' end of the NSm ORF, and 
the analogous sequence in the vcRNA flanking the 3' end of the G precursor ORF. 
Abbreviation: vRNA, viral sense RNA; vcRNA, viral complementary RNA. 
 
 
The overall efficiency in terms of transcription and translation by the TSWV 
hairpin constructs raises the question of why the viral segments carry sequences that 
apparently can fold into structures while the transcripts can also do with the A-rich stretch 
only (Figure 5-7). Although a clear answer to this question has not been provided, one can 
speculate that such a structure provides stability of the mRNAs for exonuclease cleavage. 
Considering the fact that among the ambisense RNA segments from the bunyaviruses 
(genus Phlebovirus and Tospovirus) and arenaviruses, besides AU-rich also GC-rich 
hairpin folding structures are found involved in transcription termination and present in 
viral transcripts, strongly supports the idea that the RNA folding structure is the primary 
element required for translation and in which the A-rich stretches from AU-hairpin folding 
structures can additionally support translation in a concerted poly(A) tail binding protein 
(PABP)-dependent manner. For cellular mRNAs harboring a common PABP supports 
circularization and thereby i) stabilizes the ribonucleoprotein complex involved in 
translation initiation, ii) helps protect the mRNA from decay, iii) mediates ribosome 
recycling, and/or iv) promotes preferential translation of full-length messages (Bailey-
Serres, 1999; Borman et al., 2000; Gallie, 1998, id. 2002). For the ambisense arenaviruses 
and bunyaviruses some or all of these activities may be facilitated by a hairpin folding 
structure, as a functional equivalence to the poly(A) tail. During such translation strategy, 
the hairpin structure may assists in circularization of the mRNA through specific binding of 
a viral proteins for efficient translation, prior to the sequential recruitment of additional 
translation initiation factors to the 5' end of the mRNA. Functional replacement of a 
poly(A) tail-PABP complex has been reported for many plant-infecting RNA viruses, e.g. 
Tobacco mosaic virus and Alfalfa mosaic virus (Dreher and Miller, 2006; Fabian and 
White, 2004; Gallie, 1998, id. 2002; Gallie and Kobayashi, 1994; Leonard et al., 2004; 
Matsuda and Dreher, 2004; Meulewaeter et al., 2004; Neeleman et al., 2001). For TSWV, 
such model is supported by the observation that the viral NSs and N proteins enhanced the 
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translation of REN sensor constructs containing a 3' hairpin structure. In this process the N 
and NSs proteins may likely act as a functional analog of PABP. The involvement of NSs 
in translation is not completely surprising, since the NSs proteins of several bunyaviruses 
have previously been implied to play some role in translation (Blakqori et al., 2009; 
Blakqori and Weber, 2005; Bridgen et al., 2001; Di Bonito et al., 1999; Simons et al., 
1992). Since the TSWV NSs protein has recently been shown to exhibit affinity to short (si- 
and mi-) and long double stranded (ds)RNA (Schnettler et al., 2010), it is tempting to 
hypothesize that NSs binds to the hairpin structure to prevent its recognition and subsequent 
degradation in plants by RNaseIII dicer-like (DCL) proteins, while simultaneously 
supporting translational enhancement of viral transcripts by circularization. The 
involvement of the viral N protein in translational enhancement is more intriguing and so 
far has only been reported similarly for Hantaan bunyavirus N protein (Mir and 
Panganiban, 2008). Although speculative, the N protein could be required in binding to the 
5' cap-structure to prevent decapping of the mRNA by decapping enzymes and thereby 
stabilizing viral transcripts. This hypothesis is being supported by the affinity of Hantaan 
bunyavirus N for cap-structures in cytoplasmic processing bodies (P bodies), discreet 
cytoplasmic foci which serve in mRNA degradation as well as cellular storage sites for 
mRNA (Balagopal and Parker, 2009; Brengues et al., 2005; Mir et al., 2008).  
The observation that only the A-rich part of the hairpin structure suffices for 
translation, even leaves the possibility that the AU-rich hairpin structures rely on a 
concerted action of viral proteins and PABP. A concerted action (interaction) would also 
explain why both N and NSs proteins, vice versa, stimulate translation of REN sensor 
constructs containing a poly(A) tail. A concerted action of viral proteins and PABP in 
translational enhancement is not unique as this has been earlier reported for influenza virus, 
where the viral NS1 protein was found to interact with PABP and also with elF4G 
(eukaryotic translation initiation factor) (Aragón et al., 2000; Burgui et al., 2003; Marión 
et al., 1997; Qiu and Krug, 1994; Salvatore et al., 2002; Yángüez and Nieto, 2011). 
Whether PABP indeed plays an (essential) role during translation of TSWV transcripts 
from the ambisense S and M RNA segments remains to be analyzed, e.g. by performing 
translation studies in a PABP-knock down environment.  
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Materials and methods 
 
Viruses 
Recombinant Vaccinia virus MVA-T7 (attenuated Vaccinia virus containing a 
copy of the T7 RNA polymerase gene) (Sutter et al., 1995; Wyatt et al., 1995) was used for 
T7 RNA polymerase driven expression of cDNA constructs. TSWV (De Avila et al., 1992) 
was propagated in Nicotiana benthamiana plants. Inoculum to infect plants was obtained by 
grinding systemically infected plant leaves in a 0.5% Na2SO3 solution. The inoculum was 
applied by softly rubbing the leaves using carborundum powder.  
 
Construction of plasmids 
To investigate the role of the TSWV hairpin structure in translation initiation, 
different constructs were made. TSWV constructs were generated from plasmid pTOS-S 
Dual (Duijsings, 2001), by using PCR amplification and cloning procedures. Briefly, this 
plasmid consists of a full-length DNA copy of the viral complementary strand of the 
ambisense S RNA cloned into a pUC19 plasmid containing a T7 promoter-terminator 
cassette. Luciferase marker genes were added by replacing the N and NSs genes with the 
REN and FF luciferase gene respectively to allow sensitive detection and quantification of 
translational activity. 
pREN-HA/U-rich, pREN-NoH and pREN-polyA were PCR amplified from pTOS-S 
Dual by using primer TSWV S-hepδ to remove the NSs-FF ORF and primers TSWV S-H, 
TSWV S-NoH and TSWV S-pA respectively. Deletion of the NSs-FF ORF from the 
expression plasmids allowed the use of the FF luciferase pIRES-FF vector as internal 
control. To further mimic the authentic transcripts, all expression plasmids were re-
amplified by using primers AlMV3-N-Fr and T7-AlMV3-Rv in order to add an AlMV3 
RNA 3 leader immediately after the T7 promoter. 
Amplified PCR fragments were separated by electrophoresis in a 1% agarose gel 
and purified using the GFX PCR DNA and Gel Band purification kit (GE Healthcare, 
Buckinghamshire, UK). Purified products were restriction enzyme digested with MscI and 
re-ligated using T4 DNA ligase (Invitrogen). The nucleotide sequence of individual clones 
was verified by the dideoxynucleotide chain termination method (Sanger et al., 1977) using 
standard M13 sequencing primers and ultra-high throughput (ABI Prism 3700) DNA 
sequencer (GreenomicsTM, Wageningen University and Research Centre; The Netherlands). 
A reverse complementary hairpin sequence of pREN-HA/U-rich, referred to as pREN-
HA/U*-rich, was made as follows. pREN-HA/U-rich was re-amplified with primers H-SpeI-Fr 
and H-NcoI-Rv. A second amplification of pREN-HA/U-rich was performed with primers 
RlucSpeI-Fr and RlucNcoI-Rv to obtain the appropriate vector for inserting the reverse 
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complement hairpin. Both hairpin and vector were SpeI/NcoI digested, purified and 
subsequently ligated together. For the TYRV hairpin construct (pREN-TYRV H), the 
hairpin sequence of TYRV was PCR amplified using primers TYRV-Fr and TYRV-Rv. 
The fragment obtained was ligated into the backbone of SpeI/NcoI digested and purified 
pREN-H A/U*-rich. A mutant of pREN-HA/U-rich (pREN-halfHA-rich) from which the U-rich part 
of the hairpin was removed, was made by MscI digestion of plasmid pREN-HA/U-rich, GFX 
purification and re-ligation. In a similar way, mutant pREN-halfHA*-rich was made by MscI 
digestion of pREN-HA/U*-rich. To obtain pREN-halfHU-rich, the U-rich fragment of the hairpin 
was excised from pREN-HA/U-rich by MscI digestion, and after purification subsequently 
ligated into MscI digested pREN-NoH. 
For analysis of the 5' UTR, the luciferase plasmids pREN-HA/U-rich, pREN-HA/U*-rich, 
and pREN-polyA were modified. Therefore, the plasmid-specific 5' UTR (148 nucleotides) 
of the N-REN ORF was removed by PCR re-amplification using primers UTRdel-Fr and 
UTRdel-Rv. The resulting constructs were referred to as pREN-HA/U-rich Δ5'UTR, pREN-
HA/U*-rich Δ5'UTR, and pREN-polyA Δ5'UTR and expressed a luciferase transcript without 
5' UTR. For exchanging the 5' N UTR with the 5' NSs UTR, pREN-HA/U-rich, pREN-HA/U*-
rich, and pREN-polyA were re-amplified with primer NSsUTR-Fr and NSsUTR-Rv 
harboring part of the 88 nt 5' NSs UTR. These modified REN constructs were referred to as 
pREN-HA/U-rich 5'NSsUTR, pREN-HA/U*-rich 5'NSsUTR, and pREN-polyA 5'NSsUTR. 
The ORF coding for the TSWV N protein was RT-PCR amplified using primers 
pN-Fr and pN-Rv and cloned into the BamHI site of pTUG3, resulting in plasmid pTUG-N. 
The ORF for the TSWV NSs protein was cloned into pTUG3 as a BamHI fragment from 
pAc33DZ1/NSs (Kormelink et al., 1991), resulting in pTUG-NSs. Additionally, the MBP 
ORF was PCR amplified from a donor vector with primers MBP-Fr and MBP-Rv and 
cloned into pTUG3 as a BamHI fragment. Plasmid pUC19 was used as a MOCK in the 
experiments involving the N and NSs proteins. All constructs were checked by restriction 
analysis and sequencing. Primer sequences are listed in Table 5-1. 
 
Cell culture and infection/transfection 
BHK-21 cells were maintained as a monolayer in Glasgow MEM (GMEM; 
Gibco® Invitrogen, Breda, The Netherlands), supplemented with 1× Tryptose phosphate 
broth solution (Sigma-Aldrich Chemie B.V., Zwijndrecht, The Netherlands), 10% FBS, 100 
U/ml·penicillin, and 100 µg/ml streptomycin. The cells were cultured in a 5% CO2 
atmosphere at 37 C. 
Cells grown in serum-free GMEM were inoculated at 37°C with Vaccinia virus at 
a multiplicity of infection (m.o.i.) of 10. After 1 hour post infection, the medium was 
removed and the cells washed once with serum-free GMEM. Transfection of cells was 
performed with indicated amounts of plasmid DNA by using Lipofectin transfection 
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reagent (Invitrogen, Breda, The Netherlands) according to the manufacturer’s instructions. 
The transfection performed for 5 h at 60-70% confluence in 24-well plates.  
 
Protein isolation and luciferase reporter gene assays 
Protein extracts were isolated using passive lysis buffer (Promega) in accordance 
with the manufacturer’s protocol. Luciferase expression levels were determined 23 hours 
after transfection, using the Dual-Luciferase® Reporter Assay (Promega). Luciferase 
Reporter assays were carried out by co-transfecting vaccinia infected cells with plasmids 
containing REN luciferase and FF luciferase under the control of T7 promoter. The 
transfection with the FF luciferase served as control and the luciferase activity was detected 
using a TD 20/20 Luminometer (Turner Design) of Promega. The relative light unit (RLU) 
was calculated for each sample by normalization of the REN luciferase against the FF 
luciferase levels. 
 
 
 TABLE 5-1.   
Primer sequences. 
Name Primer sequence (5'→3') 
TSWV S-hepδ 
TSWV S-H 
TSWV S-NoH 
TSWV S-pA 
AlMV3-N-Fr 
T7-AlMV3-Rv 
CCCCTGGCCAGCTCTGGCCGGCATGGTCCC 
CCCCTGGCCACTCTTTCAAATTCCTCCTGTC 
CCCCTGGCCAGCACAACACACAGAAAGCAAAC 
CCCCTGGCCAT(40)GCACAACACACAGAAAGCAAAC 
CATTTTCAGAGCAATCGTGTCAATTTTGTGTTC 
GTATTAATACTATAGTGAGTCGTATTAGGATCCCCGG 
H-SpeI-Fr 
H-NcoI-Rv 
RlucSpeI-Fr 
RlucNcoI-Rv 
TYRV-Fr 
TYRV-Rv 
ACTAGTTAACAAAAACAACGAAAACAAAAAATAAATA 
CCATGGTAGTAGAAACCATAAAAACAAAAAATAAAAATG 
CCGGACTAGTGACAGGAGGAATTTGAAAGAG 
CATGCCATGGTTTTATTATTTATTAAGCACAACACAC 
CCGGACTAGTTGTAAGTCAGTAATAAAGGAGTACTAGTTTAGA 
CATGCCATGGATCAGTGTGTTTAAGTTTTATCTGTCTATCA 
UTRdel-Fr 
UTRdel-Rv 
NSsUTR-Fr 
 
NSsUTR-Rv 
ACGAGCTAGCCACCATGACT 
CGGCTAGCGAAAATGGTATTAATACTATAGTGAGTCGT 
AGAAAATCACAATACTGTAATAAGAACACAGTACCAATAACCA 
GCTAGCCACCATGACTTCGA 
AAGTGAGGTTTGATTATGAACAAAATTCTGACACAATTGCTCTG 
AAAATGGTATTAATACTATAGTG 
pN-Fr 
pN-Rv 
MBP-Fr 
MBR-Rv 
CCCGGATCCATGTCTAAGGTTAAGCTCACTAAGG 
CCCGGATCCTCAAGCAAGTTCTGCGAGTTTTG 
CGGGATCCATGAAAATCGAAGAAGGTAAACTG 
CGGGATCCCTAGGATCCGAATTCTGAAATCCT 
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Western blot analysis 
Protein expression was characterized after plasmid transfection by Western blot 
analysis. Lysate prepared for the Dual-Luciferase® Reporter Assay was separated by 12% 
SDS/PAGE gel. After electrophoresis, proteins were semi-dry blotted to Immobilon-P 
transfer membranes (Millipore Corporation, Bedford, USA) using a Bio-Rad Mini-
PROTEAN system. For MBP, a specific MBP-rat primary and goat alkaline phosphotase 
conjugated secondary antibody were used. The protein-IgG complexes were visualized with 
NBT-BCIP as substrate (Roche) according to the manufacturers’ procedures. For 
visualization of viral proteins, specific antibody for the N or NSs protein was used 
conjugated to alkaline phosphotase and CSPD as substrate (Roche) according to the 
manufacturer’s procedures. 
 
Folding predictions  
The RNA folding prediction was performed using MFold 3.5 (Zuker, 2003). The 
most energetically stable secondary structure is shown. 
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“When a question has no correct answer, there is only one honest response.  
The grey area between yes and no. 
Silence.” 
 
Dan Brown, “THE DA VINCI CODE”. 
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General Discussion 
 
 
In this Thesis, cis- and trans-acting factors involved in transcription/translation of 
segmented, negative (-) single-stranded (ss) RNA viruses were studied with specific 
emphasis on two issues. The first one aimed to analyze whether similar cap donor 
requirements applied during influenza A genome transcription initiation (cap-snatching) 
relative to what has earlier been discovered for the plant-infecting Tomato spotted wilt virus 
(TSWV) (Chapters 2, 3 and 4). The second one aimed to analyze the involvement of 5' 
and 3' untranslated regions (UTR), the latter containing a predicted hairpin structure 
sequence, of TSWV mRNAs in transcription/translation (Chapters 5).  
During influenza transcription initiation studies, novel insights into the cap-
snatching mechanism have been provided by in vitro and in cell studies (Chapters 2, 3 and 
4). The viral transcriptase seems to prefer capped host mRNA leaders with increasing base 
complementarity to the vRNA template. The results obtained led to the proposed model for 
influenza transcription initiation as schematically presented in Figure 6-1. This model 
proposes that the viral polymerase first selects capped leaders of the host mRNA according 
to (extensive) base-pairing to the vRNA template. After selection the polymerase bound to 
the cap structure of a capped RNA leader (further onwards referred to as cap donor 
molecule), cleaves the desired leader 10-12 nucleotides downstream the cap structure. 
Finally, the remaining capped leader base pairing with the viral RNA is elongated to give 
rise to a full-length viral mRNA. The same criteria for cap donor selection have previously 
been demonstrated for TSWV (Duijsings et al., 2001; van Knippenberg et al., 2005a), 
suggesting that the proposed model most likely applies to all members of the segmented (-) 
ssRNA viruses. The finding that multiple base-pairing promotes cap donor selection and the 
possibility to use such leaders as model molecules for antiviral drug design will be further 
discussed in this chapter.  
It is now well established that poly(A) tails of eukaryotic mRNAs regulate both 
mRNA turnover and translation. Transcripts of segmented (-) ssRNA viruses lack a 
common poly(A) tail, and thus have likely developed mechanisms to generate an alternative 
structure or modifications to the 3' mRNA end that act as a substitute for a poly(A) tail. 
Viral transcripts from the bunyavirus TSWV have been well characterized and the 3' end of 
the S RNA encoded gene transcripts were shown to contain a UTR sequence predicted to 
fold into a hairpin structure. Translation studies on a large set of REN-sensor constructs 
containing (partial) deletions or nucleotide changes within this 3' UTR but also the 5' UTR 
sequence, have indicated an important role for the hairpin structure in translation (Chapter 
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5). This process seems to require a concerted action with the viral N and/or NSs protein as a 
kind of PABP-analog, in which an additional enhancement by PABP after binding to the A-
rich sequence of the hairpin structure can also not be excluded. However, most of the RNA 
segments from the segmented (-) ssRNA viruses, including the bunyaviruses, are of entire 
negative polarity and features required for translational enhancement of their transcripts are 
still unknown. In this chapter the results from our translational analysis of TSWV 
ambisense encoded gene transcripts will be discussed in light of a model for translation of 
transcripts from (-) RNA segments that seemingly lack a hairpin folding structure. 
 
 
 Figure 6-1. Proposed model for influenza virus cap-snatching. (A) Selection between leaders 
with increasing base-pairing versus a singly residue/-s to the vRNA template. (B) Endonuclease 
cleavage of the capped RNA leader. (C) Elongation for viral mRNA synthesis. 
A 
C 
B 
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Transcription initiation of segmented (-) ssRNA viruses: a common mechanism 
 
Segmented (-) ssRNA viruses, both animal- and plant-infecting, share a common 
mechanism for transcription initiation in which the synthesis of their mRNAs is initiated by 
cap-snatching. Based on our observations a model is proposed that applies to all segmented 
(-) ssRNA viruses (Figure 6-1). Data from previous transcription initiation studies can now 
be reinterpreted in the light of our proposed model.  
 
 
 TABLE 6-1.   
Sequence of the 3' vRNA terminus from members of the segmented (-) ssRNA viruses. 
Virus 3' end sequence  
of vRNA 
References 
Influenza A 
Influenza B 
Influenza C 
THOV 
HTNV 
DUGV 
SSHV 
GERV 
LACV 
BUNV 
RVFV 
UUKV 
TSWV 
TACV 
LCMV 
3'-UCGUUUU… 
3'-UCGUCUU… 
3'-UCGUCUU… 
3'-UCGUUUU… 
3'-AUCAUCU… 
3'-AGAGUUU… 
3'-UCAUCAC… 
3'-UCAUCAC… 
3'-UCAUCAC… 
3'-UCAUCAC… 
3'-ACACAAA… 
3'-UGUGUUU… 
3'-UCUGCUU… 
3'-GCGUGUC… 
3'-GCGUG(U/G)C… 
Lamb and Horvarth, 1991; Shaw and Lamb, 1984 
Lamb and Horvarth, 1991; Shaw and Lamb, 1984 
Lamb and Horvarth, 1991 
Albo et al., 1996; Leahy et al., 1997 
Garcin et al., 1995 
Jin and Elliott, 1993b 
Bishop et al., 1983 
Bouloy et al., 1990 
Dobie et al., 1997 
Jin and Elliott, 1993a 
Collett, 1986 
Simons and Pettersson, 1991 
Duijsings et al., 2001 
Garcin and Kolakofsky, 1990 
Meyer and Southern, 1993 
Viral residues potentially base-pairing with the 3' residues of RNA leader are in bold and italics. Virus 
abbreviation: BUNV, Bunyamwera virus; DUGV, Dugbe virus; GERV, Germiston virus; HTNV, Hantaan virus; 
LACV, La Crosse virus; LCMV, Lymphocytic choriomeningitis virus; SSHV, Snowshoe hare virus; RVFV, Rift 
Valley fever virus; TACV, Tacaribe virus; THOV, Thogoto virus; TSWV, Tomato spotted wilt virus; UUKV, 
Uukuniemi virus. 
 
 
In contrast to all other segmented (-) ssRNA viruses, Thogoto orthomyxovirus 
(THOV) mRNAs are thought to lack any host-derived leader sequences, and only the cap 
structure is used for initiation of viral mRNA synthesis (Table 6-1 and 6-2) (Albo et al., 
1996; Leahy et al., 1997). However, there is no evidence that excludes snatching of a larger 
capped RNA leader that, by virtue of base-pairing, primes THOV transcription. In light of 
our model, it is now not only tempting but also very possible that a very small leader 
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sequence is snatched with 1-3 nt complementary to the first vRNA template residues, like 
in the case of arenaviruses (Table 6-1 and 6-2). The 5' capped RNA leaders of the 
Lymphocytic choriomeningitis arenavirus (LCMV) S mRNAs (Meyer and Southern, 1993) 
and the ones from another arenavirus, Tacaribe virus (TACV) (Garcin and Kolakofsky, 
1990, id. 1992) were found to be heterogeneous in sequence composition. For LCMV the 
leaders were reported to range from 1 to 7 nt while for TACV they ranged from 1 to 4 nt 
(Table 6-2). Based on our (universal) model, base-pairing now likely occurs between the 
capped leader and the vRNA template for arenaviruses as well, which implies that the 
actually snatched leader sequences are most likely 1 to 3 residues larger in size. The 
snatched RNA leader sequence would then prime transcription by base-pairing at the first G 
residue at position +1 from the 3' end of the vRNA template (3'-G…), the first two GC 
residues (3'-GC…) or the first three (3'-GCG…) residues (Table 6-1 and 6-2). 
 
 
 TABLE 6-2.   
Leader sequences at the 5' ends of the indicated mRNA reported as host-derived for Thogoto 
orthomyxovirus and arenaviruses, and postulated to be host-derived according to the current model of 
cap-snatching. 
5' leader sequence of the indicated virus mRNA Virus Segment 
Reported Current model   
5'-capAGCAAAA 
5'-…(A/U/G)CGCAC(A/C)G 
5'-…(A/U/G)CGCACAG 
5'-capAGCAAAA 
5'-…(A/U/G)CGCAC(A/C)G 
5'-…(A/U/G)CGCACAG 
THOV 
LCMV 
TACV 
3, 4, 5 
S 
S 
Indicated virus sequence is underlined, while residues base-pairing to the viral template and with possible origin 
from the RNA leader are in bold and italics; the non-viral 3'-terminal nucleotide at position -1 relative to the first 
viral residue is shaded. The corresponding RNA segment from which the transcript derived is also indicated. The 
table is based on data given for arenaviruses (Garcin and Kolakofsky, 1990; Meyer and Southern, 1993) and 
thogotoviruses (Albo et al., 1996; Leahy et al., 1997). Virus abbreviation: LCMV, Lymphocytic choriomeningitis 
virus; TACV, Tacaribe virus; THOV, Thogoto virus.  
 
 
During our Influenza A virus transcription analysis, the phenomena of internal 
priming, prime-and-realignment, and combination of both were also observed (Chapters 2, 
3 and 4). For Influenza B virus, in contrast to Influenza A virus, a preference for leaders 
with a 3' CA-terminus was anticipated (Chapter 4). However, in light of the findings for 
Influenza A virus, and our proposed model for cap-snatching, almost 50% of the published 
5' non-viral leader sequences from Influenza B virus (Chapter 4, Table 4-10), most likely 
have resulted from internal priming of a G-terminated leader on the 3'-penultimate C 
residue of the vRNA template. After extension for two nucleotides and subsequent 
realignment by virtue of base-pairing a repetitive sequence (GCAGC) is obtained, which 
reflects the other 50% of the leader sequences reported (Table 6-1 and 6-3). The 
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occurrence of internal priming and consecutive re-alignment would not only reject the 
preference for a 3' CA-terminus but fully match the reported Influenza B virus leader 
sequences to the requirements as determined from our in vitro and in vivo influenza A 
studies (Chapter 3 and 4). 
 
 
 TABLE 6-3.   
Leader sequences at the 5' ends of Influenza B virus mRNA reported as host-derived and 
postulated to be host-derived according to the current model of cap-snatching. 
5' leader sequence of Influenza B virus mRNA IP PR 
Reported Current model   
5'-…GAGCAGAA 
5'-…UGCAGCAGAA 
5'-…UGCAGCAGAA 
5'-…UGCAGCAGAA 
5'-…UGCAGCAGAA 
5'-…GGCAGCAGAA 
5'-…GGCAGCAGAA 
5'-…CGCAGCAGAA 
5'-…CGCAGCAGAA 
5'-…CGCAGCAGAA 
5'-…GGCAGAA 
5'-…GGCAGAA 
5'-…UGCAGAA 
5'-…UGCAGAA 
5'-…CGCAGAA 
5'-…CGCAGAA 
5'-…CGCAGAA 
5'-…CGCAGAA 
5'-…CGCAGAA 
5'-…GAGCAGAA 
5'-…UGCAGCAGAA 
5'-…UGCAGCAGAA 
5'-…UGCAGCAGAA 
5'-…UGCAGCAGAA 
5'-…GGCAGCAGAA 
5'-…GGCAGCAGAA 
5'-…CGCAGCAGAA 
5'-…CGCAGCAGAA 
5'-…CGCAGCAGAA 
5'-…GGCAGAA 
5'-…GGCAGAA 
5'-…UGCAGAA 
5'-…UGCAGAA 
5'-…CGCAGAA 
5'-…CGCAGAA 
5'-…CGCAGAA 
5'-…CGCAGAA 
5'-…CGCAGAA 
 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
 
 
 
 
 
 
 
 
 
Influenza sequence is underlined, while residues base-pairing to the viral template and with possible origin 
from the RNA leader are in bold and italics; the non-viral 3'-terminal nucleotide at position -1 relative to the 
first viral residue is shaded. The proteins encoded by the cloned segments are also indicated. Abbreviations: 
IP, Internal Priming; PR, Prime-and-Realign.  
 
 
Most of our knowledge on the transcription and replication processes of the 
influenza virus genome has been derived from studies carried out on type A viruses and 
some on type B (Lamb and Krug, 2001). Based on the properties of the RNA-dependent 
RNA polymerase activity associated with influenza C virions (Nagele and Meier-Ewert, 
1984; Yamashita et al., 1989) and our findings on influenza transcription initiation, it is 
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very likely that transcription and replication of the Influenza C virus follow the same rules 
and criteria as determined for Influenza A and B viruses. Since Influenza A, B and C viruses 
all share a common highly conserved 3'-terminal sequence (Table 6-1), priming of 
transcription would thus require similar residues at the 3'-terminal end of capped RNA 
leaders for all these viruses. The proposed formula describing the sequence of preferred 
capped RNA leaders for Influenza A virus, would thereby apply to all influenza (A/B/C) 
viruses. 
Another look at published non-viral leader sequences from the animal-infecting 
bunyaviruses reveals that these also fit within the cap-snatching model postulated (Table 6-
4 and 6-5). Based on the non-viral leader sequences from S RNA-specific transcripts of 
Germiston bunyavirus, the snatched capped RNA leaders were initially proposed to possess 
a preference for a 3' U residue. This residue appears at position -1, i.e. the base 5' of the 
first viral A residue (Table 6-4), within the viral transcript sequence (Bouloy et al., 1990). 
In light of the proposed model and the possibility for internal priming and prime-and-
realign, this virus seems to favor leaders with a G, C or U at position -1 (Table 6-4). In 
addition, the ultimate 3' residue of the capped RNA leader for Germiston virus transcription 
initiation, likely contains (at least) a single nucleotide residue (A) to support base-pairing at 
the 3'-ultimate viral template residue (Table 6-4). In a similar way, a re-evaluation of the 
cloned non-viral leader sequences from other animal-infecting bunyavirus transcripts 
reveals that all of these can be explained to result from priming on the ultimate 3' residue of 
the vRNA template, or by internal priming or a prime-and-realign (Table 6-5). 
 
 TABLE 6-4.   
Leader sequences at the 5' ends of Germiston virus mRNA reported as host-derived and postulated to 
be host-derived according to the current model of cap-snatching. 
5' leader sequence of Germiston virus mRNA # clones IP PR 
Reported Current model    
5'-…GAGUAGUAGUG 
5'-…CAGUAGUAGUG 
5'-…GGUAGUAGUG 
5'-…UGUAGUAGUG 
5'-…CGUAGUAGUG 
5'-…CUAGUAGUG 
5'-…UUAGUAGUG 
5'-…CAGUAGUG 
5'-…GGUAGUG 
5'-…CGUAGUG 
5'-…UGUAGUG 
5'-…GAGUAGUAGUG 
5'-…CAGUAGUAGUG 
5'-…GGUAGUAGUG 
5'-…UGUAGUAGUG 
5'-…CGUAGUAGUG 
5'-…CUAGUAGUG 
5'-…UUAGUAGUG 
5'-…CAGUAGUG 
5'-…GGUAGUG 
5'-…CGUAGUG 
5'-…UGUAGUG 
2/19 
1/19 
4/19 
1/19 
1/19 
2/19 
1/19 
3/19 
1/19 
2/19 
1/19 
 
 
+ 
+ 
+ 
+ 
+ 
 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
 
 
 
 
Germiston virus sequence is underlined, while residues base-pairing to the viral template and with possible origin 
from the RNA leader are in bold and italics; the non-viral 3'-terminal nucleotide at position -1 relative to the first 
viral residue is shaded. Abbreviations: IP, Internal Priming; PR, Prime-and-Realign.   
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 TABLE 6-5.  
Leader sequences at the 5' ends of the indicated virus mRNA reported as host-derived and postulated 
to be host-derived according to the current model of cap-snatching. 
5' leader sequence of the indicated virus mRNA Virus # of IP PR 
Reported Current model  clones   
5'-…CUCUCUCAAA 
5'-…GUCUCUCAAA 
5'-…UUCUCUCAAA 
5'-…GCUCUCAAA 
5'-…ACUCUCAAA 
5'-…CCUCUCAAA 
5'-…GUCUCAAA 
5'-…CUCUCUCAAA 
5'-…GUCUCUCAAA 
5'-…UUCUCUCAAA 
5'-…GCUCUCAAA 
5'-…ACUCUCAAA 
5'-…CCUCUCAAA 
5'-…GUCUCAAA  
DUGV 11/24 
2/24 
1/24 
3/24 
2/24 
4/24 
1/24 
 
 
 
+ 
+ 
+ 
 
+ 
+ 
+ 
+ 
+ 
+ 
 
5'-…UGUAGUAGUG 
5'-…GGUAGUG 
5'-…CGUAGUG 
5'-…UGUAGUAGUG 
5'-…GGUAGUG 
5'-…CGUAGUG 
SSHV 
 
1/3 
1/3 
1/3 
+ 
+ 
+ 
+ 
 
5'-…CAGUAGUAGUG 
5'-…GGUAGUAGUG 
5'-…UGUAGUAGUG 
5'-…CUAGUAGUG 
5'-…GAGUAGUG 
5'-…CAGUAGUG 
5'-…UGUAGUG 
5'-…CGUAGUG 
5'-…GGUAGUG 
5'-…GGUAGUG 
5'-…CAGUAGUAGUG 
5'-…GGUAGUAGUG 
5'-…UGUAGUAGUG 
5'-…CUAGUAGUG 
5'-…GAGUAGUG 
5'-…CAGUAGUG 
5'-…UGUAGUG 
5'-…CGUAGUG 
5'-…GGUAGUG 
5'-…GGUAGUG 
LACV 3/37 
4/37 
1/37 
1/37 
3/37 
1/37 
21/37 
1/37 
1/37 
1/37 
 
+ 
+ 
+ 
 
 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
 
 
 
 
 
 
5'-…CAGUAGUAGUAGUG 
5'-…GGUAGUAGUAGUG 
5'-…CGUAGUAGUAGUG 
5'-…CUAGUAGUAGUG 
5'-…CAGUAGUAGUG 
5'-…GGUAGUAGUG 
5'-…UGUAGUAGUG 
5'-…AUAGUAGUG 
5'-…CGUAGUG 
5'-…CAGUAGUAGUAGUG 
5'-…GGUAGUAGUAGUG 
5'-…CGUAGUAGUAGUG 
5'-…CUAGUAGUAGUG 
5'-…CAGUAGUAGUG 
5'-…GGUAGUAGUG 
5'-…UGUAGUAGUG 
5'-…AUAGUAGUG 
5'-…CGUAGUG 
BUNV 1/21 
1/21 
1/21 
2/21 
5/21 
7/21 
1/21 
2/21 
1/21 
 
+ 
+ 
+ 
 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
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 TABLE 6-5. – Continued 
 
 
5' leader sequence of the indicated virus mRNA Virus # of IP PR 
Reported Current model  clones   
5'-…CACACACAAA 
5'-…UACACACAAA 
5'-…GCACACAAA 
5'-…UCACACAAA 
5'-…GACACAAA 
5'-…AACACAAA 
5'-…GCACAAA 
5'-…UCACAAA 
5'-…CACACACAAA 
5'-…UACACACAAA 
5'-…GCACACAAA 
5'-…UCACACAAA 
5'-…GACACAAA 
5'-…AACACAAA 
5'-…GCACAAA 
5'-…UCACAAA 
UUKV 8/25 
1/25 
3/25 
1/25 
1/25 
1/25 
9/25 
1/25 
 
 
+ 
+ 
 
 
+ 
+ 
+ 
+ 
+ 
+ 
 
 
 
 
5'-…UGUAGUAGA 
5'-…CGUAGUAGA 
5'-…GGUAGUAGA 
5'-…CAGUAGUAGA 
5'-…AAGUAGUAGA 
5'-…GGUAGUAGUAGA 
5'-…UGUAGUAGUAGA 
5'-…AAGUAGUAGUAGA 
5'-…GAGUAGUAGUAGA 
5'-…UUAGUAGUAGUAGA 
5'-..GGUAGUAGUAGUAGA 
...GAGUAGUAGUAGUAGA 
5'-…CGUAGUAGUAGA 
5'-…AUAGUAGUAGA 
5'-…CUAGUAGUAGA 
5'-…UUAGUAGUAGA 
5'-UAGUAGUAGA 
5'-…UGUAGUAGA 
5'-…CGUAGUAGA 
5'-…GGUAGUAGA 
5'-…CAGUAGUAGA 
5'-…AAGUAGUAGA 
5'-…GGUAGUAGUAGA 
5'-…UGUAGUAGUAGA 
5'-…AAGUAGUAGUAGA 
5'-…GAGUAGUAGUAGA 
5'-…UUAGUAGUAGUAGA 
5'-..GGUAGUAGUAGUAGA 
...GAGUAGUAGUAGUAGA 
5'-…CGUAGUAGUAGA 
5'-…AUAGUAGUAGA 
5'-…CUAGUAGUAGA 
5'-…UUAGUAGUAGA 
5'-UAGUAGUAGA 
HTNV 1/35 
6/35 
3/35 
1/35 
1/35 
3/35 
6/35 
1/35 
1/35 
1/35 
1/35 
2/35 
2/35 
1/35 
1/35 
1/35 
3/35 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
 
+ 
+ 
+ 
 
 
 
 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Indicated virus sequence is underlined, while residues base-pairing to the viral template and with possible origin 
from the RNA leader are in bold and italics; the non-viral 3'-terminal nucleotide at position -1 relative to the first 
viral residue is shaded. The table is based on data given for hantaviruses (Garcin et al., 1995), nairoviruses (Jin 
and Elliott, 1993b), orthobunyaviruses (Bishop et al., 1983; Dobie et al., 1997; Jin and Elliott, 1993a), 
phleboviruses (Simons and Pettersson, 1991). Abbreviations: IP, Internal Priming; PR, Prime-and-Realign. Virus 
abbreviation: BUNV, Bunyamwera virus; DUGV, Dugbe virus; HTNV, Hantaan virus; LACV, La Crosse virus; 
SSHV, Snowshoe hare virus; UUKV, Uukuniemi virus.   
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Dysfunctional capped RNA leaders with increasing base complementarity: 
possibilities for new antiviral drug design 
 
Viruses, despite their simplicity as pathogens, have evolved highly efficient 
mechanisms for replication and expression of their genomes to generate progeny virus. In 
the case of pathogenic avian influenza, its widespread geographical distribution and 
continuous evolution (genetic drift and shift) requires permanent attention in light of annual 
vaccine strain selection (WHO) and virus production investments. Also reason for serious 
concern is the observation that influenza viruses, via mutations, may obtain the capacity to 
cross species barriers, as observed for the H5N1 virus (poultry and human) (van Kerkhove 
et al., 2011). Although its spread among the human population is still limited, H5N1 may 
turn into a strain capable of efficient human-to-human transmission in near future. The 
constant danger for newly emerging variants (Mexican flu 2010) underscores the increasing 
need and interest for general antiviral compounds. 
Current options to limit the clinical impact of influenza virus infections include 
vaccination and the use of antiviral drugs. Since the current manufacturing capacity for 
vaccines is insufficient to cope with the demand during a pandemic, the availability of 
antiviral drugs may help to contain the emerging pandemic virus at its emergence. The 
efficacy of the two currently available classes of antiviral drugs, neuraminidase inhibitors 
(e.g. Tamiflu) and ion channel blockers, is limited and heavily dependent of a very early 
start of treatment. In addition, more and more cases are reported on development of 
resistance, e.g. against Tamiflu (Orozovic et al., 2011). 
The observation that a viral capped RNA leader sequence with two to three bases 
complementary to the 3'-ultimate residues of a (-) ssRNA virus template sequence is 
preferred over a leader sequence with less base complementarity offers possibilities for 
development of new antiviral compounds. In Chapter 3, a preferred capped RNA leader 
for Influenza A virus was proposed to have the consensus sequence 7mG-(N)7-8-(A/U/G)-
(A/U)-AGC-3' based on the in vitro analysis, while based on the additional in vivo data 
(Chapter 4) could be expanded to 7mG-(N)7-8-(A/U/G)-(A/U/G)-AGC-3'. Based on the 
additional available Influenza B virus data, a consensus sequence of this leader and 
applicable to all influenza viruses, could be represented by the general formula 7mG-(N)7-8-
(A/U/G)-(U/G)-AGC-3'. 
In vitro influenza transcription experiments have shown a stronger in vitro 
reduction of α-globin RNA leader initiated transcription by cap donors that fitted the 
aforementioned formula most close (triple base-pairing) compared to those with a less 
preferred sequence context (Chapter 3). This clearly suggests that such molecules may 
exhibit a strong competitive advantage over host cellular mRNA leader sequences during 
transcription initiation in a natural infection. 
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Chemical modification of capped leader sequences to prevent i) cleavage by the 
viral endonuclease (Figure 6-1A to B) or ii) elongation by the viral polymerase (Figure 6-
1B to C) could make these molecules dysfunctional and after application inhibit and treat a 
viral infection. Modifications to achieve this comprise i) a 3'-terminal phosphate group, ii) 
one or more phosphorothioate or phosphorodiamidate bonds, or iii) one or more 
morpholino rings. In the first case, the 3'-OH terminus of a capped RNA leader is modified 
into a 3'-phosphate, giving the following consensus 7mG-(N)7-8-(A/U/G)-(U/G)-AGCp-3' 
where p is a 3'-phosphate group. RNA polymerases need a 3'-OH terminus for elongation, 
thus the presence of a 3'-phosphate terminus instead of a 3'-OH will block elongation by the 
viral RNA polymerase. In contrast, a modification of the phosphodiester bonds within the 
capped leader sequence will introduce nuclease resistance and thereby prevent cleavage or 
further trimming of a leader sequence by the viral endonuclease (and other host nucleases) 
into a functional cap donor that can readily prime and become elongated. Modification of 
the phosphodiester bonds could involve replacement by phosphorothioate or 
phosphorodiamidate bonds, preferably at least the phosphodiester bonds between the A, G, 
or C at the 3' terminus. But it could also involve the entire cap donor molecule (Tado et al., 
2001). An additional advantage of the nuclease resistance of such molecules is their 
stability during application as antiviral drug. A last possible modification, i.e. a replacement 
of one or more ribose rings (or when a DNA consensus sequence is used of the 
dideoxyribose rings) within the capped RNA leader with one or more morpholino rings, 
will also provide resistance to endonucleases (Summerton and Weller, 1997; Summerton, 
1979). In morpholino modified molecules the phosphate groups are additionally replaced 
by phosphorodiamidate groups.  
Based on all our data it is not unlikely that capped RNA leaders when made 
dysfunctional may have a down regulating effect, due to their preferential usage, on the 
overall transcription level. They thereby decrease virus titres and detrimental effects of a 
viral infection providing the host’s immune system with more time to generate an adequate 
immune response. In this way a reduced illness can be achieved.  
According to our model and data from reported studies, a few examples of capped-
RNA leader sequences that, once made dysfunctional, should inhibit influenza transcription 
initiation are listed in Table 6-6. It is expected that inhibitors with more than one base 
complementarity to the vRNA (AG or AGC) will be more effective in the reduction of viral 
transcription compared to those with only a single (A) base-pairing residue. A capped RNA 
leader with more than three base-pairing residues and containing modified phosphate bonds 
may also function as inhibitor as this molecule would still bind the viral polymerase and 
align on the viral template. However, due to its modification it will not be endonuclease 
cleaved/trimmed to render a proper 3' end required for transcriptional elongation and from 
that moment onwards block transcription. In a similar way to influenza virus, dysfunctional 
capped RNA leaders could be designed and synthesized against many other segmented (-) 
ssRNA viruses, or even groups of viruses which share a homologous 3' viral RNA terminus 
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such as influenza viruses and GERV (Table 6-1). As an example, dysfunctional molecule 
(DM) 1 could be applied against Influenza A/B/C virus, while DM2 against influenza 
viruses and/or GERV bunyavirus (Table 6-7). Multifunctional inhibitors, such as DM2, not 
only could extend their applicability against different type of viruses but also reduce 
production costs.  
 
 
 TABLE 6-6.   
Dysfunctional capped leaders for influenza virus inhibition. 
Dysfunctional 
capped leader 
5' end sequence of capped leader 
DMp 1bp  
DMp 2bp  
DMp 3bp 
5'-GUAUUAAUGUAp 
5'-GUAUUAAUGUAGp 
5'-GUAUUAAUGUAGCp 
Residues potentially base-pairing (bp) to the viral template (3'-UCG…) are 
in bold and italics. Abbreviations: DM, dysfunctional molecule; p, 
phosphate group.  
 
 
 TABLE 6-7.   
Dysfunctional capped RNA leaders against different viruses. 
Dysfunctional 
capped leader 
5' end sequence of capped 
leader 
Virus 
DM1 
DM2 
5'-GUAUUAAUGUAGCp 
5'-GUAUUAAUGUAGp 
Influenza A/B/C virus 
Influenza A/B/C virus and/or GERV 
Residues potentially base-pairing to the indicated viral template are in bold and italics. Abbreviations: DM, 
dysfunctional molecules; GERV, Germiston virus; p, phosphate group THOV, Thogoto virus.  
 
 
Translation initiation of segmented (-) ssRNA viruses 
 
Eukaryotic mRNAs commonly contain a 5' cap structure and a 3' poly(A) tail 
required for translation initiation (Gallie, 1998, id. 2002; Millevoi and Vagner, 2010; 
Cowling, 2009; Dreyfus and Régnier, 2002; Gu and Lima, 2005), in which both elements 
act synergistically to stimulate protein synthesis (Gallie, 1991; Michel et al., 2001). 
Translation initiation is a stepwise process by which the 40S ribosomal subunit is recruited 
to the mRNA and then starts scanning in a 5' to 3' direction until the first initiation codon is 
encountered in a favorable sequence context. At that moment, the 80S ribosome is 
assembled (Jackson et al., 2010; Sonenberg and Hinnebusch, 2009). Critical to the 
11 
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translation process is the eIF4F cap-binding complex which mediates the initiation of 
cellular mRNA translation. This complex is composed of eIF4E (eukaryotic translation 
initiation factor) which binds to the mRNA cap, eIF4A which is a helicase necessary for 
initiation, and eIF4G which indirectly links the mRNA cap with the 43S pre-initiation 
complex (Jackson et al., 2010; Sonenberg and Hinnebusch, 2009). eIF4G also binds 
poly(A) tail-bound PABP [poly(A)-binding protein], leading to mRNA circularization by 
bringing its 5' and 3' termini into close contact [cap-eIF4E/eIF4G/PABP-poly(A)] (Figure 
6-2) (Kahvejian et al., 2001; Mangus et al., 2003). It is in this context that the poly(A) tail 
interacts with the 5' cap and stimulates translation initiation (Gallie, 1991; Michel et al., 
2001).  
In contrast to eukaryotic mRNAs, viral mRNAs of segmented (-) RNA viruses 
contain a 5' cap structure but lack a common poly(A) tail at their 3' end. To compensate the 
lack of this tail, these viruses have evolved alternative mechanisms to support translational 
enhancement of their mRNAs. In general, specific sequences within their 3' UTR act as a 
functional analog of a poly(A) tail. 
For influenza virus, all eight (-) strand RNA segments contain a stretch of 5-7 U 
residues about 17-22 nt from the 5' end. This U stretch sequence has been mapped as the 
viral polyadenylation signal (Robertson et al., 1981). It is iteratively copied by the viral 
polymerase during transcription to generate a poly(A) tail at the end of the mRNA. This 
process of polyadenylation, also described as stuttering of the polymerase, is favored by the 
binding of the viral trimeric RNA polymerase complex to the 5' end of the vRNA template. 
Viral mRNA translation in influenza virus was found to be enhanced by binding of the viral 
NS1 protein to both PABP and eIF4G (Marión et al., 1997; Salvatore et al., 2002; Qiu and 
Krug, 1994; Aragón et al., 2000; Burgui et al., 2003). Something similar has been 
postulated for the mRNA from the M segment of Sin Nombre hantavirus (Hutchinson et 
al., 1996). 
In contrast to influenza virus, less is known on the mechanism of translation for 
bunyaviruses, which generally lack a common poly(A) tail at the 3' end of their mRNAs. 
Recently, the Bunyamwera bunyavirus (BUNV) and Andes hantavirus (ANDV) were 
shown to translate their own transcripts in a PABP-independent manner (Blakqori et al., 
2009; Vera-Otarola et al., 2010), which is not surprising due to the lack of a common 
poly(A)-tail. Instead, a translation-enhancing element was reported for the 3' UTR of the 
BUNV S RNA segment encoded transcripts (Blakqori et al., 2009). Similarly, observations 
have been reported for the 3' UTR of the ANDV S mRNA where translation was 
additionally found to be independent of viral proteins (Vera-Otarola et al., 2010). For the 
plant-infecting bunyavirus TSWV, transcripts from the ambisense S and M RNAs segments 
have been shown to contain a potential 3' hairpin structure which is proposed to act as a 
translation-enhancing element, functionally equivalent to a poly(A) tail (Chapter 5; van 
Knippenberg et al., 2005b). In contrast, the TSWV L RNA segment is of entire (-) polarity 
and does not contain sequences with similarity to the intergenic region of the S and M RNA   
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 Figure 6-2. The closed loop scheme for translation initiation of plant positive strand RNA 
viruses. Panel A shows in simplified terms the circularized format in which efficiently translated 
cellular mRNAs are believed to exist. The key responsible cis-acting features are the 5' m7GpppN cap 
(purple dot) and 3'-poly(A) tail, which synergistically enhance expression. Bridging interactions 
through eIF4E or eIF-iso4E (the cap-binding proteins), eIF4G or eIF-iso4G, and the poly(A) binding 
protein (PABP) bring the 5'- and 3'-termini into close proximity, and the interactions are mutually 
stabilizing. The first stage of translation initiation, the recruitment of the 40S small ribosome subunit 
to the 5'-end, depends on simultaneous interaction of eIF3 (a complex of multiple proteins) with 
eIF4G or eIF-iso4G and the 40S subunit. This step is depicted in step (1) and is followed by ribosome 
scanning (arrow) along the 5'-UTR (black line) in search of the AUG initiation codon. In response to   
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segments, that provides these hairpin structures. A closer look, though, reveals a sequence 
downstream the stop codon that is also predicted to fold into a secondary folding structure 
(Figures 6-3; van Knippenberg et al., 2005b). This suggests that translation of all TSWV 
viral mRNAs might involve a similar mechanism, i.e. in which a 3'-terminal RNA folding 
structure is involved in the translational enhancement and recruitment of viral/host factors 
to assist in translation, although this remains to be elucidated in particular for the L mRNA. 
The presence of a hairpin structure sequence is not restricted to the tospovirus 
ambisense M and S RNA segments, but also appears within the ambisense S RNA 
segments from the related phleboviruses (Schmaljohn and Hooper, 2001), within plant 
viruses from the floating genus Tenuivirus (Ramirez and Haenni, 1994), and within 
members of the Arenaviridae (Buchmeier et al., 2001). In some of these, the predicted 
hairpin structure also involves stretches of A- and U-rich sequences [e.g. Punta toro virus 
(Emery and Bishop, 1987)], in a few others involves GC-rich sequences [e.g. Tacaribe 
virus (Iapalucci et al., 1991; Lopez and Franze-Fernandez, 2007)], while also examples 
exist in which the IR does not fold into a stable hairpin structure [e.g. Rift Valley fever virus 
 
base-pairing with the initiator tRNA (not shown) located in the ribosomal P site, the 60S large 
ribosome subunit joins (step 2) to initiate the elongation phase of translation. During peptide 
elongation (step 3), the codons in the ORF (thick red line) are read by tRNAs entering the ribosomal 
A site, until a termination codon, such as UAA, is reached (step 4), triggering termination of protein 
synthesis and subunit dissociation and release (step 5). Because of the closed loop format, ribosomes 
are near the 5'-end upon termination, facilitating new initiation. The boxed diagrams (B-G) illustrate 
variations of the initial 40S subunit recruitment step for viral mRNAs that lack a cap, poly(A) tail, or 
both. Red question marks indicate unknown or uncertain details. AlMV, TYMV, and TMV are 
examples of viruses whose RNAs have a cap but no poly(A) tail. For AlMV, a coat protein (CP) 
dimer binds to the 3'-terminal region and to eIF4G/iso4G. For TYMV RNA, aminoacylation 
(indicated by Val in the diagram) of the 3'-terminal tRNA-like structure (TLS) is needed for full 3'-
translational enhancement, and it has been postulated that eEF1A binding is involved in closed loop 
formation. TMV RNA also has a 3' TLS capable of aminoacylation (His) and eEF1A binding, but 3'-
translational enhancement relies on an upstream pseudoknot (UPSK). Intriguingly, this feature can 
also bind eEF1A, which may be involved in closed loop formation, apparently in a way that 
predominates over a TYMV-like interaction involving the TLS. TEV RNA has a poly(A) tail, but no 
5'-cap. The 5'-end is covalently linked to VPg, which is not needed for translation but does interact 
with eIF4E and eIFiso4E; it is not known whether this interaction influences translation. 40S 
ribosome subunits are recruited to the 5'-UTR through an IRES element whose function requires 
eIF4G and that may involve direct base-pairing to 18S ribosomal RNA. BYDV and STNV RNAs lack 
both canonical terminal elements and possess translational enhancer elements (BTE, TED) in an 
internal position (not at the 3'-terminus) of the 3'-UTR. These elements recruit translation initiation 
factors that are normally recruited to the 5'-end by the cap. In BYDV RNA, ribosome delivery to the 
5'-end is accomplished through direct RNA base-pairing between elements in the 5'- and 3'-UTRs, 
while in STNV RNA, base-pairing between the 5'-UTR and rRNA may be involved.  
Taken from Dreher and Miller (2006).  
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(Giorgi et al., 1991)]. It is postulated that transcription termination of ambisense mRNAs is 
dictated by the formation of a hairpin structure in nascent transcripts (Emery and Bishop, 
1987; Iapalucci et al., 1991), in the same manner as transcription termination occurs in 
prokaryotes and in some eukaryotes. The presence of hairpin structure encoding sequences 
in many ambisense RNA segments of bunyaviruses would support this idea. In the case 
where a hairpin structure is not present or RNA segments are involved of entire negative 
polarity, transcription termination is suggested to involve G- or C-rich regions present near 
or at the transcription termination sites (Collett, 1986; Giorgi et al., 1991; Gro et al., 1997; 
Schmaljohn and Hooper, 2001). Some of these cases involve inverted complementary 
repeat sequences that could fold into a small stem-loop structure (Bouloy et al., 1990). In a 
more recent publication by Ikegami et al. (2007), a 13 nt-long inverted complementary 
sequence, with the ability to fold into a RNA secondary structure, was shown to be required 
for RVFV L RNA transcription termination. Although transcription termination of the 
RVFV M and (ambisense) S RNA segment are suggested to occur differently (Albarino et 
al., 2007), the 3' UTR sequence involved in L RNA transcription termination was able to 
terminate transcription of the (ambisense) S RNA encoded genes and thus supports the idea 
of a common transcription termination strategy. For orthobunyaviruses, ongoing 
transcription has been shown to require translation (Barr, 2007; Bellocq et al., 1987; Vialat 
and Bouloy, 1992), and it is explained to prevent nascent mRNAs from (premature) 
transcription termination. This tight coupling not only indicates a resemblance with 
prokaryotic systems, as proposed by Barr (2007), but additionally indicates that for 
orthobunyaviruses mRNA circularization is not mandatory for translation initiation. 
While the information on transcription termination of bunyaviruses is still limited, 
and different strategies have been proposed to account for transcription termination of 
bunyavirus genomic RNA elements, it is possible that RNA folding structures play a major 
role in all these RNA segments, whether of ambisense or of negative polarity. Even though 
the information on translation (initiation) of bunyavirus transcripts is also limited, with the 
appearance of more publications on this topic it becomes tempting to hypothesize that 
segmented, (-) ssRNA viruses share a common transcription termination/translation 
initiation mechanism that applies to all their genomic RNA segments, irrespective of their 
host. In such model, transcription termination occurs due to stalling of the RNA polymerase 
on a 3' RNA folding structure in nascent transcripts; this folding structure would next act as 
a poly(A) tail analog to enable mRNA circularization and translational enhancement. The 
latter might involve viral proteins to functionally act as PABP-analog. Functional 
replacement of the poly(A) tail by a highly structured 3' UTR has been also demonstrated 
for the 3' UTR of flaviviruses, such as Dengue virus, rotavirus and many plant-infecting 
positive-strand RNA viruses (Dreher and Miller, 2006; Edgil et al., 2003; Ito et al., 1998; 
Vende et al., 2000). Rotavirus NSP3A and Alfalfa mosaic virus (AlMV) coat protein 
associate with both the 3' end of their respective genomes and with eIF4G (Figure 6-2; 
Piron et al., 1998; Bol, 2005), thereby enabling genome circularization.  
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 Figure 6-3. RNA folding predictions of TSWV L RNA segment. Mfold predictions of the 3' 
end of the L ORF. Abbreviation: vRNA, viral sense RNA; vcRNA, viral complementary RNA. 
 
Outlook 
 
During the research presented in this thesis, the requirements for alignment of 
capped RNA leader sequences along the viral genome during influenza cap-snatching have 
been disclosed (Chapter 2, 3 and 4). The approaches used have shown to be successful for 
the identification of the RNA leader origin and to subsequently support the design of 
capped RNA leaders that would become preferentially used during the priming of viral 
mRNA synthesis. In the light of the observation that Influenza A virus prefers leaders with 
increasing base complementarity to its vRNA template (Chapter 2, 3 and 4), similar to the 
plant-infecting bunyavirus (TSWV), supports the idea of a conserved mechanism applicable 
to all segmented (-) ssRNA viruses. To prove this hypothesis, experiments as described in 
this thesis, will need to be performed using viruses other than influenza and TSWV. For the 
near future, it will become most interesting to test the efficacy of proposed dysfunctional 
capped RNA leaders as an antiviral drug against these viruses.  
Our translation studies have indicates an important role for the 3' UTR of TSWV 
mRNAs in translation (Chapter 5), in which a 3' hairpin structure is postulated as a 
functional analog of a poly(A) tail. Due to many commonalities with the animal-infecting 
bunyaviruses, the question rises whether a similar strategy applies to their viral transcripts 
as well, and possibly to all segmented (-) ssRNA viral transcripts. In this respect, it will be 
interesting to see whether 3' UTR sequences from distinct (animal-infecting) bunyavirus 
RNA segments or even arenavirus RNA segments, and predicted to fold into a secondary 
structure or not, are able to functionally replace the existing TSWV hairpin structure 
sequence. One of the first candidate UTR sequences to analyze in such functional 
replacement test is the 3' UTR from the TSWV L RNA segment. Once these analyses 
demonstrate the requirement of RNA folding structures in transcription termination and 
translation initiation it will be interesting to find out whether or not a viral protein 
(complex) is involved in translation enhancement. The comparative analysis of plant- and 
animal-infecting bunyaviruses may even be a very useful and interesting tool to investigate 
the functional similarities between mechanisms within eukaryotic organisms belonging to 
different kingdoms.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Once you have eaten the donkey, you should not leave the tail.” 
 
Greek proverb 
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Abbreviation list 
 
 
(-)  negative 
(+)  positive 
A  Adenine 
AlMV  Alfalfa mosaic virus 
AlMV3  Alfalfa mosaic virus RNA3 
BHK-21  Baby Hamster Kidney (cells) 
bp  base-pairing (residue) 
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BUNV  Bunyamwera virus 
c  complementary (strand) 
C  Cytosine 
CCHFV  Crimean Congo hemorhagic fever virus 
CTP  Cytidine triphosphate 
DM  dysfunctional molecule 
dsRNA  double-stranded RNA 
DUGV  Dugbe virus 
e.g.  exempli gratia [Latin phrase with meaning “for example”] 
ead.  eadem [Latin word with meaning “the same (woman)”] 
ER  endoplasmic reticulum 
et al.  et alii [Latin phrase with meaning “and others”] 
G  Guanine 
Gc  glycoprotein (carboxy-terminal position within the precursor) 
Gn  glycoprotein (amino-terminal position within the precursor) 
Hep δ  Hepatitis delta virus (ribozyme) 
HFV  Hemorrhagic fever virus 
HTNV  Hantaan virus 
i.e.  id est [Latin phrase with meaning “that is”] 
id.  idem [Latin word with meaning “the same (man)”] 
IR  intergenic region  
IRES  internal ribosome entry site 
L  large (RNA segment) 
LACV  La Crosse virus 
LCMV  Lymphocytic choriomeningitis virus 
LFV  Lassa fever virus 
M  medium (RNA segment) 
MBP   Maltose binding protein 
MDCK  Madin-Darby canine kidney (cells) 
mRNA  messenger RNA 
m.o.i.  multiplicity of infection 
N  nucleoprotein 
nt  nucleotide 
NP  nucleocapsid protein  
NS1  non-structural protein 1 
NSm  cell-to-cell movement protein  
NSs  non-structural protein 
NTP  nucleoside triphosphate 
ORF  open reading frame 
p  phosphate 
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PA  polymerase acidic protein 
PABP  poly(A) tail binding protein 
PB1  polymerase basic protein 1 
PB2  polymerase basic protein 2 
PBS  phosphate buffered saline 
PCR   polymerase chain reaction 
Pol I  polymerase I 
Pol II  polymerase II 
RdRp  RNA-dependent RNA polymerase 
RNP  ribonucleoprotein or ribonucleocapsid 
Rv  reverse 
Fr  forward  
rNTP  ribonucleoside triphosphate 
REN  Renilla 
FF  Firefly 
RRL   Rabbit reticulocyte lysate 
RSV  Rice stripe virus 
RT-PCR  reverse transcriptase PCR 
RVFV  Rift Valley fever virus 
S  small (RNA segment) 
SFSV  Sandfly fever Sicilian virus 
ssRNA  single-stranded RNA 
siRNA  small interfering RNA 
miRNA  micro RNA 
T  Thymine 
THOV  Thogoto virus 
TOSV  Toscana virus 
TS-oligo  template-switch oligonucleotide 
TSWV  Tomato spotted wilt virus 
TV  Tacaribe virus 
TYRV  Tomato yellow ring virus 
U  Uracil 
UTR  untranslated region 
UUKV  Uukuniemi virus 
vc  viral-complementary (strand) 
vRNA  viral RNA 
vv-T7  T7-recombinant (or modified) Vaccinia virus 
WT  wild type 
vs.  versus 
resp  respectively  
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Summary 
 
 
The research described in this thesis focuses at the mechanisms of transcription 
(initiation/termination) and translation of segmented (-) ssRNA viruses. Although 
segmented (-) ssRNA viruses have already been studied in detail for many years, several 
research issues still have remained unsolved. One major question that still puzzles is how 
transcription initiation (cap-snatching) in detail takes place. In this thesis, the requirements 
for alignment of capped RNA leader sequences along the viral genome during influenza 
transcription initiation have been analyzed and to this end two systems (in vitro and in cell) 
were being developed. Using these systems, various Alfalfa mosaic virus RNA 3-derived 
mutant leaders, differing in i) base complementarity to the viral RNA template, ii) residues 
5' of potential base-pairing residues and iii) leader length, have been tested as cap donor 
either singly or in (pair-wise/multiple) competition during influenza virus transcription 
initiation. 
Sequence analysis of de novo synthesized transcripts within both systems, revealed 
that influenza transcriptase prefers leaders with increasing base complementarity to the 3'-
ultimate residues of the viral template, 10 or 11 nt from the 5' cap. For the first time, the 
occurrence of prime-and-realign during transcription initiation of influenza virus was 
observed. Additionally, internal priming at the 3'-penultimate residue was observed. 
Application of capped RNA leaders with enhanced complementarity to the viral RNA 
template showed stronger reduction of globin leader RNA initiated influenza transcription 
in vitro compared to those with a single base complementarity, demonstrating the 
competitiveness of such molecules during transcription initiation.  
The finding that influenza virus displays a preference for multiple base-pairing cap 
donors during transcription initiation is similar to recent observations made on this account 
for the plant-infecting bunyavirus Tomato spotted wilt virus (TSWV), and suggests a highly 
conserved mechanism of transcription initiation that most likely applies to all segmented, (-
) ssRNA viruses. The insight obtained offers possibilities for development of new antiviral 
drugs based on capped RNA leader sequences made dysfunctional for transcription 
initiation/elongation. 
In contrast to transcription initiation, less is known on the signals that trigger 
transcription termination and support translation initiation. While common eukaryotic 
messenger RNAs contain a 5' cap structure and a 3' poly(A)-tail, transcription of the TSWV 
M and S RNA ambisense-encoded genes terminates in an intergenic region (IR) that 
contains stretches of highly A- and U-rich sequences. The latter are predicted to fold into a 
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stable hairpin structure. To guarantee enhanced translation of these viral mRNAs, it is 
postulated that the predicted hairpin structure from this IR sequence acts as an equivalent to 
a poly(A) tail. To test this hypothesis, various N gene-based constructs were made in which 
the N gene was swapped for Renilla luciferase the 5' and/or 3' UTRs mutated/deleted or 
swapped for bunyaviral analogs, and tested in BHK-21 cells for translation efficiency in a 
Vaccinia-T7 expression system.  
Whereas the Renilla luciferase gene, flanked with the 5' and 3' untranslated region 
(UTR) of the N gene and including the sequence for the hairpin structure, showed good 
expression levels, no luciferase expression was observed when the hairpin structure 
sequence was deleted from this Renilla sensor construct. Exchanging the TSWV hairpin 
structure sequence by the one from Tomato yellow ring virus (TYRV), another distinct 
tospovirus, did not affect luciferase expression levels. While the 3' UTR of the N gene was 
sufficient, and did not require the additional presence of the 5' UTR sequence for 
translation, the 3' UTR from the NSs gene only supported good translation in the additional 
presence of the homologous 5' UTR and indicating a possible interaction. Finally, the 
presence of the viral N and NSs proteins enhanced translation of luciferase constructs 
containing the hairpin structure sequence, suggesting a concerted action for translational 
enhancement.  
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Nederlanse Samenvatting 
 
 
Het onderzoek beschreven in dit proefschrift richt zich op transcriptie- 
(initiatie/terminatie) en translatie-mechanismen van gesegmenteerde, negatief (-) strengs 
RNA virussen en dan in het bijzonder van het Tomatenbronsvlekken virus [Engels “Tomato 
spotted wilt virus” (TSWV)] en het griepvirus [Engels “Influenza A virus”]. Alhoewel deze 
virussen al voor lange tijd in detail bestudeerd worden, zijn tal van vragen nog steeds 
onbeantwoord gebleven. Dit gaat onder andere op voor transcriptie-initiatie (ook wel “cap-
snatching” genoemd) van het virale RNA genoom. In dit proefschrift zijn de vereisten voor 
ge’cap’te RNA leadersequenties, om transcriptie op het influenza A RNA genoom te 
kunnen initiëren, onderzocht en daartoe werden twee systemen (in vitro en in vivo) 
ontwikkeld. Gebruik makend van beide systemen zijn vervolgens verschillende Luzerne 
mozaïek virus [Engels “Alfalfa mosaic virus” (AlMV)] RNA-3 mutanten die verschilden in 
i) basecomplementariteit tot het virale RNA genoom, ii) nucleotideresiduen 5' van de 
potentiële base-parende residuen, en iii) RNA leader lengte, getest als capdonor in een 
individuele of simultane, competitie-achtige setting tijdens influenzagenoom transcriptie-
initiatie.  
Nucleotidensequentie-analyse van nieuw gemaakte boodschapper RNA 
transcripten in beide systemen liet een voorkeur zien van Influenza A virus voor RNA 
leaders met toegenomen basecomplementariteit tot het 3'-uiteinde van het RNA genoom, op 
een positie rond 10-11 nucleotiden vanaf de 5' cap structuur. Voor het eerst werd een 
zogenaamd “prime-and-realign” tijdens influenza transcriptie initiatie waargenomen. 
Tevens werd interne initiatie op nucleotidepositie +2 van het virale RNA genoom 
aangetoond. Toediening van ge’cap’te RNA moleculen met toegenomen 
basecomplementariteit tijdens in vitro influenza virus transcriptie initiatie leidde tot een 
grotere reductie in globine RNA geïnitiëerde genoomtranscriptie dan wanneer ge’cap’te 
RNA moleculen met lagere basecomplementariteit werden toegediend. Hiermee werd het 
belang van base-parende en het competitie karakter van dergelijke moleculen gedurende 
influenza virus transcriptie initiatie onderstreept. 
De constatering dat Influenza A virus, net als het TSWV, een voorkeur heeft voor 
cap donoren met verhoogde basecomplementariteit gedurende transcriptie initiatie 
suggereert een zeer geconserveerd mechanisme van transcriptie initiatie, dat 
hoogstwaarschijnlijk van toepassing is op alle gesegmenteerde (-) ssRNA virussen. Het 
inzicht dat is verkregen biedt mogelijkheden voor de ontwikkeling van nieuwe antivirale 
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middelen gebaseerd op ge’cap’te RNA leadersequenties, welke disfunctioneel gemaakt zijn 
voor transcriptie initiatie/elongatie. 
In tegenstelling tot het proces van transcriptie initiatie bij gesegmenteerde (-) 
ssRNA virussen is veel minder bekend over de nucleotiden sequenties die uiteindelijk 
leiden tot transcriptie terminatie en die daarnaast vereist zijn voor, en eventueel stimulerend 
zijn tot translatie (initiatie). In tegenstelling tot eukaryote boodschapper RNA’s, bezitten de 
dier- en plant-infecterende bunyavirussen, waaronder TSWV, aan het 3' uiteinde geen 
poly(A) staart. Voor TSWV vindt transcriptie terminatie van de M en S RNA ambisense 
gecodeerde genen plaats in de zogenaamde intergene sequentie regio (IR). Deze laatste is 
rijk in A- en U- nucleotide residuen en in staat tot vouwing in een zogenaamde haarspeld of 
“hairpin” structuur. Deze structuur wordt verondersteld een belangrijke rol te spelen in het 
bevorderen van een goede translatie van de TSWV M en S RNA transcripten, op een 
manier die functioneel analoog wordt geacht aan een poly(A)-staart. Om dit te toetsen, zijn 
verschillende constructen gemaakt van het N gentranscript waarin het open leesraam voor 
het N eiwit was vervangen door dat van het gevoelige marker enzym Renilla luciferase, en 
de flankerende 5' en 3' “untranslated regions” (UTR) of zijn verwijderd, òf 
gemutageniseerd òf vervangen voor de analoge UTR’s van andere (plant- en dier-
infecterende) bunyavirussen. De gemaakte constructen zijn vervolgens op 
translatieefficiëntie getoetst via het Vaccinia virus-T7 expressie systeem.  
Terwijl het Renilla luciferase gen geflankeerd met de 5' en 3' UTR sequenties van 
het N gen, inclusief de “hairpin” coderende sequentie, goed tot expressie kwam werd er 
geen Renilla luciferase activiteit gemeten indien de “hairpin” coderende sequentie 
verwijderd was. Daarentegen bleek een uitwisseling van de “hairpin” coderende sequentie 
voor die van het Tomato yellow ring virus (TYRV), een ander afwijkend tospovirus, geen 
invloed te hebben op het luciferase expressieniveau. Uit de analyse van mutanten bleek 
tevens dat de 3' UTR sequentie voor expressie van het N gen voldoende was en geen 
aanwezigheid van de 5' UTR sequentie vereiste, terwijl voor expressie van het NSs gen 
zowel de 5' en 3' UTR vereist waren. Dit laatste wijst op een mogelijke interactie tussen 
beide UTR sequenties. Translatie studies in aanwezigheid van de virale N en NSs eiwitten 
bleek te leiden tot verhoogde expressie niveau’s, hetgeen wijst op een gezamelijke 
(inter)actie van deze eiwitten met de “hairpin” stuctuur tijdens translatie.  
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